Screening and characterization of novel genes involved in the embryogenesis of Xenoplus laevis by Cao, Ying
Screening and characterization of novel genes
involved in the embryogenesis of Xenopus laevis
Inaugural-Dissertation
zur
Erlangung des Doktorgrades
Dr.rer.nat.
des Fachbereiches
Bio- und Geowissenschaften,
Landschaftsarchitektur
an der
Universität Essen
vorgelegt von
Ying Cao
aus Jiangsu, China
April 2002
Dedicated to the memory of my mother
Die der vorliegenden Arbeit zugrundeliegenden Experimente wurden in der
Abteilung für Zoophysiologie der Universität Essen durchgeführt.
1. Gutachter:  Prof. Dr. H. Grunz,
   FB9 (Biology), Universität Essen
2. Gutachter:  Prof. Dr. G. Ryffel,
   Uniklinikum Essen
3. Gutachter:
Vorsitzender des Prüfungsausschusses: Prof. Dr. H. Esche,
   Uniklinikum Essen
Tag der mündlichen Prüfung: 02/07/2002
ICONTENTS
CONTENTS       I
ABBREVIATIONS    IV
1. INTRODUCTION       1
1.1 A molecular sketch of Xenopus early embryonic development       1
1.1.1 β-catenin and the establishment of early dorsal axis       1
1.1.2 The three germ layers       3
1.1.3 Spemann-Mangold organizer       5
1.2 The objective of this research       7
1.3 Calpains, XCL-2 and convergent extension movements       9
1.4 ETO/MTG8/CDR, XETOR and primary neurogenesis     10
2. MATERIALS AND METHODS     16
2.1 Preparation of embryos     16
2.2 Screening of cDNA library using whole mount in situ hybridization     17
2.2.1 PCR amplification of cDNA inserts     17
2.2.2 Transcription of antisense RNA probes for library screening     18
2.2.3 Whole mount in situ hybridization     19
2.3 Plasmid preparation     24
2.3.1 Using TELT     24
2.3.2 Using QIAGEN Plasmid Midi Kit     25
2.4 Agarose gel electrophoresis     25
2.5 Preparation of antisense probes for functional analyses     25
2.6 Histological sections     26
2.7 RT-PCR     26
2.7.1 Total RNA preparation     26
2.7.2 Reverse transcription     27
2.7.3 PCR     28
2.7.4 Primers used for RT-PCR     28
2.8 Generation of complete coding sequences
of XCL-2 and XETOR with RACE     29
2.8.1 Preparation of poly(A)+ RNA     29
2.8.2 Isolation of 5’ end coding sequence of XCL-2     29
II
2.8.3 Isolation of 5’ end coding sequence of XETOR     31
2.8.4 Primers used for 5’RACE     31
2.9 Constructs     32
2.9.1 XODC2 constructs     32
2.9.2 XCL-2 constructs     33
2.9.3 XETOR constructs     33
2.10 DNA Ligation     34
2.11 Large-scale preparation of competent E. coli and transformation     35
2.11.1 Preparation of competent E. coli     35
2.11.2 E. coli Transformation     35
2.12 Microinjection     35
2.13 β-galactosidase staining     36
3. RESULTS     38
3.1 Identification of XODC2, XCL-2 and XETOR     38
3.1.1 cDNA and amino acid sequences of XODC2     40
3.1.2 cDNA and amino acid sequences of XCL-2     41
3.1.3 cDNA and amino acid sequences of XETOR     44
3.2 Spatial and temporal expression of XODC2, XCL-2 and XETOR     47
3.2.1 Expression pattern of XODC2     47
3.2.2 Expression pattern of XCL-2     49
3.2.3 Expression pattern of XETOR     51
3.3 Functional analyses on XODC2, XCL-2 and XETOR     53
3.3.1 Functional analysis on XODC2     53
3.3.2 Functional analysis on XCL-2     54
3.3.2.1 Overexpression of XCL-2 causes severe developmental
defects in Xenopus embryos         54
3.3.2.2 Ectopic expression of XCL-2 affects the location of mesodermal
or neural markers and disrupts convergent extension         55
3.3.2.3 Overexpression of a dominant-negative type mutant of XCL-2     57
3.3.2.4 Rescue of the C105S phenotype by wild-type XCL-2     58
3.3.3 Functional analysis on XETOR     59
3.3.3.1 XETOR overexpression inhibits formation of primary neurons
but does not disrupt the neural plates         59
III
3.3.3.2 Truncated mutants of XETOR behave similarly to the wild
type protein         60
3.3.3.3 XETOR is required for primary neurogenesis     61
3.3.3.4 XETOR and lateral inhibition are negatively crossregulated     63
3.3.3.5 Crossregulation between the expression of XETOR
and proneural genes         65
3.3.3.6 XETOR overexpression inhibits the function of
proneural genes except Xngnr-1         66
4. DISCUSSION     69
4.1 XCL-2 and its role during embryogenesis     69
4.1.1 XCL-2 is a novel m-type Calpain and disrupts morphogenetic
movements during embryogenesis in Xenopus laevis         69
4.2 XETOR and its role during primary neurogenesis     72
4.2.1 XETOR is an inhibitory factor for primary neurogenesis in
independence of lateral inhibition         72
4.2.2 The molecular mechanism for transcriptional
repression actvity of XETOR     74
4.2.3 XETOR and lateral inhibition comprise a dual inhibitory mechanism
to refine the number and localization of primary neurons     76
5. SUMMARY     80
6. ZUSAMMENFASSUNG     82
7. SYNOPSIS     84
7.1 Eine kurze Darstellung der frühen Embryogenese
und das Ziel dieser Untersuchungen     84
7.2 Identifizierung von XODC2, XCL-2 und XETOR     86
7.3 Zeitliche und räumliche Expression von XODC2, XCL-2 und XETOR     88
7.4 XCL-2 unterbricht die morphogenetischen Bewegungen
während der Embryogenese in Xenopus laevis     89
7.5 XETOR ist ein Schlüssel Inhibitionsfaktor während
der primären Neurogenese     90
8. REFERENCES     94
CURRICULUM VITAE (Lebenslauf)   107
ACKNOWLEDGEMENTS   109
Abbreviations IV
ABBREVIATIONS
The amino acids
A;(Ala) Alanine
C;(Cys) Cysteine
D;(Asp) Aspartic acid
E;(Glu) Glutemate
F;(Phe) Phenylalanine
G;(Gly) Glycine
H;(His) Histidine
I;(Ile) Isoleucine
K;(Lys) Lysine
L;(Leu) Leucine
M;(Met) Methionine
N;(Asn) Asparagine
P;(Pro) Proline
Q;(Gln) Glutamine
R;(Arg) Arginine
S;(Ser) Serine
T;(Thr) Threonine
V;(Val) Valine
W;(Trp) Tryptophan
Y;(Try) Tyrosine
Other abbreviations
A adenosine
APS ammonium peroxydisulphate
ATP adenosine 5’-triphosphate
BCIP 5-bromo-4-chloro-3-indolyl phosphate
bp base pair
BSA bovine serum albumin
C cytidine
°C degree Celsius
Abbreviations V
cat.no. catalogue number
cDNA complementary DNA
CHAPS 3-[(-cholamidopropyl)dimethylammonio]-1-propansulphate
CTP cytidine 5’-triphosphate
Da Dalton
dATP deoxyadenosine 5’-triphosphate
dCTP deoxycytidine 5’-triphosphate
DEPC diethyl pyrocarbonate
dGTP deoxyguanosine 5’-triphosphate
DMSO dimethyl sulfoxide
DNA deoxyribonucleic acid
DNase deoxyribonuclease
dNTP deoxynucleotide 5’-triphosphate
ds double strand
DTT dithiothreitol
dTTP deoxythymidine 5’-triphosphate
EDTA ethylene-diamine tetra-acetate
EGTA ethylene-glycol-bis(2-aminoethylether)-N,N’-tetra-acetate
EtBr ethidium bromide
FA formaldehyde
g gram
G guanosine
GTP guanosine 5’-triphosphate
h, hr, hrs hour, hours
HEPES N-(2-hyhroxyethyl)piperazine-N’-2-ethane sulfonic acid
IU international unit
k kilo
l liter
LB Luria-Bertani culture medium
m milli
M molar
mg milligram
min minute
Abbreviations VI
mm millimeter
ml milliliter
MOPS 3-(N-morpholino)propanesulfonic acid
mRNA messenger ribonucleic acid
µg microgram
µl microliter
NBT nitro-blue-tetrazolium
ng nanogram
nl nanoliter
OD optical density
PBS phosphate buffered saline solution
PCR polymerase chain reaction
pg picogram
poly(A)+ polyadenylated
PVP polyvinylpyrrolidone
RACE rapid amplification of cDNA ends
RE restriction endonuclease
RNA ribonucleic acid
RNAse ribonuclease
rpm round per minute
rRNA ribosomal ribonucleic acid
RT room temperature, reverse transcription
RT-PCR reverse transcription-polymerase chain reaction
sec second
ss single stranded
SDS sodium dodecylsulphate
T thymine
Tet tetracycline
Tris trishydroxymethylaminomethane
U unit of enzymatic activity
UV ultraviolet light
X-gal 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside
1. Introduction 1
1. INTRODUCTION
The study on developmental biology is largely dependent on a feasible
model system. For the study on embryonic development of vertebrates, the
African clawed frog (Xenopus laevis) is favored because of a few reasons. Large
number of eggs (around 1,500 per female) can be obtained and in vitro
fertilization can be easily conducted without seasonal limitation. The large size
(1-2 mm in diameter) of embryos facilitates delicate embryological
manipulations, such as preparation of explants. Another attractive trait is rapid
embryonic development (Fig.1.1). However, as a working model its advantage is
also compromised because about 2-3 years is generally required for the frogs to
reach sexual maturity, which is too long for genetic study. The allotetraploidy of
Xenopus laevis makes another disadvantage, as gene knockout is difficult to
perform in tetraploid organisms. For these reasons, Xenopus tropicalis has been
selected recently as an alternative for genetic manipulations.
1.1 A molecular sketch of Xenopus early embryonic development
1.1.1 β-catenin and the establishment of early dorsal axis
Embryonic development involves astonishingly complex biochemical
procedures. Great progress has been achieved towards disentangling these
procedures. The unfertilized egg of Xenopus laevis is polarized along its animal-
vegetal axis, though radially symmetrical. Such a radial symmetry along animal-
vegetal axis, however, is broken upon fertilization because cortical cytoplasm is
driven by microtubules to rotate an average of 30 degree during the first cell
cycle (Vincent and Gerhart, 1987). As a consequence, the dorsal side of the
embryo forms in the animal region approximately opposite to the random point
of sperm entry (Fig.1.1). And the so-called Nieuwkoop signaling center is also
1. Introduction 2
formed in the dorsal side of the vegetal region (Nieuwkoop, 1952; Nieuwkoop,
1973). Molecular events for early dorsal axis establishment have been proposed
Fig.1.1 The develop-
ment of Xenopus. The
ovarian oocyte is radial-
ly symmetrical and is
divided into an animal
and a vegetal domain.
One  hou r  a f t e r
fertilization, an unpig-
mented dorsal crescent
is formed in the
fertilized egg opposite
the sperm entry point.
As the embryo rapidly
di-vides into smaller
and smaller cells,
without intervening
growth (cleavage), a
cavity called the
blastocoel is formed, which defines the blastula stage. By the late blastula stage (9h of
development), the three germ layers become defined. The ectoderm, or animal cap, forms the
roof of the blastocoel. The mesoderm is formed in a ring of cells in the marginal zone, located
between the ectoderm and endoderm. At the gastrula stage (10 h), involution of the mesoderm
towards the inside of the embryo starts at the dorsal blastopore lip. The morphogenetic
movements of gastrulation lead to the formation of the vertebrate body plan, patterning the
ectoderm, mesoderm and endoderm. At the neurula stage (14 h), the neural plate, or future
central nervous system (CNS), becomes visible in dorsal ectoderm. By the tailbud stage (24-
42 h), a larva with a neural tube located between the epidermis and the notochord has formed.
The blastopore gives rise to the anus, and the mouth is generated by secondary perforation
(modified from De Robertis et al., 2000). CNS, central nervous system.
(Moon and Kimelman, 1998; De Robertis et al., 2000), in which β-catenin
seems to play the key role. β-catenin is present in the eggs of Xenopus and early
embryos (DeMarais and Moon, 1992; Fagotto and Gumbiner, 1994). The
importance of β-catenin in dorsal axis determination resides in that its
overexpression mimics the dorsal inducing activity and thus induces a complete
secondary axis (Guger and Gumbiner, 1995; Kelly et al., 1995), while loss-of-
function analyses reveal that the formation of embryonic endogenous axis is
blocked (Heasman et al., 1994; Heasman et al., 2000). In addition,
immunostaining studies show that β-catenin is enriched in nuclei on the dorsal
side of the embryos during cleavage and blastula stages (Schneider et al., 1996;
Larabell et al., 1997). These lines of evidence indicate that β-catenin is the first
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component of a signaling pathway shown to be required for endogenous dorsal
axis formation and dorsalizes the three germ layers.
Dorsal accumulation and nuclear localization of β-catenin protein is
correlated with the activation of maternal Wnt signaling pathway on the dorsal
side. In the absence of Wnt, β-catenin is phosphorylated, by glycogen synthase
kinase 3β (GSK-3) via formation of complex with adenomatous polyposis coli
(APC) tumor suppressor protein, resulting in the degradation of β-catenin (Yost
et al., 1996). While when Wnt binds to the frizzled receptor, disheveled (Dsh) is
activated. Activation of Dsh results in the inhibition of GSK-3, hence the
stabilization and enrichment of β-catenin. As β-catenin accumulates, it is
translocated to the nuclei and forms complexes with transcription factor Lef/Tcf-
3, which lead to the regulation of target genes such as siamois, twin and Xnr3
(Moon and Kimelman, 1998). Subsequently, these genes activate transcription
of early genes in the Spemann-Mangold organizer.
1.1.2 The three germ layers
The basic body plan in almost all metazoans is derived from the three germ
layers, endoderm, mesoderm and ectoderm. Induction and patterning of the
germ layers have also been described in somewhat details in Xenopus. The
endoderm arises from blastomeres in the vegetal region during early cleavage
stages (Fig.1.1). The organs such as gastrointestinal and respiratory tracts, liver,
and pancreas originate from this germ layer (Wells and Melton, 1999; Chalmers
and Slack, 2000). A two-step molecular model was proposed for endoderm
formation (Yasuo and Lemaire, 1999; Yasuo and Lemaire, 2001). First, maternal
factors, primarily VegT (Lustig et al., 1996; Zhang and King, 1996; Horb and
Thomsen, 1997; Xanthos et al., 2001; Engleka et al., 2001) activate cell-
autonomous expression of endoderm-specific genes encoding transcription
factors such as Xsox17α (Hudson et al., 1997; Clements and Woodland, 2000)
and Mix.1 (Rosa, 1989; Lemaire et al., 1998) and other proteins of TGF-β
family, such as Xnr-1, 2, and 4, Activin B and Derriere (Clements et al., 1999;
Yasuo and Lemaire, 1999; Sun et al., 1999). Second, zygotically expressed Xnr-
1, Xnr-2, Derriere, and possibly other TGF-β factors subsequently activate the
zygotic expression of Mixer (Henry and Melton, 1998) and GATA-4. Further,
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expression of Xsox17α, Mix.1, Xnr-1 and Xnr-2, which involve in the formation
of endoderm, are upregulated (Yasuo and Lemaire, 1999).
Mesoderm is formed in the equatorial marginal zone of Xenopus blastula
(Fig.1.1), and fated to form head mesoderm, notochord, somites in the dorsal
side, and blood cells and also somites in the ventral side. It is believed that three
signals (Dale and Jones, 1999; Chan and Etkin, 2001) or sometimes called two
signals (De Robertis et al., 2000) work sequentially to execute the task. The first
signal emits from the ventral endoderm to induce ventral mesoderm. While a
small dorsal part of endoderm, i.e., the Nieuwkoop center, releases a second
signal to induce dorsal mesoderm, i.e., the Spemann-Mangold organizer tissue.
Finally, the organizer gives out the third signal to pattern the initial mesoderm.
The organizer itself differentiates into notochord, prechordal mesoderm,
floorplate and dorsal endoderm. Growth factors of the TGF-β or FGF families,
including activins A, B, and D, Vg1, Xnr-1, 2, and 4, and BMP2, 4, and 7,
mimic the mesoderm-inducing signals and therefore are able to induce
mesoderm in animal cap explant experiments (Kimelman et al., 1992; Harland
and Gerhart, 1997). Amongst these factors, only Vg1 is considered a suitable
candidate for mesoderm inducer, because it is maternally encoded and localized
to the vegetal region. A processed form of Vg1 induces mesoderm and
endoderm in animal cap assays. When it is inhibited by dominant-negative
ligands, both dorsal mesoderm and endoderm formation are disrupted,
suggesting the role of Vg1 in mesoderm induction (Dale et al., 1993; Thomsen
and Melton, 1993; Kessler and Melton, 1995; Joseph and Melton, 1998).
However, it is not completely convincing since the wild type Vg1 has no
mesoderm inducing activity. The idea that TGF-β and FGF factors are
responsible for mesoderm induction has been partially revised recently by the
observation that mesoderm induction is dependent on the T-box transcription
activator VegT (Zhang et al., 1998; Kimelman and Griffin, 1998). VegT is also
maternally transcribed and the translated products are localized to vegetal
hemisphere of cleaving embryos (Stennard et al., 1999). Convincing evidence
has shown the central role of VegT in forming mesoderm and endoderm germ
layers (Zhang et al., 1998; Kofron et al., 1999).
Ectoderm is derived from the cells in the animal region. Dorsal ectoderm
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close to the organizer develops into neural folds, from which the central nervous
system is derived, while ventral ectoderm develops into epidermis (Fig.1.1). At
the boundary between neural folds and epidermis, cement gland, various
placodes and neural crest are formed. It has been shown that, by ectoderm
dissociation experiments, the default state of ectoderm is neural (Grunz and
Tacke, 1989; Grunz and Tacke, 1990; Hemmati-Brivanlou and Melton, 1997).
Further evidence shows that BMP-4 plays the key role to prevent neural
development in the ectoderm (Wilson and Hemmati-Brivanlou, 1995). Dorsal
ectoderm is induced to adopt a neural fate by dorsalizing activities of factors in
the organizer, such as Chordin, noggin, follistatin, Xnr-3, Cerberus and dkk-1.
Chordin, noggin, follistatin and Xnr-3 are antagonists of BMP-4 (Piccolo et al.,
1996; Zimmerman et al., 1996; Iemura et al., 1998; Hansen et al., 1997), while
Cerberus and dkk-1 are antagonists of Wnt (Piccolo et al., 1999; Glinka et al.,
1998). Therefore, repression of BMP or Wnt signaling leads to neural induction
in the ectoderm. It is also shown that FGF signaling is involved in anterior
neural induction (Hongo et al., 1999). Briefly, the dorsal ectoderm absent of
BMP and Wnt pathway adopts a neural fate, while the ventral ectoderm with
active BMP and Wnt signaling differentiates into epidermis.
1.1.3 Spemann-Mangold organizer
The most significant event in developmental biology is of course the
discovery of the “organizer” by Spemann and Mangold. A small piece of tissue
in gastrulae, the dorsal lip of blastopore, is able to pattern an early embryo with
distinct anterior-posterior, dorsal-ventral and left-right axes. When transplanted
to a heterotopic location of a recipient embryo, the dorsal lip can induce a
complete secondary body axis, hence the name “organizer”. Formation of the
organizer has been extensively reviewed (Harland and Gerhart, 1997; Nieto,
1999; De Robertis et al., 2000; Bouwmeester, 2001). It can be traced back to the
dorsal stabilization of β-catenin during early cleavage. Subsequently after
midblastula transition (MBT), the β-catenin signal, in combination with other
maternal genes including Vg1 and VegT, activates a dorsal-ventral gradient of
Nodal related signals (Xnr) in the endoderm. In turn, this gradient induces the
formation of mesoderm: low doses of Xnrs in ventral side induce ventral
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mesoderm, while high doses in the dorsal side lead to the formation of
organizer.
The axis inducing activities by the organizer have been elucidated at the
molecular level. It has been revealed by molecular studies that the organizer is
indeed an enrichment of secreted antagonists of growth factors, including
Chordin, noggin, follistatin, ADMP, Crescent, shh, Xnrs, cerberus, Lefty,
Antivin, Frzb-1 and dkk-1 (De Robertis et al., 2000). It also harbors many
nuclear factors, such as Gsc, Xlim-1, HNF-3β, Xnot, Xanf-1, Otx-2, Siamois,
Xtwn, Iro3, and bozozok (De Robertis et al., 2001). Amongst these secreted
proteins, Chordin, noggin and follistatin act as antagonists against BMP4 by
direct binding (Piccolo et al., 1996; Zimmerman et al., 1996; Fainsod et al.,
1997). Crescent, Frzb-1 and dkk-1 antagonize Wnt (Wang et al., 1997; Pera and
De Robertis, 2000; Glinka et al., 1998). Cerberus is a multivalent antagonist for
Wnt-8, Xnrs and BMPs (Bouwmeester et al., 1996; Piccolo et al., 1999; Fig.1.1).
Lefty/Antivin blocks nodal signaling by binding to TGF-β/Nodal receptor
(Meno et al., 1996; Thisse and Thisse, 1999).
In addition to self-differentiation of the organizer as aforementioned, the
principal proposed functions are body axis patterning, neural induction of the
ectoderm, and morphogenesis (Harland and Gerhart, 1997; Bouwmeester, 2001).
First, the organizer reveals a function in dorsal-ventral patterning. Ventral
overexpression of mRNAs for Chordin, noggin and follistatin results in the
formation of twinned axes, an effect reminiscent of organizer grafting
experiments. These factors function as agonists of ventral cell fates, which are
specified by BMP4. Such a dorsalization of ventral mesoderm by these proteins
has led to the proposal that BMP antagonism is the main inductive activity of the
“trunk organizer”. Second, the “head organizer” patterns the anterior-posterior
axis as it expresses secreted factors, Cerberus, dkk-1 and Frzb-1. These factors
are expressed in the dorsoanterior endoderm and prechordal plate, and
antagonize Wnt glycoproteins. Combinatorial expression of Wnt antagonists
together with BMP antagonists leads to secondary axis with head structures
(Glinka et al., 1997; Glinka et al., 1998; Piccolo et al., 1999). Third, in addition
to the function as dorsalizing factors, Chordin, noggin and follistatin also act as
neural inducers. Based on the neural default model, the ectoderm has a natural
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tendency to differentiate into neural tissue (Hemmati-Brivanlou and Melton,
1997). This tendency is inhibited, however, by BMP signaling. The ectoderm
with active BMP signaling differentiates into epidermis. Chordin, noggin and
follistatin can disable BMP signaling via direct ligand binding. Therefore, the
ectoderm free of BMP signaling will be neural, from which future nervous
system will be derived. Finally, the organizer also controls some of the complex
morphogenetic movements (Harland and Gerhard, 1997; Bouwmeester, 2001).
The first reason should be that extensive morphogenesis is necessary to bring the
organizer to the vicinity of other tissue so that the organizer’s inducers can reach
the distant targets. Some, nevertheless not all, morphogenetic movements are
dependent on the organizer, i.e., the movement of the organizer itself and thus
induced movement of neighboring tissues, in particular the somitic mesoderm.
Anterior organizer cells perform a spreading migration. The posterior organizer
cells, and the somites which are induced from lateral-ventral mesoderm by
organizer signals, engage in convergent extension.
Once the germlayers are formed and body axes are established, embryos will
proceed to organogenesis, thus a free-swimming larva of Xenopus laevis comes
into entity.
1.2 The objective of this research
Last year the most celebrated event in biology was the announcement of the
completion of human genome sequencing. The deciphering of genomic genetic
codes of human and many other organisms makes some think that it is time to
understand how an organism is built. This is apparently a great leap towards this
goal but still far from it. Because the single words in the tome of genome are
recognized, and herculean efforts are required to compile words into meaningful
sentences and paragraphs, that is to say, to probe gene functions and
crossregulation between genes during life cycles. If for embryogenesis, it is
exactly the objective of modern developmental biology. In the case of
amphibians including Xenopus laevis, some 50,000 genes are estimated to
participate in embryonic development (Wolpert et al., 1998). Albeit many key
molecules in Xenopus development have been characterized and to some extent
the framework of early embryogenesis has been established as outlined above,
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the major part of the genes have yet to be discovered and functionally analyzed.
To achieve this goal, a variety of approaches have been developed. One simple
way is to identify genes in homology with those well described in the
embryogenesis of other organisms, such as Drosophila and mice. This is a
valuable approach to investigate whether or not the functions of these genes are
conserved through invertebrate to vertebrate. Or in most other cases, genes are
identified from cDNA libraries constructed from specific stages or tissues, for
example oocytes (I. Dawid, D. Melton) (names indicating group leaders), eggs
(M. King), embryos at different stages (I. Dawid, M. King, P. Lemaire, C.
Kintner, T. Pieler), LiCl-dorsalized embryos (P. Lemaire, C. Niehrs), dorsal
blastopore lip (E.M. De Robertis), or induced pronephros (M. Asashima), etc.
Research works with these libraries have been leading to the identification of
many genes that improve profoundly our knowledge of embryogenesis. The
highlighted events may be the discovery of genes in the Spemann-Mangold
organizer from a dorsal blastopore lip library (Bouwmeester et al., 1996) and a
LiCl-treated stage 13 embryo library (Glinka et al., 1998). Some strategies were
also developed specifically for the isolation of genes for secreted proteins (Klein
et al., 1996; Jacobs et al., 1997; Pera and De Robertis, 2000; Matsui et al., 2000;
Tsuda et al., 2002), as they play key roles in cell-cell signaling. In addition,
there is a strategy particularly developed for isolating genes for DNA-binding
proteins (Mead et al., 1998).
A few years ago, Professor Dr. Horst Grunz proposed an idea to isolate
endoderm inducing or neural inducing genes by constructing endoderm- or
notochord-specific cDNA library. In order to obtain adequate amount of
endoderm or notochord tissue for library construction, an in vitro system that
was well established on the basis of earlier results was employed (Grunz, 1969;
Minuth and Grunz, 1980; Grunz, 1983; Grunz and Tacke, 1989). The principle
is that disaggregated animal cap cells at stage 8-9 treated with high
concentration of activin will differentiate into homogeneous endoderm-like
tissue or into homogeneous notochord tissue when treated with lower
concentration of activin. The homogeneity of these induced tissues was
confirmed with histological sections or markers, such as endoderm-specific gene
endodermin (Sasai et al., 1996). The libraries were constructed successfully.
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These led to the identification of the transcription factor XER81, which
interferes with activin-mediated induction of Xegr-1 and Gsc (Chen et al.,
1999), and the retinoic acid hydroxylase XCYP26, which helps to establish
boundaries of retinoic acid signaling during embryogenesis (Hollemann et al,
1998). Here what will be described is the screening and characterization of three
genes XODC2, XCL-2 and XETOR from the endoderm-like cDNA library.
1.3 Calpains, XCL-2 and convergent extension movements
Calpains are intracellular nonlysosomal cysteine protease that absolutely
requires Ca2+ for activity. There are three forms of Calpains, µ-Calpain requiring
Ca2+ in micromole for activity in vitro, m-Calpain requiring Ca2+ in millimole,
and an intermediate form identified in chicken. Both µ-Calpain and m-Calpain
are heterodimers consisting of an 80 kDa large subunit and a common 30 kDa
small subunit (Sorimachi et al., 1994; Arthur et al., 1995; Suzuki and Sorimachi,
1998). Calpains play a role in various pathological states, including degenerative
diseases of muscle and nerve, apoptosis, hypertension, cataract formation,
rheumatoid arthritis, and Alzheimer's disease. Calpain was originally discovered
as an activator of phosphorylase b kinase (Huston and Krebs, 1968) and later
identified as an activator of protein kinase C (Takai et al., 1977). Actually
Calpains cleave many membrane proteins and membrane-associated proteins.
There are typical Calpains with four complete domain structures and atypical
Calpains generally with only protease domain. Moreover, some typical Calpains
are ubiquitous while others are tissue-specific (Sorimachi et al., 1994). Calpains
have been discovered in a wide spectrum of organisms from Aspergillus, yeast,
nematode, Drosophila to chicken and human, though, their functions in
embryonic development are very poorly known. The Calpain identified here,
XCL-2, is a typical tissue-specific m-type Calpain large subunit. It will be
shown here some lines of evidence for its role in convergent extension
movements during embryonic development of Xenopus laevis.
Convergent extension movements are the major driving force for the process
of gastrulation, neurulation and formation of body axis in Xenopus laevis
(Keller, 1986). During gastrulation, mesoderm at the blastopore lip involutes,
converges toward the dorsal midline (convergence), and at the same time
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elongates along the future anterior-posterior axis (extension), thus the axial
mesoderm, paraxial mesoderm as well as neural tissues are formed
symmetrically (Keller and Tibbetts, 1989). Moreover, the movement is also the
driving force for the closure of blastopore (Keller and Tibbetts, 1989).
Cellular basis for convergent extension movements have been more
comprehensively investigated as compared to the molecular mechanism.
However, there have been increasing evidences that some molecules are
involved in this procedure. Among them known in somewhat more details are
the second group of Xwnts, i.e., Xwnt4, Xwnt5 and Xwnt11 (Moon et al., 1993;
Tada and Smith, 2000), the receptors frizzled-7 (Djiane et al., 2000), frizzled-8
(Deardorf et al., 1998) and frizzled-11 (Tada and Smith, 2000). Some Ca2+-
dependent proteins, such as C-cadherin, were also shown to take part in
morphogenetic movements by interfering cell adhesion (Lee and Gumbiner,
1995). More recently, Disheveled signaling was shown to regulate both neural
and mesodermal convergent extension (Wallingford and Harland, 2001).
In the following, it will be presented that overexpression of wild-type XCL-2
disrupted gastrulation movement and convergent extension during gastrulation
and neurulation. Moreover, overexpression of a dominant-negative mutant
caused a phenotype morphologically similar to, but histologically different from,
that caused by overexpression of wild-type XCL-2. The mutant phenotype can
be rescued by injection of wild-type XCL-2. These data suggest that XCL-2
plays an important role in convergent extension movements during
embryogenesis in Xenopus laevis.
1.4 ETO/MTG8/CDR, XETOR and primary neurogenesis
The proto-oncogene ETO (for Eight-Twenty One, also known as MTG8 or
CDR) encodes a protein with potent activity of transcriptional repression. ETO
on chromosome 8 in human is often translocated to AML1 on chromosome 21 to
make a fusion transcript in acute myeloid leukemias (Feinstein et al., 1995;
Melnick et al., 2000; Wang et al., 1998). AML1 contains a “Runt domain”
named after the Drosophila gene runt, and its Xenopus homologue Xaml has
been identified to play a significant role in primitive hematopoiesis, albeit it is
also expressed in the sensory neurons during neural plate stage (Tracey et al.,
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1998; Koyano-Nakagawa et al., 2000). So far the ETO coding sequence has also
been revealed to be conservative through Drosophila to human (Feinstein et al.,
1995; Kitabayashi et al., 1998). One attractive feature of these genes is that they
are mainly expressed in the nervous system in different species (Feinstein et al.,
1995; Wolford and Prochazka, 1998), suggesting they should be functionally
conservative. But so far no functional analyses have been made for these genes
during the development of nervous systems.
In Xenopus laevis, a primary nervous system is formed in the neural plate
stage from neuroectoderm, which is induced by neuralizing signals such as
noggin, Chordin and follistatin from the organizer (Saxen, 1989; Harland and
Gerhart, 1997; Streit and Stern, 1999). These inducers function to induce and
pattern the neural plate by antagonizing the BMPs, Wnts, and the newly
identified Tiarin (Tsuda et al., 2002; Wessely and De Robertis, 2002). The
neural inducers of organizer activate neuralizing genes in the Sox and Zic
families, such as SoxD, Zic-r1, Zic3, Sox2 and geminin, which subsequently
activate proneural genes (Mizuseki et al., 1998a; Mizuseki et al., 1998b; Nakata
et al., 1997; Kroll et al., 1998). Expression of these Sox and Zic genes is
localized to the dorsal ectoderm during early gastrula. They are promoted by
Chordin but inhibited by BMP signaling. Overexpression of these genes leads to
an increase of proneural genes such as Xngnr-1, Xash-3, and XNeuroD, and
consequently, the promotion of primary neuronal differentiation. These
neuralizing genes, therefore, may act to link neural inducers to activate
proneural genes.
Primary neurogenesis is promoted by proneural genes both in Drosophila
and Xenopus (Fig.1.2). The basic Helix-Loop-Helix (bHLH) transcription
factors encoded by the achaete-scute complex (AS-C) and atonal genes in
Drosophila provide cells with the potential to adopt a neural fate, therefore they
are termed “proneural genes”. A few of such transcription factors have also been
characterized in Xenopus. When embryos are still at early gastrula (stage 10.5),
a bHLH transcription factor gene Xngnr-1 starts to express, and defines the three
prospective patches of primary neurons in the neural plate. Overexpression of
this gene will lead to strong ectopic neuron formation (Ma et al., 1996).
Expression of Xngnr-1 precedes that of Xash-3 and Xath3, which begin to
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express since stage 11 and 12 (Zimmerman et al., 1993; Takebayashi et al.,
1997), respectively. Xash-3  is an AS-C homologue, too. Overexpression of
Xash-3  promotes neuron formation within neuronal domains in lower
concentration while inhibits neuron formation in higher concentration due to the
activation of lateral inhibition (Ferreiro et al., 1994; Chitnis and Kintner, 1996).
When overexpressed in concert with a zinc-finger transcription factor gene
XMyT1, however, it induces ectopic neurons in naïve ectoderm (Bellefroid et al.,
1996). In the case of Xath3, a Drosophila atonal homologue, overexpression
will lead to strong ectopic neuron formation, too (Takebayashi et al., 1997;
Perron et al., 1999). Overexpression showed that Xngnr-1 activates Xath3 in a
unidirectional way (Bellefroid et al., 1996; Perron et al., 1999). Still
downstream, a neural differentiation gene XNeuroD is activated by Xngnr-1 also
in a unidirectional way (Ma et al., 1996). XNeuroD is another bHLH
transcription factor starting to express since stage 13.5 (Lee et al., 1995). Again,
overexpression of this gene induces formation of ectopic neurons in nonneural
ectoderm (Lee et al., 1995). More recently, Xebf3  was identified as a
downstream target of XNeuroD (Pozzoli et al., 2001). It is activated at 15.5 and
promotes neuronal differentiation, as XNeuroD does. The temporal sequence of
expression of these genes and the unidirectional way of activation reflect that
they regulate successive stages of primary neurogenesis.
On the other hand, neurogenesis is repressed by neurogenic genes via
downregulating proneural proteins. In Drosophila, the products of neurogenic
genes Delta and Notch comprise a cell-cell signaling mechanism termed lateral
inhibition whereby a cell committed to neural fate forces its neighbors to remain
nonneural (for reviews, see Artavanis-Tsakonas et al., 1995; Kopan and Turner,
1996; Beatus and Lendahl, 1998). Neural precursors are first specified by
proneural genes in clusters of cells within the neuroepithelium. In the meantime,
proneural proteins also enhance the expression of the inhibitory ligand encoded
by Delta  (Kunisch et al., 1994), and in turn they are inhibited by signaling via
the receptor encoded by Notch in the neighboring cells. By this way, cells
expressing proneural genes and hence Delta adopt a neural fate while their
neighbors remain nonneural. When these genes are mutated in Drosophila,
massive over-production of neurons will be resulted, hence the name
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“neurogenic genes”.
The mechanism is also conserved in vertebrates (Fig.1.2). Homologues of
Delta and Notch have been identified in Xenopus, namely, X-Delta-1 and X-
Notch-1. It was shown that they control the number of primary neurons in very
much the same way as in Drosophila (Chitnis et al., 1995; for review, see
Beatus and Lendahl, 1998). Increased density of primary neurons is observed
within the neuronal domains when the signaling is blocked by X-Delta-1STU, a
dominant negative form of the ligand. In contrast, when the pathway is activated
by a dominant active form of the receptor, X-Notch-1ICD, primary neuron
formation is repressed (Chitnis et al., 1995), as a result of inhibition of proneural
genes including Xngnr-1, Xash-3, and Xath3 (Ma et al., 1996; Chitnis and
Kintner, 1996; Perron et al., 1999; Bellefroid et al., 1996). Therefore, lateral
inhibition plays an instrumental role in keeping the balance between the number
of neuronal precursors and the number of primary neurons.
After these successive waves of neurogenesis, a number of neuroectodermal
cells are sorted out to become neurons while others remain epidermal (Lewis,
1996; Lee, 1997; Chitnis, 1999). This primary nervous system is composed
symmetrically of lateral, intermediate and medial longitudinal stripes on each
side of the dorsal midline, which differentiate into motorneurons, interneurons
and sensory neurons, separately.
Fig.1.2 A simplified model
for primary neurogenesis. It
is pro-moted by proneural
genes while repressed by
lateral inhibition via cell fate
selection, as a result of
inhibitory effect of lateral
inhibi-tion signaling on the
function of early pro-neural
genes. But late expressed
proneural genes are refractory
to lateral inhibition. Such a
mechanism determines the
number but not the localization of primary neurons.
So far, lateral inhibition is known to be the principal inhibitory mechanism
for the regulation of primary neurogenesis. Blocking of lateral inhibition will
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lead to more densely formation of primary neurons without alteration in the size
of neurogenic domains, suggesting that lateral inhibition regulates primary
neurogenesis by the way of limiting only the number of primary neurons. It is
interesting to notice that Xngnr-1 defines proneural domains much larger than
the area where primary neurons form, as shown by a much larger expression
domains of Xngnr-1 than those of N-tubulin. Furthermore, the early proneural
genes often have broader expression domains than those of late expressed ones,
for example, Xngnr-1 is expressed in broader domain than is Xath3, and the
domain of Xath3 is broader than XNeuroD (Ma et al., 1996; Perron et al., 1999;
Lee et al., 1995). Such a correlation of temporal and spatial expression is also
reported between XMyT1 and N-tubulin, since XMyT1 is expressed earlier in a
broader domain than is N-tubulin (Bellefroid et al., 1996). Therefore, there
should be a mechanism to regulate proneural genes such that primary
neurogenesis can occur at an exact localization. It is known that lateral
inhibition is particularly responsible for the regulation of earlier expressed
genes, in particular those for neuronal determination (Chitnis and Kintner,
1996), such as Xngnr-1  and Xash-3 . While in later stages, neuronal
differentiation genes such as XNeuroD and its downstream regulator Xebf3 are
proved to be resistant to lateral inhibition, although overexpression of XNeuroD
itself also activates X-Delta-1 (Lee et al., 1995; Chitnis and Kintner, 1996;
Pozzoli et al., 2001). Then it comes another question how primary neurogenesis
is negatively regulated when lateral inhibition is no longer effective for late
expressed genes.
In the following it will be shown the molecular cloning of XETOR, an ETO
related gene in Xenopus, and its functions during primary neurogenesis. Briefly,
it was found that expression of XETOR starts from stage 12.5 in symmetrical
stripes on either side of dorsal midline. The expression domain overlaps with but
is broader than that of N-tubulin. By both gain-of-function and loss-of-function
analyses, it was found that 1) XETOR is an inhibitory factor for primary
neurogenesis in independence of lateral inhibition; 2) XETOR functions via
establishing a negative feedback loop with proneural genes, similar to the case
of lateral inhibition; 3) XETOR puts into action when lateral inhibition is no
longer effective, because proneural genes sensitive to lateral inhibition are not
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sensitive to XETOR while those insensitive to lateral inhibition are sensitive to
XETOR; 4) XETOR and lateral inhibition antagonizes each other; 5) loss of
XETOR function in vivo causes expansion of neurogenic domains; and
conclusively 6) XETOR and lateral inhibition comprise a dual inhibitory
mechanism to refine the number and localization of neurons for primary
neurogenesis.
2. Materials and methods 16
2. MATERIALS AND METHODS
2.1 Preparation of embryos
Eggs of Xenopus laevis were obtained by the way of hormone induction.
Various doses (250-1,500 IU, depending on the condition of frogs) of chorionic
gonadotropin (Sigma, cat.no.: CG-10) dissolved in 0.4% NaCl solution were
subcutaneously injected to the dorsal lymph sac of healthy female frogs. In general
the injected frogs were kept at room temperature waterbath overnight and began
spawning eggs the next morning. In some cases when the frogs wouldn’t give eggs
the next morning, then an additional dose of around 500 IU was injected.
Testes used for in vitro fertilization were dissected out from adult male frogs
and maintained in L-15 (Leibovitz, Sigma, cat.no.: L-4386) solution (5 ml L-15, 1
ml calf serum (Sigma, C-6204), 4 ml sterile water and 100 µl penicillin/
streptomycin stock solution (10,000 IU/10,000 µg/ml)) on ice or at 4°C. In this way
they can be kept for as long as two weeks, still viable of fertilization.
For in vitro fertilization, female frogs were encouraged to lay eggs into a large
petri dish by gentle squeezing. Simultaneously a small piece of testis was cut into
fine pieces with scissors, suspended in 0.5-1 ml 0.1× MMR (Marc’s Modified
Ringer’s Solution; 1×: 100 mM NaCl, 2 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 5
mM HEPES, pH7.4) and transferred onto the eggs. The eggs were gently mixed
well with the sperm suspension, spread to a single layer on the bottom of petri dish.
Five minutes later, plenty volume of 0.1× MMR was added to the fertilized eggs so
that they could be submerged in the solution. About 30-40 min later, fertilization
rates can be determined by observing cortical rotation. Embryos were dejellyed
with 2% cysteine (Merck, cat.no.: 1.02839.0100) adjusted to pH8.0, washed
intensively and cultured in 0.1× MMR until the desired stages (Nieuwkoop and
Faber, 1967).
When used for whole mount in situ hybridization, normal or treated embryos at
the desired stages were first fixed in HEMFA (0.1 M HEPES, 2 mM EGTA, 1 mM
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MgSO4, 4% formaldehyde) for 1 hr at room temperature, then dehydrated in 100%
ethanol and stored at –20°C. For RT-PCR, embryos were snap-frozen in liquid
nitrogen and stored at –80°C.
2.2 Screening of cDNA library using whole mount in situ hybridization
The screening procedure started from a λZAP ExpressTM cDNA library, which
was constructed with endoderm-like tissue induced from disaggregated/
reaggregated Xenopus animal caps treated with activin (Cao et al., 2001). A part of
the phage cDNA library was converted to plasmid library by in vivo excision of the
pBK-CMV phagemid vector containing cloned insert from the phage vector,
according to the manufacturer’s protocol (Stratagene). Single colonies were grown
using the phagemid library on LB-kanamycin agar plates (LB agar, Sigma, cat.no.:
L-2897). Around 4,000 single colonies were randomly picked out and cultured
separately in each well of the 96-well microplate that contained 2× LB medium
(LB broth, Sigma, cat.no.: L-3022). The strategy of large-scale whole mount in situ
hybridization was employed for library screening.
2.2.1 PCR amplification of cDNA inserts
To prepare antisense RNA probes used for in situ hybridization, cDNA inserts
were amplified using PCR with forward primer CMV-F and reverse primer CMV-
R. The amplified products contained the whole inserts and T7 promoter, allowing
transcription of antisense RNA using T7 RNA polymerase. Amplification was
carried out in a volume of 20 µl.
Preparation of PCR mixture:
sterile millipore H2O 16.14 µl
10× PCR buffer 2        µl
dATP, dCTP, dGTP, dTTP mix (25 mM each,
Roche Molecular Biochemicals, cat.no.:1969064) 0.16   µl
CMV-F (10 mM) 0.3     µl
CMV-R (10 mM) 0.3     µl
single colony culture medium as template 1        µl
Goldstar Taq DNA polymerase (5 U/µl,
Eurogentec, cat.no.: L026/E01-7) 0.1     µl
20      µl
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PCR mixture was loaded to each well of a 200 µl Thermal Cycler (thin walled
96 well) Plate (Whatman, cat.no.: 7703-1901). Amplification program was as
follow: predenaturation at 95°C for 4 min; then 40 cycles of denaturation at 95°C
for 45 sec, annealing at 56°C for 45 sec, and extension at 72°C for 3 min;
afterwards an extra extension of 10 min. Five microliters of the amplification
products were directly used for transcription.
Primers:
CMV-F (forward): 5’-CGCGCCTGCAGGTCGACACTA-3’
CMV-R (reverse): 5’-GCAAGGCGATTAAGTTGGGTA-3’
2.2.2 Transcription of antisense RNA probes for library screening
For the experiments hereinafter in which RNase was a concern, all solutions
were prepared with DEPC (Sigma, cat.no.:D-5758) treated millipore water, and all
RNase-free utensils and disposables were used.
Preparation of rNTP mixture:
rATP (10 mM) 50    µl
rCTP (10 mM) 50    µl
rGTP (10 mM) 50    µl
rUTP (10 mM) 32.5 µl
fluorescein-12-UTP (10 mM, Roche Molecular
 Biochemicals, cat.no.: 1373242) 17.5 µl
200  µl
Preparation of transcription reaction mixture:
PCR product 5      µl
5× transcription buffer 4      µl
DTT (0.75 M) 0.8   µl
rNTP mix 2      µl
RNase inhibitor (40 U/µl, Strategene,
cat.no.: 300151) 0.25 µl
T7 RNA polymerase (50 U/µl, Stratagene,
cat.no.: 200340) 0.25 µl
DEPC-H2O 7.7   µl
20    µl
Transcription was performed at 37°C for 4 hrs. Probes were purified with
Sephadex G-50 (medium, Sigma, cat.no.: G-50-150) in 96-well filter plates. The
Sephadex G-50 columns were prepared as follow: 50 g of Sephadex G-50 was
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suspended thoroughly in 700 ml of Sephadex G-50 storage solution (0.1% SDS, 0.3
M NaCl, 10 mM Tris-HCl pH8.0) and autoclaved. This suspension was loaded with
full volumes to each well of the 96-well filter plates, which were spun at 1,200 rpm
for 10 min to condense Sephadex. Afterwards adequate volumes of STE (50 mM
NaCl, 10 mM Tris-HCl pH7.5, 2 mM EDTA) buffer were loaded to each well to
equilibrate the Sephadex columns for twice. Centrifuge at 1,200 rpm for 5 min. To
purify the probes, transcription products were loaded to the columns and centrifuge
at 1,200 rpm for 10 min. Probes were subsequently collected and examined with
agarose gel electrophoresis without EtBr.
2.2.3 Whole mount in situ hybridization
The protocols were essentially as described (Harland, 1991; Oschwald et al.,
1991; Jowett, 2001). For single hybridizations, digoxigenin-labeled probes were
always used and a purplish dark color was developed with chromagen NBT/BCIP;
for double hybridization, a digoxigenin-labeled probe and a fluorescein-labeled
probe were used simultaneously.
Whole mount in situ hybridization was performed in glass vials with a volume
of 5 ml; while large scale hybridization was performed in a special 4×6 well
stainless steel plates fitting in 4×6 tissue culture plates (Nalse Nunc International,
cat.no.: 146485). The volumes of all solutions used were 4 ml in each glass vial and
500 µl in each well of a plate. All treatments were made at RT unless otherwise
indicated in the experimental procedure.
Embryos at three representative stages: gastrula, neurula and tailbud, were used
for library screening.
Solutions:
10× PBS: 0.1 M Na2HPO4, 20 mM KH2PO4, 1.4 M NaCl, 28 mM KCl.
PTw: 1× PBS, 0.1% Tween-20 (Sigma, cat.no.: P-1379).
20× SSC: 3 M NaCl, 0.3 M sodium citrate.
100× Denhart’s solution: 2% BSA (Sigma, cat.no.: A-2153), 2% PVP (Sigma,
cat.no.: P-5288), 2% Ficoll-400 (Sigma, cat.no.: F-4375).
Hybridization solution: 50% formamide (Sigma, cat.no.: F-7503), 5× SSC, 1
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mg/ml Torula RNA (Sigma, cat.no.: R-6625), 100 mg/ml heparin (Sigma, cat.no.:
H-9399), 1× Denhart’s solution, 0.1% Tween-20, 0.1% CHAPS (Sigma, cat.no.: C-
5849), 10 mM EDTA.
5× MAB: 0.5 M maleic acid, 0.75 M NaCl, pH7.5.
10% BMB: 10% Boehringer Mannheim Blocking Reagent (Roche Molecular
Biochemicals, cat.no.: 1096176) in 1× MAB, autoclave, aliquot and store at –20°C.
goat serum (Gibcol BRL, cat.no.: 16210-064, or Sigma, cat.no.: G-9023): treat
at 55°C for 30 min, aliquot and store at –20°C.
APB: 100 mM Tris-HCl pH9.5, 50 mM MgCl2, 100 mM NaCl, 0.1% Tween-
20.
NBT (Roche Molecular Biochemicals, cat.no.: 1087479) stock solution: 75
mg/ml NBT in 70% dimethylformamide, -20°C.
BCIP (Roche Molecular Biochemicals, cat.no.: 1383221) stock solution: 50
mg/ml BCIP in 100% dimethylformamide, -20°C.
NBT/BCIP stock solution (Roche Molecular Biochemicals, cat.no.: 1681451),
4°C.
Magenta phosphate (Molecular Probes, cat.no.: B-8409) stock solution: 50
mg/ml in 100% dimethylformamide, -20°C.
Tetrazolium red (Sigma, cat.no.: T-8877) stock solution: 75 mg/ml in 70%
dimethylformamide, -20°C.
Fast Red (Roche Molecular Biochemicals, cat.no.: 1496549) chromagenic
solution: 1 Fast Red tablet in 2 ml of 0.1 M Tris-HCl pH8.2.
Day 1
Rehydration of embryos:
100% ethanol 5 min  1×
75%  ethanol in H2O 5 min  1×
50%  ethanol in H2O 5 min  1×
25%  ethanol in PTw 5 min  1×
PTw 5 min  4×
proteinase K treatment:
Embryos in each vial were treated with 10 µg/ml proteinase K (Sigma, cat.no.:
P-2308) in 2 ml PTw for 15-30 min, depending on different stages. Generally
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gastrula or early embryos were treated for about 10-15 min, neurulae for 20 min,
while longer treatment was used for later stages. The embryos were immediately
subject to subsequent steps.
acetification:
0.1 M triethanolamine (pH7.5) (Sigma, cat.no.: T-1502)  5 min   2×
0.1 M triethanolamine (pH7.5) 4 ml + acetic anhydride 10 µl 5 min   1×
0.1 M triethanolamine (pH7.5) 4 ml + acetic anhydride 20 µl 5 min   1×
PTw 5 min   2×
fixation and washing:
PTw+4%FA 20 min 1×
PTw 5 min   5×
For large-scale hybridization in library screening, a bleaching step was added
here to remove the pigments on embryos, so as to facilitate observation of signals
immediately after color development. While this bleaching may cause the embryos
to be fragile, therefore, in other cases the embryos were only bleached after color
development.
bleaching:
5× SSC+50% formamide+1% H2O2      light        5-25 min 1×
5× SSC+50% formamide 10 min 5×
hybridization:
First the embryos in each vial were briefly washed with a mixture of 500 µl
PTw and 500 µl hybridization solution, then washed once more with 1 ml
hybridization solution at 65°C for 10 min. Afterwards prehybridization was
performed in 1 ml hybridization solution at 60°C for 6 hrs. Then hybridization was
carried out in 1 ml hybridization solution containing antisense RNA probes at 60°C
overnight.
Day 2
Probes in hybridization solution were collected and stored at –20°C for future
use up to multiple times. Subsequently the embryos were subject to the following
steps.
washing:
hybridization solution 500 µl 60°C   10 min  1×
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2× SSC 60°C   20 min  3×
RNase treatment:
20 µg/ml RNase A (Sigma, cat.no.: R-5000) +10 U/ml RNase T1 (Roche
Molecular Biochemicals, cat.no.: 109193) in 2× SSC 37°C 1hr    1×
again washing:
2× SSC 10 min  1×
0.2× SSC 60°C 30 min  2×
then blocking:
MAB 15 min  2×
MAB+2% BMB 15-60 min  1×
MAB+2% BMB+20% goat serum (Gibcol BRL,
cat.no.: 16210-064, or Sigma, cat.no.: G-9023) 60 min  1×
and antibody incubation:
MAB+2% BMB+20% goat serum+
anti-digoxigenin antidody (1:5000, Roche
Molecular Biochemicals, cat.no.: 1093274) 4 hrs     1×
again washing:
MAB 30 min  2×
MAB 4°C overnight
Day 3
chromagenic reaction with NBT/BCIP:
MAB 1 hr      1×
APB 5 min   2×
2 µl of NBT stock/3.5 µl BCIP stock in 1 ml APB
or every 20 µl NBT/BCIP stock in 1 ml APB 5 min-1 week
After sufficient staining, embryos were treated in absolute methanol for 10 min
to make color differentiation. In the case of large scale in situ hybridization, now
the stained embryos were ready for observation. Otherwise the embryos would be
bleached in methanol/10% H2O2 for one to two weeks. Then embryos were stored
in HEMFA or subject to sectioning.
For double hybridization, the fluorescein-labeled probes, which represent more
abundant transcripts, must be viewed first. Also, Fast Red should be the first
chromagenic reagent if it is used. If magenta phosphate/tetrazolium red is used for
double staining, then either magenta phosphate/tetrazolium or NBT/BCIP can be
used first, and chromagenic reaction protocol is exactly the same. Albeit magenta
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phosphate generally produces slight or even no background staining, the signal is
weak and much longer time is required for color reaction. The concentration of
antibody could vary to some extent. For the detection of rare transcripts, such as the
genes expressed in the primary neurons, the concentration of anti-fluorescein
antibody can be increased to 1:2,000, and the anti-digoxigenin antibody can be
1:1,000. The following is a protocol for double in situ hybridization:
Day 1-2
The same as described above.
Day 3
chromagenic reaction with Fast Red:
MAB 1 hr       1×
0.1 M Tris pH8.2 5 min    2×
1 Fast Red tablet in 2 ml 0.1 M Tris (pH8.2) 5 min-48 h
or Day 3
chromagenic reaction with magenta phosphate/tetrazolium red:
MAB 1 hr       1×
APB 5 min    2×
3.5 µl of magenta phos stock/4.5 µl tetrazolium red stock
in 1 ml APB 5 min-72 h
When the first signal reached the desired intensity, the following steps were
followed for the second signal development.
Day 1
stop the first chromagenic reaction:
PTw                                                           5 min     2×
inactivation of the first alkaline phosphatase activity (the red signal by Fast
Red is unstable in heat and organic solvents, therefore the first alkaline phosphatase
activity is killed with low pH instead of heating. While in the case of magenta
phosphate, the color precipitate is stable in heat and organic solvents):
0.1M glycine hydrochloride (Sigma, cat.no.: G-2879) pH2.2   30 min   1×
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thorough washing:
PTw 5 min     5×
signal fixing:
PTw+4%FA 20 min   1×
again blocking and anti-digoxigenin antibody incubation:
MAB 10 min    3×
MAB+2%BMB 30 min    1×
MAB+2%BMB+20% goat serum 1 hr         1×
MAB+2%BMB+20% goat serum
          +anti-digoxigenin antibody (1:1000) 4 hrs        1×
washing:
MAB 30 min     2×
MAB 4°C overnight
Day 2
chromagenic reaction with NBT/BCIP:
The same as described above.
For rare transcripts, color reaction was performed at RT or 37°C; while for
abundant transcripts, it was carried out at 4°C. Chromagenic reaction was stopped
with washing in PTw.
After large scale in situ hybridization, clones that generated staining patterns of
potential interests were singled out and respective plasmids were prepared. Around
300-500 bp of inserts in these plasmids were sequenced and compared with
Genbank databases. Finally 3 clones were selected to get full sequences of the
inserts.
2.3 Plasmid preparation
2.3.1 Using TELT
At some occasions a mini-preparation of plasmids was performed for
sequencing or diagnostic purposes, as described below:
1) Harvest cells from 1.5 ml overnight culture by centrifugation at 6,000 rpm
for 5 min, using a conventional table-top microcentrifuge;
2) Remove supernatant completely with vacuum sucking and resuspend the
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cells in 150 µl TELT solution (50 mM Tris-HCl pH7.5, 10 mM EDTA, 3.2 M LiCl,
0.5% Triton X-100);
3) Add 15 µl of 50 mg/ml lysozyme (Sigma, cat.no.: L-6876) to the cells, mix
well by vortexing, and incubate at RT for 5 min;
4) Incubate the cells in boiling water for 2 min and immediately chill on ice for
5 min;
5) Centrifuge at full speed (13,000 rpm) for 8 min. Remove the pellets of cell
debris and genomic DNA with sterile toothpicks;
6) Add 100 µl isopropanol to the supernatant and vortex;
7) Centrifuge at full speed for 15 min. Remove supernatant with pipette and
wash pellets with 200 µl 70% ethanol;
8) Centrifuge at full speed for 5 min, remove supernatant carefully and air-dry
plasmid pellets;
9) Dissolve the pellets in 30 µl of 10 mM Tris-HCl (pH8.5) containing 10
ng/ml RNase A, incubate first at RT for 2-5 min and then at 65°C for 5 min;
10) Spin down and transfer the solution into a new tube, store at –20°C.
2.3.2 Using QIAGEN Plasmid Midi Kit
For in vitro transcription, plasmids were prepared using QIAGEN Plasmid
Midi Kit (Qiagen, cat.no.: 12143). The protocol provided with the kit was
eventually followed. Concentrations of samples were determined with UV-
spectrophotometer.
2.4 Agarose gel electrophoresis
The protocol for agarose gel electrophoresis was essentially as described
(Sambrook et al., 1989).
2.5 Preparation of antisense probes for functional analyses
Plasmids were linearized with respective restriction endonucleases and purified
using QIAquick PCR purification kit (Qiagen, cat.no.: 28104). The protocol
provided with the kit was exactly followed. Every 1 µg of the linearized plasmids
was used for antisense probe transcription. Afterwards probes were purified using
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Qiagen RNeasy kit (Qiagen, cat.no.: 74104). The protocol of the kit was essentially
followed, with only minor modification in that 400 µl of buffer RLT was used
instead of 350 µl. Because it was observed that, for purification of in vitro
transcripts, the yield was quite low when 350 µl of buffer RLT was used as
recommended by the kit protocol. While 50 µl more of RLT will increase the yield
about two folds.
For each whole mount hybridization, 1/2 of the antisense probes prepared from
1 µg linearized plasmids were used in 1 ml of hybridization solution. While in the
case of N-tubulin, 1/8 of the antisense probe prepared from 1 µg of linearized
plasmid was used in 1 ml of hybridization solution. Empirical experiments showed
that higher concentrations of probes brought about heavy background overstaining.
XODC1 (Bassez et al., 1991) was cut with BamHI and transcribed with T3
RNA polymerase, XODC2 was cut with NdeI and transcribed with T7, XCL-2 was
cut with EcoRI and transcribed with T7, Chordin and Xsox3 were cut with EcoRI
and transcribed with T7, Xbra, XNAP and Xvent-1 were cut with SalI and
transcribed with T7, XMyoD was cut with BamHI and transcribed with T7, Xotx2
was cut with BamHI and transcribed with T3, XETOR was cut with EcoRI and
transcribed with T7, N-tubulin and Xngnr-1 were cut with BamHI and transcribed
with T3, X-Delta-1 was cut with XhoI and transcribed with T7, Xaml1 was cut with
SalI and transcribed with T7, XMyT1 was cut with BamHI and transcribed with T7,
Xath3 was cut with NotI and transcribed with T7, ESR1 was cut with EcoRI and
transcribed with SP6,  Xash3 was cut with NotI and transcribed with T3, and
XNeuroD was cut with XbaI and transcribed with T7 RNA polymerase.
2.6 Histological sections
After whole mount in situ hybridization, embryos were embedded in paraffin
and sections were prepared as described (Grunz, 1973; Penzel et al., 1997).
2.7 RT-PCR
2.7.1 Total RNA preparation
Total RNA used for RT-PCR was extracted from whole embryos of stages 0-42
or adult tissues, using RNACleanTM (Hybaid-AGS, cat.no.: RC100) solution.
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1) Into a 1.5-ml RNase-free Eppendorf tube put 10 embryos or adequate
amount of adult tissues pulverized in liquid nitrogen. Stand the tube on dry ice;
2) Add 1 ml RNACleanTM solution to each tube. Homogenize the embryos by
pipetting until no cell clumps can be seen;
3) Add 100 µl (0.1 volume) CHCl3 to each tube, mix well by vortexing;
4) Incubate the tubes on ice for 5 min;
5) Precipitate the homogenate at 13,000 rpm at 4°C for 15 min;
6) Carefully transfer the aqueous phase to a new tube, and add 600 µl of
isopropanol, mix well;
7) Incubate the tube at –20°C for 15 min;
8) Pellet RNA at 13,000 rpm at 4°C for 15 min;
9) Wash RNA pellet twice: first with 900 µl of 70% ethanol, and then with 500
µl of 70% ethanol;
10) Air-dry the RNA pellet for about 10 min;
11) Dissolve the RNA pellet in 50 µl of DEPC-H2O, check the purity and
concentration with UV-spectrophotometer and the integrity with agarose gel
electrophoresis, and store the sample at –80°C.
2.7.2 Reverse transcription
Reverse transcription was carried out in a total volume of 20 µl.
1) Preparation of Mix1:
Total RNA (0.5 µg/µl) 2   µl
Hexamer random primer p(dN)6 (0.1 mM, Roche
Molecular Biochemicals, cat.no.:1034731) 1   µl
DEPC-H2O 9   µl
 12 µl
2) Incubate the mixture at 70°C for 10 min. Immediately chill on ice;
3) Preparation of Mix2:
5× first strand buffer 4  µl
0.1M DTT 2  µl
dNTPs mix (10 mM each) 1  µl
7  µl
4) Add Mix1 and Mix2 together and mix well gently, precipitate briefly, then
incubate at 25°C for 10 min;
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5) Add 1 µl (200 units) of SuperScriptTMII Reverse Transcriptase (Gibcol BRL,
cat.no.: 18064-014) to the above mixture in step 3); for negative control (RT-), add
1 µl DEPC-H2O instead of reverse transcriptase to make a total volume of 20 µl.
Mix well;
6) Incubate the transcription mixture first at 42°C for 50 min, then at 70°C for
15 min. Afterwards store the sample at –20°C.
2.7.3 PCR
Amplification was performed in total volume of 50 µl.
Preparation of PCR mixture:
H2O 32.9 µl
10× PCR reaction buffer 5      µl
dNTPs mix (1.25 mM each) 8      µl
forward primer (50 mM) 1      µl
reverse primer (50 mM) 1      µl
RT product 2      µl
Goldstar Taq DNA polymerase (5 U/µl) 0.1   µl
50    µl
The annealing temperatures and numbers of cycles for amplification were
dependent on primers used. For XODC1, the annealing temperature was 55°C and
cycle number was 27; for XODC2, 60°C, 29 cycles; XCL-2, 60°C, 31 cycles.
Because probably the transcripts of XETOR are very rare, it had been not possible
to obtain enough products for detection in one round of amplification even the
cycle numbers were increased to as many as 45, therefore temporal expression of
XETOR was not analyzed with RT-PCR. For all amplifications, 25 µl of each final
product was loaded into 1% agarose gels for electrophoresis detection with EtBr.
2.7.4 Primers used for RT-PCR
XODC1 (product size: 387 bp):
 Forward: 5’-GGGCAAAGGAGCTTAATGTG-3’
 Reverse: 5’-CATTGGCAGCATCTTCTTCA-3’
XODC2 (product size: 404 bp):
 Forward: 5’-AGCTGGGAGCTGGATTTGACTG-3’
 Reverse: 5’-GCGTGCATCAGAAATAGCCTGA-3’
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XCL-2 (product size: 400 bp):
 Forward: 5’-AGAGGTCGCCAGGAGAAGTTGA-3’
 Reverse: 5’-TACAGCACGGCTCATTGTTCGT-3’
2.8 Generation of complete coding sequences of XCL-2 and XETOR
with RACE
Coding sequences of XCL-2 and XETOR were found to be incomplete at their
5’ ends. Therefore 5’RACE (Frohman et al., 1989) was employed to get the
complete coding regions from poly(A)+ RNA.
2.8.1 Preparation of poly(A)+ RNA
About 500 µg of total RNA was extracted from 100 embryos at stage 25 for
XCL-2 or stage 30 for XETOR using the RNAcleanTM protocol. An OligotexTM
mRNA Mini kit (Qiagen, cat.no.: 70022) was used to extract poly(A)+ RNA from
500 µg of total RNA. The midi-preparation protocol in the kit was essentially
followed except that the time for secondary structure disruption and for
Oligotex:mRNA hybridization was doubled. In addition, the steps from secondary
structure disruption to Oligotex:mRNA complex precipitation were repeated once.
Finally the poly(A)+ RNA from 500 µg of total RNA was dissolved in 30 µl elution
buffer and checked with agarose gel electrophoresis.
2.8.2 Isolation of 5’ end coding sequence of XCL-2
1) First-strand cDNA synthesis
Preparation of first-strand cDNA synthesis mix:
cDNA synthesis buffer 4   µl
dNTPs mix (10 mM each) 2   µl
gene-specific cDNA synthesis primer 11sp1 (12.5 µM) 1   µl
poly(A)+ RNA 10 µl
AMV reverse transcriptase (20 units/µl, Roche
Molecular Biochemicals, cat.no.: 1495062) 1   µl
RNase-free H2O 2   µl
20 µl
2) The mixture was incubated at 55°C for 60 min and then at 65°C for 10 min.
3) Purification of cDNA: First-strand cDNA was purified using High Pure PCR
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Product Purification Kit (Roche Molecular Biochemicals, cat.no.: 1732668)
according to the instruction manual of the kit. Finally the cDNA was eluted with 50
µl of 10 mM Tris-HCl pH8.5 instead of 1 mM Tris-HCl.
4) Tailing reaction of cDNA: A poly dA tail should be added to the 3' end of
the cDNA.
Preparation of the following mixture:
purified cDNA 19   µl
10× reaction buffer 2.5  µl
dATP (2 mM) 2.5  µl
24   µl
5) The above mixture was incubated first at 94°C for 3 min and then
immediately chilled on ice. Afterwards 1 µl of terminal transferase (10 units/µl,
Roche Molecular Biochemicals, cat.no.: 220582) was added to the mixture and
incubated for 30 min at 37°C for tailing and 10 min at 70°C for the inactivation of
terminal transferase. This dA-tailed cDNA was directly used as template for PCR.
6) First round of PCR amplification
Preparation of PCR mixture:
H2O 29.5 µl
10× PCR reaction buffer 5      µl
dNTPs mix (1.25 mM each) 8      µl
dA-tailed cDNA 5      µl
anchor-dT primer (12.5 µM) 1      µl
gene-specific nested primer 11sp2 (12.5 µM) 1      µl
PfuTurbo DNA polymerase (2.5 units/µl,
Stratagene, cat.no.: 600250) 0.5   µl
50    µl
Reaction mixture was incubated for 2 min at 94°C and followed first by 5
cycles of (94°C, 45 sec; 55°C, 1 min; 72°C, 3 min) and then by 33 cycles of (94°C,
45 sec; 60°C, 1 min; 72°C, 3 min), finally an extra extension at 72°C for 10 min.
The first round PCR product was purified and every 2% of it was used as template
in the second round of PCR in a total reaction volume of 100 µl. In the second
round, the simple anchor primer and a further nested gene-specific primer 11sp3
were used. Thirty cycles of (94°C, 45 sec; 60°C, 1 min; 72°C, 2.5 min) were
carried out. The final PCR product was extracted from agarose gel using QIAquick
Gel Extraction kit (Qiagen, cat.no.: 28704) and sequenced. A final cDNA sequence
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of 2639 bp was obtained. The putative translation initiation codon for ORF is
preceded by a stop codon 12 triplets upstream, indicating that the coding region is
complete.
2.8.3 Isolation of 5’ end coding sequence of XETOR
Because XETOR is a rare transcript in Xenopus embryonic cells, it was not
successful to get the correct 5’ coding region with the above method, probably due
to its low specificity. Therefore the SMART™ RACE cDNA Amplification Kit
(Clontech, cat.no.: K1811-1) and the protocol provided by the kit was used instead.
cDNA was first reverse transcribed from Poly(A)+ RNA from stage 30 embryos
using gene-specific primer GSP-RT and SuperScriptII RNaseH- Reverse
Transcriptase (Gibcol BRL, cat.no.: 18064-014). The first strand cDNA was used
as template in the first round of RCR, which was performed first at (94°C, 10 sec;
72°C, 3min) for 5 cycles, then at (94°C, 10 sec; 70°C, 15 sec; 72°C, 3 min) for
another 5 cycles, and again at (94°C, 10 sec; 68°C, 15 sec; 72°C, 3 min) for 25
cycles, using a nested gene-specific primer GSP1 and the Universal Primer Mix in
the kit. In order to obtain adequate quantity of product, a second round of PCR was
performed using the first round PCR product as template and a further nested gene-
specific primer NGSP1 and the Nested Universal Primer in the kit. The product
was purified again from agarose gel and sequenced. A final cDNA sequence of
2936 bp was obtained. The putative translation initiation codon for ORF is also
preceded by a stop codon 11 triplets upstream, indicating that the coding region is
complete.
2.8.4 Primers used for 5’RACE
Anchor-d(T) primer: 5’-GACCACGCGTATCGATGTCGACT17-3’
Simple anchor primer: 5’-GACCACGCGTATCGATGTCGAC-3’
11sp1: 5’-CGAGGTGGGCATCTGTATGGTC-3’
11sp2: 5’-TACAGCACGGCTCATTGTTCGT-3’
11sp3: 5’-TGGTGAGGGTGTCAGGAGACAG-3’
GSP-RT: 5’-TGTTCTGCTCCCAAAGTCACGA-3’
GSP1: 5’-TATCCACTTCCTGACAGCGACGCAGCAC-3’
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NGSP1:  5’-TCTAACGTCCCGGTGTTCGCCGATCTTG-3’
2.9 Constructs
In order to investigate the functions of XODC2, XCL-2 and XETOR for
embryogenesis, expression constructs and a series of mutants were made for these
genes.
2.9.1 XODC2 constructs
The open reading frame of XODC2 was amplified from plasmid pBK-CMV-
XODC2 using PCR with primers 4Forf and 4Rorf, and subcloned to EcoRI-XbaI
sites of pCS2+ to make pCS2+XODC2. It was previously shown that a mutant of
human ODC in which the active site K69 and C360 were both changed to A works
in a dominant negative manner in vivo, therefore, these two corresponding sites,
K68 and C357, in XODC2 were also mutated to make a similar mutant by the way
of PCR. First, three fragments P1, P2 and P3 were PCR amplified from pBK-
CMV-XODC2 with primer pairs 4Forf and K68A-R, K68A-F and C357A-R, and
C357A-F and 4Rorf, separately. Fragments P1 and P2 were then joined together to
make P12 with primers 4Forf and C357A-R, and finally P12 was joined with P3 to
make a full sequence of ORF using primers 4Forf and 4Rorf but K68 and C357
were changed to A, separately. This mutated ORF was again subcloned to EcoRI-
XbaI sites of pCS2+ to make pCS2+dnXODC2. Both constructs were confirmed by
sequencing.
Primers:
4Forf (forward): 5’-CCGGGAATTCAAAATGCAAGGGTATATCCA-3’
4Rorf (reverse): 5’-GCTCTAGAGCTCAAATGATGCTGGTGGCTG-3’
K68A-F (forward): 5’-TTCTATGCAGTGGCGTGTAACAGC-3’ (mutated
codon underlined, AAG→GCG)
K68A-R (reverse): 5’-GCTGTTACACGCCACTGCATAGAA-3’
C357A-F (forward): 5’-GGACCCACGGCCGATGGCTTAGAT-3’ (mutated
codon underlined, TGC→GCC)
C357A-R (reverse): 5’-ATCTAAGCCATCGGCCGTGGGTCC-3’
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2.9.2 XCL-2 constructs
Both wild type and dominant negative expression construct were made for
XCL-2. To subclone the ORF of XCL-2, first-strand cDNA was synthesized in
exactly the same way as used in RACE, except that the cDNA synthesis primer was
simple11#rorf. Wild-type ORF was PCR amplified from the purified cDNA using
primers n11#forf and n11#rorf. To construct a dominant negative mutant, in which
the active site C105 was mutated to S, two fragments were PCR amplified from the
same cDNA above, using primer pairs n11#forf and 11#C105Sr (300 bp), and
11#C105Sf and n11#rorf (1800 bp), respectively. Then a mutated complete ORF
was generated by PCR linking the two fragments together using primer pair
n11#forf and n11#rorf. Finally, the amplified wild-type ORF and mutated ORF,
both of 2100 bp, were purified from agarose gel, double digested with ClaI and
XbaI, and ligated to the ClaI and XbaI sites of pCS2+ to make pCS2+XCL-2 and
pCS2+C105S, separately. Both constructs were confirmed by sequencing.
Primers:
simple11#rorf: 5’-TCAGACCAATGTTGCGCAGAGCC-3’
n11#forf: 5’-CCATCGATGGCCCATCATGTCGAGAAGTGCTG-3’
n11#rorf: 5’-GCTCTAGAGCTCAGACCAATGTTGCGCAGAGCC-3’
11#C105Sf: 5’-CCTCGGGGATTCCTGGCTTCTG-3’ (mutated codon
underlined, TGC→TCC)
11#C105Sr: 5’-CAGAAGCCAGGAATCCCCGAGG-3’
2.9.3 XETOR constructs
To make an expression construct for microinjection, the open reading frame of
XETOR was PCR amplified from cDNA reverse transcribed with primer 13#Rorf
from stage 30 Poly(A)+ RNA, and cloned to EcoRI-XbaI sites of pCS2+ to generate
pCS2+XETOR. A series of constructs of truncations (cf. Fig.3.15) were also made
using PCR method. Inserts were all ligated to EcoRI-XbaI sites of pCS2+.
Truncation construct 1 (assigned as p13#trunc1) consists of amino acids from 1 to
496 with NHR4 deleted using primers 13#Forf and R13#496∆; truncation construct
2 (p13#trunc2) from aa1-425 with NHR3 and 4 deleted using primers 13#Forf and
R13#425∆; construct 3 (p13#trunc3) from aa216-425 with NHR1, 3 and 4 deleted
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using primers F13#∆216 and R13#425∆; construct 4 from (p13#trunc4) aa216-586
with NHR1 deleted using primers F13#∆216 and 13#Rorf; and truncation construct
5 (p13#trunc5) consists of aa364-586 with NHR1 and 2 deleted using primers
F13#∆363 and 13#Rorf. All constructs were confirmed by sequencing.
Primers:
13#Forf: 5’-CCGGGAATTCGATAGAATGGTTGGGATTCCAGGA-3’
13#Rorf: 5’-GCTCTAGAGCTCACAGGCCATCAACAGCAGTGAC-3’
R13#425∆: 5’-GCTCTAGAGCTCAATCTGTTACATAGCCTGCTCCTGT-3’
R13#496∆: 5’-GCTCTAGAGCTCAGCTCTCAGTGGACTCTTCCTGCTC-3’
F13#∆216: 5’-CCGGGAATTCGATAGAATGGAAATGAATGGCAATGGG
AAA-3’
F13#∆363: 5’-CCGGGAATTCGATAGAATGCGTCGCTGTCAGGAAGTG
GAT-3’
2.10 DNA Ligation
The DNA Ligation Kit (Fermentas, cat.no.: K1412) was used for DNA ligation
and the protocol in the kit was essentially followed.
Preparation of ligation mixture:
Double digested pCS2+ (0.25 µg/µl) 1.5 µl
Double digested insert X   µl
10× ligation buffer 2    µl
T4 DNA ligase (2 U/µl) 1    µl
H2O Y   µl
20  µl
The volume of DNA to be inserted was variable according to its concentration.
In principle, the more foreign DNA is used, the higher is the possibility to obtain
positive clones and also the higher is the ratio of positive clones. Ligation reaction
was carried out at 22°C for 6-24 hrs, depending the quantity of foreign DNA in the
ligation mixture. After ligation, 5 µl of the ligation mixture was used for E.coli
transformation. Either PCR or minipreparation of plasmids from single colonies
could be used to confirm positive clones. However, it is not reliable to check
whether or not a ligation is successful by directly comparing the DNAs before and
after ligation reaction with agarose gel electrophoresis.
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2.11 Large-scale preparation of competent E. coli and transformation
2.11.1 Preparation of competent E. coli
1) Inoculate 1 ml of E.coli (strain XLOLR or XL1-Blue MFR’; Stratagene,
cat.no.: #200304 or #200301) overnight culture into 500 ml LB broth with
tetracycline;
2) Incubate in the orbital shaker at 37°C. Cells are ready for harvesting when
OD660nm is between 0.6 and 1;
3) Quickly cool cells on ice for 10 min;
4) Transfer cells to cooled 50 ml Falcon tube and spin cells at 4,000 rpm for 10
min at 4°C using a Megafuge 1.0R tabletop centrifuge and a 3360 rotor (Heraeus
Instruments), discard supernatant;
5) Wash cells with 50 ml of 0.1 M ice-cold sterile CaCl2;
6) Resuspend cells in 50 ml of 0.1 M ice-cold sterile CaCl2;
7) Leave cells on ice for 40 min, then spin cells in the same way as in step 4),
discard supernatant.
8) Resuspend cells with 10 ml of ice-cold sterile 0.1 M CaCl2/20% glycerol;
9) Aliquot on ice as 100µl aliquots, snap-frozen in liquid nitrogen and store
cells at -80°C.
2.11.2 E. coli Transformation
1) Ligation mix and controls or plasmids to be amplified were diluted to a
volume of 10 µl, and added to pre-thawed 100 µl competent cells;
2) Incubate on ice for 30 minutes;
3) Cells were then heat shocked by placing at 42°C for 2 minutes, then quickly
placed on ice for 5 minutes;
4) 400 µl (for transforming ligation products) or 800 µl (for transforming
plasmids) of LB broth was added to the cells and incubated at 37°C for 42 min;
5) Plate out cells on agar containing appropriate antibiotics, such as ampicillin;
6) Single colonies would appear after incubation overnight at 37°C.
2.12 Microinjection
mRNAs used for injection were prepared as follow: NLSLacZ, pCS2+XODC2,
pCS2+dnXODC2, pCS2+XCL-2, pCS2+C105S, pCS2+X E T O R , p13#trunc1,
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p13#trunc2, p13#trunc3, p13#trunc4, p13#trunc5, X-Delta-1STU, X-Notch-1ICD
(Chitnis et al., 1995), Xngnr-1 (Ma et al., 1996), XMyT1 (Bellefroid et al., 1996),
XNeuroD (Lee et al., 1995), and Xash-3 (Zimmerman et al., 1993) were linearized
with NotI; and Xath3 (Takebayashi et al., 1997; Perron et al., 1999) was linearized
with AccI. All capped mRNAs for microinjection were prepared with SP6
CapScribe kit (Roche Molecular Biochemicals, cat.no.: 1581040). 1.0, 1.5 or 2.0 ng
of mRNA of either XODC2 or dnXODC2 was injected into two dorsal or ventral
blastomeres at equatorial region at 4-cell stage. 2.0 or 2.5 ng of mRNA of XCL-2,
or 1.5 or 2.0 ng of mRNA of C105S alone was also injected into two dorsal or
ventral blastomeres at either animal, equatorial or vegetal region at 4-cell stage. 3.0
ng, 3.75 ng or 4.5 ng of XCL-2 together with 2.0 ng of C105S was coinjected
respectively in rescue experiments. The above mRNAs were injected in a total of
10 nl; 1-1.5 ng of mRNAs of XETOR  and the 5 XETOR truncation mutant
constructs, 500 pg of X-Delta-1STU, X-Notch-1ICD, XMyT1 or XNeuroD, 200 pg of
Xngnr-1, Xash-3 or Xath3 was injected into one blastomere at equatorial region at
2-cell stage in a total of 5 or 10 nl together with 50 pg of LacZ mRNA serving as
lineage tracer. LacZ alone was always injected as control.
For loss-of-function analysis on XETOR , a morpholino antisense oligo
MOXETOR with base composition 5’-GATAGGGTCCTGGAATCCCAACCAT-
3’ (Gene Tools, LLC), was designed against the first 25 bases in the ORF of
XETOR. A standard control antisense morpholino oligo, ctrlMO (Gene Tools,
LLC), was also used for microinjection. Morpholino oligos were dissolved in
RNase-free water and injected into the equatorial region of one blastomere at 2-cell
stage with doses ranging 7-30 ng in a volume of 10 nl. 50 pg of LacZ mRNA was
always included in the injections.
Microinjection was made in 0.1× MMR containing 4% Ficoll-400 (Sigma,
cat.no.: F-4375). The injected embryos were kept for several hours or overnight at
14-16°C for healing. Afterwards the embryos were grown in 0.1× MMR till desired
stages. Then injected embryos were subject to HEMFA fixation, β-gal staining and
subsequent whole mount in situ hybridization or sectioning.
2.13 β-galactosidase staining
Embryos microinjected with β-galactosidase mRNA were fixed in HEMFA for
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1 hr, then washed twice in PBS containing 1 mM MgCl2 and twice in staining
buffer (SB: 10 mM K3Fe(CN)6, 10 mM K4Fe(CN)6, 1 mM MgCl2, in PBS), 5-10
min each time. Embryos were stained in SB containing 1.5 mg/ml freshly added 5-
bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal, Sigma, cat.no.: B-4252)
for 1-2 hrs at 37°C. After staining, embryos were washed twice in PBS, fixed in
HEMFA for 30 min, and stored in 100% ethanol at –20°C, until processed for in
situ hybridization.
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3. RESULTS
3.1 Identification of XODC2, XCL-2 and XETOR
Using large-scale whole mount in situ hybridization, expression patterns
were generated for altogether 384 clones, among which the patterns of 29 clones
were specific. For the others, 332 were expressed ubiquitously on the embryos,
and 23 had no discernible staining on any stage of embryos. On the basis of
staining patterns, 383 clones were ectoderm- or mesoderm-related; only 1 was
with certainty derived from endoderm (20D8, endodermin).
Through comparison with GenBank DNA sequence databases, it was
demonstrated that among the 29 clones, 11 are homologous to already known X.
laevis genes with high similarities (>90%), nine are similar in the most parts of
their sequences to known genes in other species as human and mouse,
suggesting that these clones may be X. laevis homologues. While for the
remaining nine clones, the search results revealed little information, suggesting
that they may be completely novel genes (Table 3.1).
Table 3.1 Brief summary of BLAST comparison results
No. of
clone
Best hit and its functional classification
(?: function unknown)
E-value1)
of best hit
Accession
no.
18B2 C. elegans cosmid C14F11. ? 0.51 AI880918
18D7 Human malate dehydrogenase precursor mRNA.
Metabolism 1e-47 AI880919
18D11 Human Cosmid Clone p129d11. ? 0.13 AI880920
18E3 X. laevis Xlim-1 mRNA. Homeobox
transcription factor 0.0
18E9 Mouse mRNA for p38-2G4. Cell cycle 4-e11 AI880921
18F3 X. laevis mRNA for calreticulin (clone 3).
Metabolism 0.0
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18F6 X. laevis 71.0 kDa protein (retrotransposon
1a11 related) mRNA. DNA  transposable
element 0.0
18G1 Human pre-B-cell colony-enhancing factor
mRNA. Signal transduction 7e-25 AI880922
18G6 X. laevis cytokeratin type II mRNA. Structure 0.0
18G11 Human Calpain, large polypeptide L2 mRNA;
human Ca2-activated neural protease large
subunit mRNA. 1e-04 AI880923
18H1 X.  laevis mRNA for Xsox17-beta protein 7e-61
18H2 Human core-binding factor, runt domain,
alpha subunit 2. Putative transcription factor 1e-11 AI880924
18H7 X. laevis Xotx2 mRNA. Homeobox
transcription factor e-152
20A7 Human desmoplakin (DPI, DPII) mRNA. Cell
adhesion 7e-28 AI880934
20A9 X. laevis mRNA for alpha-tubulin. Structure 0.0
20D8 X. laevis endodermin gene. ? 0.0
20E7 Chicken retinaldehyde dehydrogenase 2
mRNA. ? e-102 AI880925
20F1 X. laevis cytokeratin type II mRNA. Structure 0.0
20G12 X. laevis mRNA for elongation factor 1-alpha.
Metabolism 0.0
2B10 Rat intestinal epithelium proliferating cell-
associated mRNA sequence. Cell proliferation 6e-16 AI880926
2C3 Human genomic DNA sequence. ? 0.51 AI880927
2C4 A. thaliana chromosome II BAC F27I1
genome sequence. ? 0.13 AI880928
2G8 Human actin-related protein 3 homologue  (yeast)
mRNA. Structure 3e-21 AI880929
7C7 Human insulin receptor gene, last exon. ? 0.51 AI880930
7E4 Human genomic sequence. ? 0.13 AI880931
7F1 X. laevis mitochondrial DNA. Metabolism 0.0
7F4 Mouse mRNA for serine/threonine protein
kinase. Metabolism 8e-40 AI880932
7F12 X. laevis alpha-tubulin gene. Structure 0.0
7G3 Rat L-arginine:glycine amidinotransferase
mRNA. Metabolism 4e-23 AI880933
1) The E-value is a parameter that describes the number of hits one can “expect” to see just by
chance when searching a Genbank database. It is used as a convenient way to create a
significance threshold for reporting results, as well as to report the significance of sequence
matches.
3. Results 40
Based on localized staining patterns, three clones, 18D11, 18G11 and 18H2,
were selected for further investigation.
3.1.1 cDNA and amino acid sequences of XODC2
A cDNA sequence of 1842 bp was obtained from clone 18D11. The 1368 bp
of open reading frame (ORF) could be conceptually translated into a protein of
456 amino acids (Fig.3.1A). Comparisons using BLAST search program showed
that this protein shares 66% identity in amino acid sequence with the ubiquitous
ornithine decarboxylase (ODC) in human, 65% in Xenopus laevis and rat, and
63% in chicken (Fig.3.1B). In addition, the active sites in ubiquitous ODCs are
also conserved in the protein (Almrud et al., 2000; Fig.3.1B). Therefore it most
(A)
                                                        gttagtctgagtacca   16
gggacggagacacttccacatttctattaatgggcaacggccgtgtcaatgcatgttaagaaagcgataaac   88
gccagaagcggcgacttcactcacagcccggggtgttgcaaaatctccgagttcactgcggagcctccctgg  160
ttgctctgataaaagcttgttgcgtacttaaaaacaatcttggtagaagtgcttaaaatcccagatttcaaa  232
atgcaagggtatatccaggagtcagattttaacttggttgaagaaggctttttggccagagacttgatggag  304
M  Q  G  Y  I  Q  E  S  D  F  N  L  V  E  E  G  F  L  A  R  D  L  M  E     24
gaaatcattaatgaagtctcacagactgaggatcgtgatgccttttttgtggctgatctaggggatgtggta  376
E  I  I  N  E  V  S  Q  T  E  D  R  D  A  F  F  V  A  D  L  G  D  V  V     48
aggaaacatctccgttttctgaaagccttgcctcgtgtgaagcctttctatgcagtgaagtgtaacagcagc  448
R  K  H  L  R  F  L  K  A  L  P  R  V  K  P  F  Y  A  V  K  C  N  S  S     72
aaaggagtggtgaagatcttggctgagctgggagctggatttgactgcgccagcaagacagagattgagcta  520
K  G  V  V  K  I  L  A  E  L  G  A  G  F  D  C  A  S  K  T  E  I  E  L     96
gtccaggacgttggtgtggcaccagaacgtatcatctatgccaacccatgcaagcagatttcccagattaag  592
V  Q  D  V  G  V  A  P  E  R  I  I  Y  A  N  P  C  K  Q  I  S  Q  I  K    120
tatgcagctaagaatggtgtccaaatgatgacgtttgacaatgaagtagagctttccaaggtgtcaagaagc  664
Y  A  A  K  N  G  V  Q  M  M  T  F  D  N  E  V  E  L  S  K  V  S  R  S    144
catcccaatgcaagaatggttctgcgtatagcaacggatgactctaaatcctctgctcgtttaagtgtgaaa  736
H  P  N  A  R  M  V  L  R  I  A  T  D  D  S  K  S  S  A  R  L  S  V  K    168
tttggcgcccccttaaaatcctgcagacgcttattggaaatggctaaaaacctcagtgtggatgtcattggt  808
F  G  A  P  L  K  S  C  R  R  L  L  E  M  A  K  N  L  S  V  D  V  I  G    192
gttagtttccacgttggtagtggatgcactgattccaaggcctatactcaggctatttctgatgcacgcttg  880
V  S  F  H  V  G  S  G  C  T  D  S  K  A  Y  T  Q  A  I  S  D  A  R  L    216
gtttttgaaatggcatctgagtttgggtacaaaatgtggctgctggatattggtggtggcttccctggaaca  952
V  F  E  M  A  S  E  F  G  Y  K  M  W  L  L  D  I  G  G  G  F  P  G  T    240
gaggattccaaaattagatttgaggagattgcaggtgtaataaatccagcactggacatgtatttccctgag 1024
E  D  S  K  I  R  F  E  E  I  A  G  V  I  N  P  A  L  D  M  Y  F  P  E    264
agctctgacgtgcaaattatcgctgaaccaggaagatattacgtagcatctgctttttcattggctgttaac 1096
S  S  D  V  Q  I  I  A  E  P  G  R  Y  Y  V  A  S  A  F  S  L  A  V  N    288
gttattgctaagaaagaagtggaacactctgtatctgatgatgaggaaaatgagtccagcaaaagcatcatg 1168
V  I  A  K  K  E  V  E  H  S  V  S  D  D  E  E  N  E  S  S  K  S  I  M    312
tattatgttaatgatggagtgtatggatcctttaattgcttggtctttgatcatgctcatccaaaaccaatc 1240
Y  Y  V  N  D  G  V  Y  G  S  F  N  C  L  V  F  D  H  A  H  P  K  P  I    336
ctccacaagaaaccttctccagatcagccattatacaccagtagcctttggggacccacgtgcgatggctta 1312
L  H  K  K  P  S  P  D  Q  P  L  Y  T  S  S  L  W  G  P  T  C  D  G  L    360
gatcagattgcagagcgcgttcagctgcctgagcttcatgttggcgactggcttttgtttgagaatatgggt 1384
D  Q  I  A  E  R  V  Q  L  P  E  L  H  V  G  D  W  L  L  F  E  N  M  G    384
gcatacaccatagcagcatcttccaatttcaatggtttccagcagtctccagtacattacgccatgccccgt 1456
A  Y  T  I  A  A  S  S  N  F  N  G  F  Q  Q  S  P  V  H  Y  A  M  P  R    408
gctgcttggaaagctgttcagttgctgcagagaggattacagcaaaccgaggagaaagaaaatgtgtgcacc 1528
A  A  W  K  A  V  Q  L  L  Q  R  G  L  Q  Q  T  E  E  K  E  N  V  C  T    432
cctatgtcttgtggctgggagatttctgattccttgtgcttcactcgtacctttgcagccaccagcatcatt 1600
P  M  S  C  G  W  E  I  S  D  S  L  C  F  T  R  T  F  A  A  T  S  I  I    456
tgaattcctgcatcatgggagtgacatgcaaatgcttgtcttagcgtagcttgtctcttgtttttaagtatg 1672
stop
caacataaagcatttgtaccttcctggatttgtctctgtatcatctgggagcaatttatgcataagaaacgg 1744
atatttttatcattaattgcatgcagccaccgacatcaattgattttcattaaattttttttcatttgaaaa 1816
aaaaaaaaaaaaaaaaaaaaaaaaaa                                               1842
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(B)
XODC2    MQGYIQES.DFNLVEEGFLARDLMEEIINEVSQTEDRDAFFVADLGDVVRKHLRFLKALP 59
XODC1    -NSFSNDDF-FSFLE---S-R-IVEQK-----LSD-K---Y---F--IVK--V-WF---- 60
hODC     -NNFGNEEF-CHFLD---T-K-ILDQK-----SSD-K---Y---L--ILK--L-WL---- 60
rODC     -GSFTKEEF-CHILD---T-K-ILDQK-----SSD-K---Y---L--VLK--L-WL---- 60
cODC     ..........FTFLD---T-K-ILDQK-----SSD-K---Y---L--IVK--M-WH---- 50
XODC2    RVKPFYAVKCNSSKGVVKILAELGAGFDCASKTEIELVQDVGVAPERIIYANPCKQISQI 119
XODC1    --T--------DGKAI-KT-SIL-A----------Q---SI--S------------V--- 120
hODC     --T--------DSKAI-KT-AAT-T----------Q---SL--P------------V--- 120
rODC     --T--------DSRAI-ST-AAI-T----------Q---GL--P------------V--- 120
cODC     --T--------DSEAV-KT-AVL-A----------Q---SI--P------------L--- 110
                 *                  *
XODC2    KYAAKNGVQMMTFDNEVELSKVSRSHPNARMVLRIATDDSKSSARLSVKFGAPLKSCRRL 179
XODC1    -Y--SC--EK----S-V--M-VA-N--N-KLV---A-----AVC--------T-KTS-L- 180
hODC     -Y--NN--QM----S-V--M-VA-A--K-KLV---A-----AVC--------T-RTS-L- 180
rODC     -Y--SN--QM----S-I--M-VA-A--K-KLV---A-----AVC--------T-KTS-L- 180
cODC     -H--NS--RM----S-V--M-IA-P--K-KLL---T-----AVC--------T-KTS-L- 170
                                          *              *
XODC2    LEMAKNLSVDVIGVSFHVGSGCTDSKAYTQAISDARLVFEMASEFGYKMWLLDIGGGFPG 239
XODC1    --R--E-NVDII------------PQTYV--V----C--D-GA-L-FN-H---------- 240
hODC     --R--E-NIDVV------------PETFV--I----C--D-GA-V-FS-Y---------- 240
rODC     --R--E-NIDVI------------PETFV--V----C--D-GT-V-FS-Y---------- 240
cODC     --R--E-DLAIV------------PETFV--I----C--D-GA-L-FN-Y---------- 230
                         *                                     ***
XODC2    TEDSKIRFEEIAGVINPALDMYFPESSDVQIIAEPGRYYVASAFSLAVNVIAKKEV..EH 297
XODC1    S--V-LK----TS-------K---AD-G-K------------SFT----I----VMVN-Q 300
hODC     S--V-LK----TG-------K---SD-G-R------------AFT----I----IVLK-Q 300
rODC     S--T-LK----TS-------K---SD-G-R------------AFT----I----TVWK-Q 300
cODC     S--V-LK----TS-------K---LD-E-T------------AFT----I----IVSK-Q 290
                                             *
XODC2    SVSDDE.ENESSKSIMYYVNDGVYGSFNCLVFDHAHPKPILHKKPSPDQPLYTSSLWGPT 356
XODC1    SG----EDAANDKTL--------------ILF----V-PV-T-K-K--EKF-SS-I---- 360
hODC     TG----.DESSEQTF--------------ILY----V-PL-Q-R-K--EKY-SS-I---- 359
rODC     TG----.DESNEQTL--------------ILY----V-AL-Q-R-K--EKY-SS-I---- 359
cODC     TG----.DDVNDKTL--------------ILY----V-PV-Q-R-K--DGC-SC-I---- 349
                                *        *
XODC2    CDGLDQIAERVQLPELHVGDWLLFENMGAYTIAASSNFNGFQQSPVHYAMPRAAWKAVQL 416
XODC1    -----R-V--FEL--LQ----M---------V--A-T-----RPTLY-V-SRPH-QLMHD 420
hODC     -----R-V--CDL--MH----M---------V--A-T-----RPTIY-V-SGPA-ELMQQ 419
rODC     -----R-V--CSL--MH----M---------V--A-T-----RPNIY-V-SRSM-QLMKQ 419
cODC     -----R-V--CNM--LQ----I---------V--A-T-----RPTIH-V-SRPA-QLMQQ 409
         **                           *        *
XODC2    LQRG..LQQTEEKENVCTPMSCGWEISDSLCFTRTFAATSII 456
XODC1    IKEHGILPEVP..DLSALHV--AQ-SGMELAPAVCTA-SINV 460
hODC     FQNPDFPPEVEEQDASTLPV--AW-SGMKRHRAACAS-SINV 461
rODC     IQSHGFPPEVEEQDVGTLPM--AQ-SGMDRHPAACAS-SINV 461
cODC     IKEQEFLAEVEEQDVASLPL--AC-SGIE-YPATCAS-SINV 450
Fig.3.1 XODC2 is a paralogue to ubiquitous ODCs. (A) Conceptual translation of XODC2.
The putative translation start codon is preceded by a stop codon 21 triplets upstream
(underlined). (B) Multi-alignment of amino acid sequences of Xenopus ODC2 (XODC2) and
the ubiquitous ODCs from Xenopus laevis (XODC1), human (hODC), rat (rODC) and
chicken (cODC). Amino acids marked underneath with asterisks are active sites in ODCs.
Dashes represent identical residues. Dots are introduced for optimal alignment. The same as
in following alignments.
likely represents a paralogue of Xenopus ubiquitous ODC (Bassez et al., 1990;
hereafter designated as XODC1). Here the cDNA was designated as XODC2
(Genbank accession number: AF217544).
3.1.2 cDNA and amino acid sequences of XCL-2
A cDNA sequence of 2033 bp was obtained from clone 18G11. However, it
was found that the coding region of this cDNA was not complete at its 5’-end.
Therefore, 5’RACE (Rapid Amplification of cDNA ends; Frohman et al., 1988)
was employed to extend the coding sequence to the 5’-end. Finally, a cDNA
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sequence of 2639 bp with a complete ORF for a Calpain protein large subunit
was  obtained  (Fig.3.2A). The protein  was found  to  be  mostly  related  to rat
(A)
                                aatctgactctgcaaagtctgggacaccaaaaggcccatc    40
atgtcgagaagtgctgctgtgatagccaaggacaggacattggctgatggtggtggaacgaagaggaaccca   112
M  S  R  S  A  A  V  I  A  K  D  R  T  L  A  D  G  G  G  T  K  R  N  P      24
gaaaaatatttggatcaagaatttgagaagctgagggcacaatgcttggcatctggtgctctgtataaagat   184
E  K  Y  L  D  Q  E  F  E  K  L  R  A  Q  C  L  A  S  G  A  L  Y  K  D      48
gaagaattcccagcatgcccatctgcactgggttacaatgaactaagacccggctcatacaaaaccagtggg   256
E  E  F  P  A  C  P  S  A  L  G  Y  N  E  L  R  P  G  S  Y  K  T  S  G      72
gtcatatggaagagacctacggaaatttgtcccaacccccagttcattgtggatggagcaacacgaggagac   328
V* I  W  K  R  P  T  E  I  C  P  N  P  Q  F  I  V  D  G  A  T  R  G  D      96
atccgtcaaggggccctcggggattgctggcttctggctgccatcgcatctcttacactggagccagatctt   400
I  R  Q  G  A  L  G  D  C  W  L  L  A  A  I  A  S  L  T  L  E  P  D  L     120
gtagctcaagtggttcctgagaatcaaagtttccagaaaaactacgctggaatcttccacttccggttctgg   472
V  A  Q  V  V  P  E  N  Q  S  F  Q  K  N  Y  A  G  I  F  H  F  R  F  W     144
cagtatggagagtgggtggatgtggtggtggatgaccggctgccgacaaagaatgggaaactggtatttgtc   544
Q  Y  G  E  W  V  D  V  V  V  D  D  R  L  P  T  K  N  G  K  L  V  F  V     168
cactcagcagaaggggatgagttctggagtgctctgcttgaaaaggcctacgcaaagttgaacggctcctac   616
H  S  A  E  G  D  E  F  W  S  A  L  L  E  K  A  Y  A  K  L  N  G  S  Y     192
gaggctctgactggcggttctaccatagagggatttgaagactttaccggaggtatcgctgaggtgtatgaa   688
E  A  L  T  G  G  S  T  I  E  G  F  E  D  F  T  G  G  I  A  E  V  Y  E     216
ctgaagaaggctccacctaatttattccagatcatccagaaagcccttaaggctgaatcactgcttggctgc   760
L  K  K  A  P  P  N  L  F  Q  I  I  Q  K  A  L  K  A  E  S  L  L  G  C     240
tctattgatattacaaacgcctatgatactgaagccatcacaagcagaaagctggttaaagggcacgcctat   832
S  I  D  I  T  N  A  Y  D  T  E  A  I  T  S  R  K  L  V  K  G  H  A  Y     264
tctgtcactggtgctgaggaggtgttgtacagaggtcgccaggagaagttgatccgagtgagaaatccctgg   904
S  V  T  G  A  E  E  V  L  Y  R  G  R  Q  E  K  L  I  R  V  R  N  P  W     288
ggtgaggtagaatggactggaccttggagtgatgaggctccagaatggaattatgttgatccaaaagtaaaa   976
G  E  V  E  W  T  G  P  W  S  D  E  A  P  E  W  N  Y  V  D  P  K  V  K     312
gctgttctggataaaaaatctgaggatggagaattttggatggcgttttcagactttctcagagagtattcc  1048
A  V  L  D  K  K  S  E  D  G  E  F  W  M  A  F  S  D  F  L* R  E  Y  S     336
cgtctggagatctgtaacctgtctcctgacaccctcaccagcaaccaccaacataaatggaacataacattg  1120
R  L  E  I  C  N  L  S  P  D  T  L  T  S  N  H  Q  H  K  W  N  I  T  L     360
tacaccgggagctgggcacgggggtctactgccggaggctgccaaaattacccagcaacattttggaccaac  1192
Y  T  G  S  W  A  R  G  S  T  A  G  G  C  Q  N  Y  P  A  T  F  W  T  N     384
ccgcaatttcgcattaaactggatgagcccgatgatgatcatcaggggacgaacaatgagccgtgctgtacc  1264
P  Q  F  R  I  K  L  D  E  P  D  D  D  H  Q  G  T  N  N  E  P  C  C  T     408
gtcattgtgggactgatgcagaaaaaccgcagaagaaagaagaagatgggggaggacttgctcagcattggc  1336
V  I  V  G  L  M  Q  K  N  R  R  R  K  K  K  M  G  E  D  L  L  S  I  G     432
tactcactctttaagatccctgatcagcttcaggaccatacagatgcccacctcggcagggacttcttgcaa  1408
Y  S  L  F  K  I  P  D  Q  L  Q  D  H  T  D  A  H  L  G  R  D  F  L  Q     456
aagactccaacggccgcccgatctgacacctatatcaacgtacgggaggtgtccaaccgcttccacctaccg  1480
K  T  P  T  A  A  R  S  D  T  Y  I  N  V  R  E  V  S  N  R  F  H  L  P     480
gtcggggattatctgattgtgccatccacctttgagccctttaaaaatggcgacttctgccttcgtgtcttc  1552
V  G  D  Y  L  I  V  P  S  T  F  E  P  F  K  N  G  D  F  C  L  R  V  F     504
tcagaaaaggaggccaaatcgctagaagttggtgatgtagtgattgcgaaaccatatgaacctcagatttct  1624
S  E  K  E  A  K  S  L  E  V  G  D  V  V  I  A  K  P  Y  E  P Q  I  S      528
aacaaggatgtccctgatgatttcaagaatatttttgacaagctggcgggagataaagaagaagttgatgca  1696
N  K  D  V* P  D  D  F  K  N  I  F  D  K  L  A  G  D  K  E  E  V  D  A     552
agagaacttcaaaccattctaaataaactcatttcaaagaggccggacttgagatccaatggatttactctt  1768
R  E  L  Q  T  I  L  N  K  L  I  S  K  R  P  D  L  R  S  N  G  F  T  L     576
aacacatgcagagagatgatcagcttacaagatatggatggaaccgcaacactgagccttctggagttccgt  1840
N  T  C  R  E  M  I  S  L  Q  D  M  D  G  T  A  T  L  S  L  L  E  F  R     600
attctgtggatgaagatacagaaatatttggcaatctatttaaaggcagactcggatcgttctggaatcatg  1912
I  L  W  M  K  I  Q  K  Y  L  A  I  Y  L  K  A  D  S  D  R  S  G  I  M     624
gactctcatgagctgagaacagctttgcaagaagcaggttttactctgaataataagatccatgaatcaatt  1984
D  S  H  E  L  R  T  A  L  Q  E  A  G  F  T  L  N  N  K  I  H  E  S  I     648
gtgcagcgctacgcatccaatgacctggctcttaactttgatggctttatcgcttgtatgatgcgcctggag  2056
V  Q  R  Y  A  S  N  D  L  A  L  N  F  D  G  F  I  A  C  M  M  R  L  E     672
accttgttcaaaatgtttcagatgttggacaagagtaagagaggggtcgttgagctgagtttacaagagtgg  2128
T  L  F  K  M  F  Q  M  L  D  K  S  K  R  G  V  V  E  L  S  L  Q  E  W     696
ctctgcgcaacattggtctgaacctttactgccgtcgctgtgcaattctgtctccgtctggaagtgcattgc  2200
L  C  A  T  L  V  stop                                                     702
acttgatgtaaaaacagatacacacacacatgtaaatgagagaatatttgtaaaatagaatattatttcttg  2272
gaaaggttgttacgcacagataatgacatgtatgtgcactcgtttgaagggatggttcacctttgggttaac  2344
ttttggtatgttatagaatgccctattcatagcaatttttcaattggtcttcattatttattttgtataggt  2416
ttttaagtatttgccccatctcctgactcttcccggctttcaaatgggtcactgaccccatttaaaacagat  2488
gctttgtaaggctacagatttagtgggttatttattaaatatcaaattgtgacatctcaaaaaattcactag  2560
aaaacttgaatttttagagggaaaaaaagttttttcaagatttattataccttgatgctgcaaaaaaaaaaa  2632
aaaaaaa                                                                   2639
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(B)
XCL-2       MSRSAAVIAKDRTLADGGGTKRNPEKYLDQEFEKLRAQCLASGALYKDEEFPACPSALGY 60
nCL-2       -AAL--GVS-Q-AV-E-L-SNQNAVK--G-DFET--KQ--NS-V-FK-PE---C-S---Y 60
hCalpain    -AGI--KLA-D-EA-E-L-SHERAIK--N-DYEA--NE--EA-T-FQ-PS---I-S---F 60
cCalpain    -AGM--ALA-E-AA-A-A-RHGQAVP--G-DFGA--RE--QG-R-FH-PS---G-A---Y 60
XCL-2       NELRPGSYKTSGVIWKRPTEICPNPQFIVDGATRGDIRQGALGDCWLLAAIASLTLEPDL 120
nCL-2       KD-G-G-PD-Q-IV-K----L-PN-Q--VG----T--R--G-V-------------NEKL 120
hCalpain    KE-G-Y-SK-R-MR-K----I-AD-Q--IG----T--C--A-G-------------NEEI 120
cCalpain    RE-G-N-YK-K-VV-C----L-SC-R--AG----T--C--A-G-------------NEEI 120
XCL-2       VAQVVPENQSFQKNYAGIFHFRFWQYGEWVDVVVDDRLPTKNGKLVFVHSAEGDEFWSAL 180
nCL-2       LYR-L-RD----KD-------Q--------E--I-------N-Q-L-L--E--N------ 180
hCalpain    LAR-V-LN----EN-------Q--------E--V-------D-E-L-V--A--S------ 180
cCalpain    LAR-V-RD----DE-------Q--------D--V-------N-E-L-V--A--S------ 180
XCL-2       LEKAYAKLNGSYEALTGGSTIEGFEDFTGGIAEVYELKKAPPNLFQIIQKALKAESLLGC 240
nCL-2       -------L--S----V--S-I----------S-F-D-K-P-E--YY------RKG----- 240
hCalpain    -------I--C----S--A-T----------A-W-E-K-P-P--FK------QKG----- 240
cCalpian    -------L--S----S--T-T----------A-W-E-Q-A-P--FK------QKG----- 240
XCL-2       SIDITNAYDTEAITSRKLVKGHAYSVTGAEEVLYRGRQEKLIRVRNPWGEVEWTGPWSDE 300
nCL-2       ---VST-AEA--T-RQ------------V---NFH-RPE----L---------S-A-S-N 300
hCalpain    ---ITS-ADS--I-FQ------------A---ESN-SLQ----I---------T-R-N-N 300
cCalpain    ---ITS-AET--V-SQ------------A---NFR-SIQ----I---------T-K-N-N 300
XCL-2       APEWNYVDPKVKAVLDKKSEDGEFWMAFSDFLREYSRLEICNLSPDTLTSNHQHKWNITL 360
nCL-2       A-E-NYI--RRKEE-DKKA-------S-S---KQ---------S--S-S-EEIH--NLVL 360
hCalpain    C-S-NTI--EERER-TRRH-------S-S---RH---------T--T-T-DTYK--KLTK 360
cCalpain    C-N-SGV--EVRER-TRRH-------A-N---RH---------T--T-A-DRYK--SLLK 360
XCL-2       YTGSWARGSTAGGCQNYPATFWTNPQFRIKLDEPDDDHQGTNNEPCCTVIVGLMQKNRRR 420
nCL-2       FN-R-T--S-----L---G-Y-T---FK-H-D-V-E-QEEGTS-PC--VLL--M--N--R 420
hCalpain    MD-N-R--S-----R---N-F-M---YL-K-E-E-E-EEDG..-SG--FLV--I--H--R 418
cCalpain    LD-N-R--A-----R---N-F-T---YL-K-E-E-E-PDDP..-GG--FLI--I--H--K 418
XCL-2       KKKMGEDLLSIGYSLFKIPDQLQDHTDAHLGRDFLQKTPTAARSDTYINVREVSNRFHLP 480
nCL-2       QKRI-QGMLS--YAVYQI-KELESH-DA--GRD-FLGRQPSTC-S-YM-L---SS-VR-- 480
hCalpain    QRKM-EDMHT--FGIYEV-EELSGQ-NI--SKN-FLTNRARER-D-FI-L---LN-FK-- 478
cCalpain    QRKM-EDMHT--FAIYEV-PEFSGQ-NI--SKN-FLTNKAREK-N-FI-L---LN-FK-- 478
XCL-2       VGDYLIVPSTFEPFKNGDFCLRVFSEKEAKSLEVGDVVIAKPYEPQISNKDVPD.DFKNI 539
nCL-2       P-Q-LV-------FKD----L------K-KALEIG-TVSGHPH-PHPRDM-EEDEHVRSL 540
hCalpain    P-E-IL-------NKD----I------K-DYQAVD-EIEANLE-FDISED-IDD.GVRRL 537
cCalpain    A-E-II-------NLN----L------N-NSTVID-EIEANFE-TEIDED-IEP.SFKKL 537
XCL-2       FDKLAGDKEEVDARELQTILNKLISKRPDLRSNGFTLNTCREMISLQDMDGTATLSLLEF 599
nCL-2       -EEFV-KDS-IS-NQ-KRV-NEVLS--T-MKFD--NIN--RE-ISLL-S--TGS-GPM-- 600
hCalpain    -AQLA-EDA-IS-FE-QTI-RRVLA--Q-IKSD--SIE--KI-VDML-S--SGK-GLK-- 597
cCalpain    -GQLA-SDA-IS-FE-RSI-NKILA--Q-IKSD--SIE--KI-VDLL-N--SGK-GLK-- 597
XCL-2       RILWMKIQKYLAIYLKADSDRSGIMDSHELRTALQEAGFTLNNKIHESIVQRYASNDLAL 659
nCL-2       KT--L--RT-LE-FQEM-HNHV-TIEAH-M-T--KK---TLNNQVQQT-AM-Y-CSK-GV 660
hCalpain    YI--T--QK-QK-YREI-VDRS-TMNSY-M-K--EE---KMPCQLHQV-VA-F-DDQ-II 657
cCalpain    HT--T--QK-QK-YREI-VDRS-TMNSY-M-R--EA---KLSCQLHQI-VA-F-DED-II 657
XCL-2       NFDGFIACMMRLETLFKMFQMLDKSKRGVVELSLQEWLCATLV 702
nCL-2       D-NGFVA-MI-----F-L-RL--KDQN-IVQ-S-AE--CCVLV 703
hCalpain    D-DNFVR-LV-----F-I-KQ--PENT-TIE-D-IS--CFSVL 700
cCalpain    D-DNCVR-LI-----Y-M-RK--TEKT-TIE-N-IN--FFTVI 700
Fig.3.2 XCL-2 is novel member of m-type Calpain protease family. (A) Conceptual
translation of XCL-2. The putative translation start codon is preceded by a stop codon 12
triplets upstream (underlined). The four domains are separated by asterisks, the tentative
active sites Cys 105, His 262 and Asn 286 in proteolytic domain are in bold and the four
calcium-binding EF-hand motifs in Ca2+ domain are underlined. (B) Multi-alignment between
the amino acid sequences of XCL-2, rat stomach-specific m-type Calpain nCL-2, human
ubiquitous m-type Calpain (hCalpain), and chicken ubiquitous m-type Calpain (cCalpain).
stomach-specific m-type Calpain nCL-2 (Sorimachi et al., 1993), with 64%
identity in amino acids, and ubiquitous m-type Calpains in species such as
human and chicken, both with 60% identity (Fig.3.2B). Moreover, the protein
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has exactly the same domain structure, the calcium-binding motifs (EF-hands)
and the three active sites (Cys 105, His 262 and Asn 286) in proteolytic domain,
as in other typical Calpains (Arthur et al., 1995; Sorimachi et al., 1997; Fig.3.3).
It was hence designated as Xenopus CL-2 (XCL-2) (Genbank accession number:
AF212199).
Fig.3.3 Schematic struc-
ture of XCL-2, nCL-2
and the ubiquitous m-
type Calpain large
subunit (mCL). The four
domains are indicated
with I, II, III, and IV,
respectively; per-centages
represent the identities between XCL-2, nCL-2 and ubiquitous Calpains in human or chicken;
and C, H and N are the three active sites in Fig. 3.2A. aa, amino acid.
3.1.3 cDNA and amino acid sequences of XETOR
A cDNA sequence of 2377 bp was obtained from clone 18H2. Similarly, the
coding region of this cDNA was not complete at its 5’-end, either, and 5’RACE
was again applied to extend the coding sequence to the 5’-end. Finally, a cDNA
sequence of 2936 bp with a complete ORF was obtained (Fig.3.4A). The
complete open reading frame encodes a protein of 586 amino acids with an
overall homology of 72% to MTG8-like protein MTGR1, 59% to ETO in human
and 29% to Nervy in Drosophila (Fig.3.4B). MTG8 (also known as ETO or
CDR) is a proto-oncogene because it composes most of the fusion transcript that
is consistently present in acute myeloid leukemias containing the t(8;21)
translocation. XETOR in structure like other ETO/MTG8 related proteins has
four conserved domains termed Nervy Homologous Regions (NHRs; NHR1,
aa101-198; NHR2, aa336-363; NHR3, aa426-474; NHR4, aa497-534; Fig.3.4B)
because they share greater than 45% homology in these regions. Analysis of
NHR1 showed that it is homologous to TATA-binding protein-associated
factors (Erickson et al., 1994; Feinstein et al., 1995) and NHR2 is a helical
domain (Kitabayashi et al., 1998) with an oligomerization function (Zhang et al.,
2001). NHR3 has also a helical structure (Hildebrand et al., 2001). While NHR4
corresponds to two zinc-finger motifs (-C-x-x-C-7x-C-x-x-C-; -C-x-x-x-C-7x-H-
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x-x-x-C-; Fig.3.4B)(Feinstein et al., 1995; Kitabayashi et al., 1998). It was
therefore named as Xenopus ETO Related protein (XETOR), and the nucleotide
sequence was deposited in Genbank with accession number AF212198.
(A)
    ggccctttaaccttctgtgtatt    23
gtagcaacatcaagattatattcattttactggggacttgtgtgacattgtggctttgcatttgctttggataga    98
atggttgggattccaggaccctatcagtttactggggacaagagggtgccagccatgcctgggtctcccatggaa   173
M  V  G  I  P  G  P  Y  Q  F  T  G  D  K  R  V  P  A  M  P  G  S  P  M  E      25
gtgaagatccactccagatcctcgccgccaatcatggcaccacttcctcctgtgaatcctggtggacttcggcct   248
V  K  I  H  S  R  S  S  P  P  I  M  A  P  L  P  P  V  N  P  G  G  L  R  P      50
gtcggctttcccccatcatcacattccaatggtatcaaccattctccccccacacttaatggagccccatcccca   323
V  G  F  P  P  S  S  H  S  N  G  I  N  H  S  P  P  T  L  N  G  A  P  S  P      75
cctcagcgttccagcaatggtccatcatcatcatcctcctcttccctggccaatcagcagcttcctgccacctgt   398
P  Q  R  S  S  N  G  P  S  S  S  S  S  S  S  L  A  N  Q  Q  L  P  A  T  C     100
ggggtgaggcaactcagcaaactgaaaagatttctcactacattgcagcagtttggaaacgacatctctccagag   473
G  V  R  Q  L  S  K  L  K  R  F  L  T  T  L  Q  Q  F  G  N  D  I  S  P  E     125
ataggggaaaaggtccgcaccctagttttggccctggtgaactcaactgtaaccattgaggaatttcactgcaaa   548
I  G  E  K  V  R  T  L  V  L  A  L  V  N  S  T  V  T  I  E  E  F  H  C  K     150
ctgcaagaagccaccaattttcccttgcgcccctttgtcattccattcctgaaggccaacttgcctcttctgcag   623
L  Q  E  A  T  N  F  P  L  R  P  F  V  I  P  F  L  K  A  N  L  P  L  L  Q     175
cgggagttactacactgtgcccgagctggcaagcagaccccttcccagtacctggcacagcatgaacatattctc   698
R  E  L  L  H  C  A  R  A  G  K  Q  T  P  S  Q  Y  L  A  Q  H  E  H  I  L     200
ctgaataccagcacttcttccccagcagattcctcagaactgcttatggaaatgaatggcaatgggaaacgacat   773
L  N  T  S  T  S  S  P  A  D  S  S  E  L  L  M  E  M  N  G  N  G  K  R  H     225
agccctgacaggagagaagaagagagagaaactgcacccgcggaacctccagttaagagagtctgcactatcagt   848
S  P  D  R  R  E  E  E  R  E  T  A  P  A  E  P  P  V  K  R  V  C  T  I  S     250
ccagcccccagacacagcccggctttgtccctccctctcgtgaacagcaccagccacttccacccaacaccacca   923
P  A  P  R  H  S  P  A  L  S  L  P  L  V  N  S  T  S  H  F  H  P  T  P  P     275
ccccttcagcactactccttggaggatattcccagctctcagctttacagagaccacctaaacaagatcggcgaa   998
P  L  Q  H  Y  S  L  E  D  I  P  S  S  Q  L  Y  R  D  H  L  N  K  I  G  E     300
caccgggacgttagagatcggcatcacagttctggagtcaatggcaacttaaataatggctaccaggaagaactt  1073
H  R  D  V  R  D  R  H  H  S  S  G  V  N  G  N  L  N  N  G  Y  Q  E  E  L     325
gtagaccatcggctgacagagcgagaatgggcagaagaatggaagcatctggaccatgcattgaactgtatcatg  1148
V  D  H  R  L  T  E  R  E  W  A  E  E  W  K  H  L  D  H  A  L  N  C  I  M     350
gagatggtagagaagactcggcgctcaatggccgtgctgcgtcgctgtcaggaagtggatagagacgagctcaac  1223
E  M  V  E  K  T  R  R  S  M  A  V  L  R  R  C  Q  E  V  D  R  D  E  L  N     375
tactggaaacggagattcaacgagtcaaatgagatccggaagggaagtgagcatcccagcaggcaacatagccct  1298
Y  W  K  R  R  F  N  E  S  N  E  I  R  K  G  S  E  H  P  S  R  Q  H  S  P     400
tccagcaccgattcaggagccagcgattccgttcgtgactttgggagcagaacaggagcaggctatgtaacagat  1373
S  S  T  D  S  G  A  S  D  S  V  R  D  F  G  S  R  T  G  A  G  Y  V  T  D     425
gagatctggagaaaagcagaggaggcagtgaatgaagtcaaacggcaggcaatgtctgaagtacaaaaggctgtc  1448
E  I  W  R  K  A  E  E  A  V  N  E  V  K  R  Q  A  M  S  E  V  Q  K  A  V     450
tcggaagcagagcagaaagcatttgagatgatagcatcagagagagcaaggatggaacagaccattgtggacgca  1523
S  E  A  E  Q  K  A  F  E  M  I  A  S  E  R  A  R  M  E  Q  T  I  V  D  A     475
aagaggagggctgcagaagacgccgtcttggttgtgaatgagcaggaagagtccactgagagctgctggaattgt  1598
K  R  R  A  A  E  D  A  V  L  V  V  N  E  Q  E  E  S  T  E  S  C  W  N  C     500
ggtcggaaagcgagcgagacatgcagtggctgtaacatcgctcgctactgtggctccttctgtcagcacaaggac  1673
G  R  K  A  S  E  T  C  S  G  C  N  I  A  R  Y  C  G  S  F  C  Q  H  K  D     525
tgggagaaacatcaccgcatctgtggccaaagcatgcatacacaggcaaaaccactcaccccatctcgttccctg  1748
W  E  K  H  H  R  I  C  G  Q  S  M  H  T  Q  A  K  P  L  T  P  S  R  S  L     550
atccccaaagcctctgaccccgtccttctgagccccactctggagaggtcttccagcgccacctcacgctcctct  1823
I  P  K  A  S  D  P  V  L  L  S  P  T  L  E  R  S  S  S  A  T  S  R  S  S     575
acacctgcttctgtcactgctgttgatggcctgtgaagagagaatgagaatgagtctttttccccctatggattt  1898
T  P  A  S  V  T  A  V  D  G  L  stop                                         586
atttaccccctttttgcgctcagagtaacataataagtccacgagacagcagcaattcggcctttctctgaagag  1973
aaaatttcatccatcttgatgtatttaaataattgctggtgcagcaaaatacaagaagagacagttaataaagaa  2048
gatgggaaaaaaactgaaatcgcccggagacctattggcccatctctttaaaaaggcaattgcccaaatgggatc  2123
taaattgtgtgtgtatatatatatatatatatttgaaatggacattcatttggctgatttctagtggaccagatt  2198
gctagggacttctatctgggcctcaaagtgttatcccagttatagactgcattctggactaaccaagcaatcggt  2273
atgttcgtgtttggcctttgcatcccgtattttcttgcccagaagaaaaagcagatatgtaatatatctccctca  2348
gcctaacccatgttgtctatcaggaagagtcagcatgagtcgtttggttgttaaatgggcaaatatcagggccat  2423
acaataaagactatttgtgaaactgagattttataagagatcatgtaccccctattgttaagtatgaatatatta  2498
catcacttagcatatggatatgcatatggactgtgctattgtctaggagcagttgtgcctatggctttgcagcac  2573
aagggatttgcaaaatggcagactggccaaaccaaatgtaaacttcagatggattatttttcacttccaaagatg  2648
tcaccaaatatgagattaaattgtcagtctttccgtgtagataatgtaacataataaggattattctcactccgt  2723
attttcgtgtctgttgaaagtgataaacgtttcctcccatcgtcagagctgcgttggttcattgttggaaattgc  2798
tcattttataaagtgctgtttcatgaataagctacatatattatgtgagtcctgtacagattacagatatactaa  2873
tcatttattatggagtttattcaataaagttcattttaccagtaaaaaaaaaaaaaaaaaaaa              2936
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(B)
XETOR    ............................................................
MTGR1    ............................................................
ETO      ............................................................
Nervy    MMALDGKAIIKEEITDKDAYDAAAAAAAAVAAGRALAVASAAAVQVPPASSSSAGSASSA 60
XETOR    .................MVGIPGPYQFTG........DKRVPAMPGSPMEVKIHSRS... 32
MTGR1    ......MAKESGISLKEIQVLARQWKVGP........EKRVPAMPG-PVEVKIQS-S... 43
ETO      ......MISVKRNTWRALSLVIGDCRKKGNFEYCQDRTEKHSTMPD-PVDVKTQS-L... 51
Nervy    AAAATNNTTSAAATAAAISRRLKASSSGGDKSSTSSSSSKDSSHTS-SRSERDRE-ERER 120
XETOR    .............SPP....IMAPLPPVNPGGLRPVGFPPSSHSNGINHSPPTLNGAPSP 75
MTGR1    .............S--....TMP-LP-INPGGPRPVSFTPTALSNGINH-PPTLN-AP-P 86
ETO      .............T--....TMP-.P-TTQGAPRTSSFTPTTLTNGTSH-PTALN-AP-P 93
Nervy    ERERDRLCRTPPDS--DSSRSLA-RS-HSPLQLHQRPQRNASVSPVVNG-SSGGG-VG-S 180
XETOR    PQRSSNGPSSSSSSSLANQQLPATCG....VRQLSKLKRFLTTLQQFGNDIS.PEIGEKV 130
MTGR1    PQRFSNG-A-STSSA-TNQQLPATCG....A-QL--LKR--TT-Q--GNDIS.--IG-K- 141
ETO      PNGFSNG-S-SSSSS-ANQQLPPACG....A-QL--LKR--TT-Q--GNDIS.--IG-R- 148
Nervy    GTSPTPT-G-QHAAS-AAAAAAAAAAHVEQA-LV--MRK--GA-V--SQELGQ--VS-R- 240
XETOR    RTLVLALVNSTVTIEEFHCKLQEATNFPLRPFVIPFLKANLPLLQRELLHCARAGKQTPS 190
MTGR1    -T---A-VNSTVTI---HCK----T-F----F-I-F--ANLP-L---L-HC--AAK-TPS 201
ETO      -T---G-VNSTLTI---HSK----T-F----F-I-F--ANLP-L---L-HC--LAK-NPA 208
Nervy    -A---S-CSGSISV---RLA----I-L----Y-V-L--NSIA-V---I-AL--ATN-SAL 300
                                   I
XETOR    QYLAQHEHILLNTSTS..SPADSSELLMEMNG...NGKRHSPDRREE...ERETAPAEPP 242
MTGR1    --LAQH-HLLLNTSIA..SPADSSELLMEVHG...--KRPSPE-REENSFDRDTIAPEPP 256
ETO      --LAQH-QLLLDASTT..SPVDSSELLLDVNE...--KRRTPD-TKENGFDREPLHSEHP 263
Nervy    --VTNN-QAVMEFAPHGVASAEFGDIFIQLEAPTS--SSAVFK-RSSDSMMEHGGHNGLQ 360
XETOR    VKRVCTISPAPRHSPALSLPLVNSTSHFHPTPPPLQHYSLEDIPSSQLYRDHLNKIGEHR 302
MTGR1    AKRVCTI-PAPRHS-ALTVPLMNPGGQFHPTPPPLQHYTLEDIATSHLYRE.PNKMLEHR 315
ETO      SKRPCTI-PGQRYS-NNGLSYQ.PNGLPHPTPPPPQHYRLDDMAIAHHYRD.SYRHPSHR 321
Nervy    EWSEYMA-GGAGYP-PPSKRLTLHPAHSVVAYGEYGVSSAEGLPSAAAFMQRDERDLRMS 420
XETOR    DVRDRHHSSGVNGNLNNGYQEELVDHRLTEREWAEEWKHLDHALNCIMEMVEKTRRSMAV 362
MTGR1    EVRD-HHSLGLNG....GYQDELVDHRLTEREWAD---HLDHA----ME--E--R-SMAV 371
ETO      DLRD-NRPMGLHG....TRQEEMIDHRLTDREWAE---HLDHL----MD--E--R-SLTV 377
Nervy    EAQA-HAAPPQRAG-NPQPNPNAAAPGAPGAGGEE---NIHTM----SA--D--K-AITI 479
                                                           II
XETOR    LRRCQEVDRDELNYWKRRFNESNEIRK.GSEHP..SRQHSPSSTDSGASDSVRDFGSRTG 419
MTGR1    -RRCQESDREELNYWKRRYNENTELRKTGTELV..SRQHS-GSADSLSNDSQREFNSRPG 429
ETO      -RRCQEADREELNYWIRRYSDAEDLKKGGGSSSSHSRQQS-VNPDPVALDAHREFLHRPA 437
Nervy    -QQRG..............................IEPQH-NSGQEVTPAAMAELRR..Q 507
XETOR    AGYVTDEIWRKAEEAVNEVKRQAMSEVQKAVSEAEQKAFEMIASERARMEQTIVDAKRRA 479
MTGR1    TGYVPV-FWKKT-E--NK--I--MS-V-K--AE--QK-FEVIAT--AR--QTIADVK-QA 489
ETO      SGYVPE-IWKKA-E--NE--R--MT-L-K--SE--RK-HDMITT--AK--RTVAEAK-QA 497
Nervy    TEEKVA-FKRNA-D--TQ--R--VI-I-R--VA--TR-AEIMTQ--LR--KFFMEMS-HS 567
                                      III
XETOR    AED........AVLVVNEQEESTESCWNCGRKASETCSGCNIARYCGSFCQHKDWEKHHR 531
MTGR1    AED........AFLVINEQEESTEN--------S-------I----GSF--HK--ER--R 541
ETO      AED........ALAVINQQEDSSES--------S-------T----GSF--HK--EK--H 549
Nervy    SGERDLDNKSPSMASAQNGSNLQQQ--------T-------M----SAS--YR--DS--Q 627
                                  *  *       *  *  IV *   *       *
XETOR    ICG.........QSMHT.........QAKPLTPS.RSLIPKASDPVLLSPTLERSSSATS 572
MTGR1    L--.........QNLHGQS....PHGQGRPLL-VGRGSSARSADCSVPSPALDKTSATTS 588
ETO      I--.........QTLQA.........QQQGDT-AVSSSVTPNSGAGSP...MDTPPAATP 588
Nervy    V--NTRASELSAKHLHSASNLSLRNAMATRSP-TPNSAAHLQAAAAAAAAAAGAREAVSA 687
          *
XETOR    RSSTPASVTAVD..GL........................................ 586
MTGR1    RSST-ASVTAIDTNGL........................................ 604
ETO      RSTT-GTPSTIETTPR........................................ 604
Nervy    PVGG-GAGIAVGTGAGSGGQSGGGGGGGGGGGGGAAAAAVAAATPGALVANGLGSK 743
Fig. 3.4 XETOR is a novel member of ETO oncoprotein family. (A) Conceptual
translation of XETOR. The translation start codon is preceded by a stop codon 11 triplets
upstream (underlined). (B) Amino acid sequence comparison between XETOR and human
MTG8-related protein (MTGR1), human ETO and Drosophila Nervy proteins. The four
conserved Nervy Homologous Regions are underlined and marked with I, II, III, and IV
underneath. The two zinc finger motifs (-C-x-x-C-7x-C-x-x-C-; -C-x-x-x-C-7x-H-x-x-x-C-)
are in bold and the cysteine and histidine residues in the motifs are marked with asterisks.
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3.2 Spatial and temporal expression of XODC2, XCL-2 and XETOR
3.2.1 Expression pattern of XODC2
The expression of XODC2 was first detected by whole mount in situ
hybridization at stage 9 at the animal pole (Fig.3.5D), and increases during
gastrulation (Fig.3.5E). At neurula stages the expression shifts to neural folds
but more pronounced in the two extreme cranial and caudal regions along the
anterior-posterior axis (Fig.3.5F). However, starting from tailbud stage, its
expression is gradually restricted to certain tissues: forebrain, inner layer of
epidermis of the head area, stomodeal-hypophyseal anlage, frontal gland, ear
vesicle, branchial arches, the most anterior neural tube, the inner- and outer fin
of the tail and proctodeum (Fig.3.5G, H). This prominent localized expression
was also confirmed by histological sections through the head and tail areas
(Fig.3.5I, J, K). After stage 34 the expression was no longer detectable by in situ
hybridization. RT-PCR was also used to study the temporal expression of the
gene. It could be shown that this gene is already expressed in the unfertilized
egg, but at a very low level. Starting from stage 9 its expression increases
gradually and reaches the highest level at the end of neurula and the beginning
of the tailbud stage, and then decreases gradually (Fig.3.6).
Since the gene encodes a protein that is highly homologous to XODC1,
which has been found ubiquitously in almost every cell type studied, it is of
certain interest to compare the expression of the two genes. No discernible
signals of XODC2 could be seen in embryos before stage 9, while significant
staining is already observed in the animal pole of unfertilized eggs, cleavage and
gastrula embryos (Fig.3.5L and data not shown). Starting from neurula stage,
expression of XODC2 is gradually localized as described above, while in
contrast, during neurula and tailbud stages, as expected the expression of
XODC1 is ubiquitously observed throughout the whole embryos except cement
glands in tailbud embryos (Fig.3.5M, N). Additional studies with RT-PCR
demonstrated that XODC2 is different from XODC1 in its temporal expression.
In the case of XODC1, the expression is nearly uniform through all stages
examined, but the expression level of XODC2 varies to a certain degree during
embryonic development. It is quite low in embryos before stage 9 followed by a
dramatic  increase up till stage 29, and then decreases gradually (Fig.3.6). In
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Fig. 3.5 Expression patterns of XODC2 (A-K) and XODC1 (L-N) by whole mount in situ hybridi-
zation. (A-C) Unfertilized egg and early embryos before stage 8 showing no significant signal for
XODC2. (D, E) Late blastula and gastrula embryos showing strong signal. (F, G) During neurula and
early tailbud stages the expression extends to both ends of body axis and becomes gradually localized.
(H) stage 33 embryo showing tissue-specific expression in anus, branchial arches, the surface of the
lower part of cement gland, ear vesicle, forebrain, frontal gland, and inner- and outer-fin at tail tip. (I)
A mid-sagittal section through the head of a stage 26 embryo, showing the expression of XODC2 in
stomodeal-hypophyseal anlage, and the inner layer of epidermis of the forehead area and underneath
the cement gland. (J) A mid-sagittal section through the head of a late tailbud (stage 30) embryo,
confirming the expression in frontal gland, prosencephalon and lower surface of cement gland, as
revealed in (H); moreover, it also confirms its expression in most anterior neural tube. (K) A sagittal
section through the tail of a stage 33 embryo confirming the expression of XODC2 in anus. (L-N)
Ubiquitous expression of XODC1 in early embryogenesis. In all the figures the animal pole or dorsal
is up and the anterior is left. an, anus; ba, branchial arch; cg, cement gland; ev, ear vesicle; fb,
forebrain; fin, fin; fg, frontal gland; ie, inner layer of epidermis; nt, neural tube; pc, prosencephalon;
pr, proctodeum; sha: stomodeal-hypophyseal anlage.
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conclusion, by whole mount in situ hybridization the author could show the
tissue-specific expression pattern of a novel cDNA paralogous to ubiquitous
ODC in Xenopus laevis.
Fig.3.6 Tem-poral expres-sion of XODC2 and XODC1 revealed by RT-PCR. The
expressions of both genes were detected since unfertilized egg. However, there is little
variation in the expression level of XODC1, while the expression level of XODC2 in different
stages changes significantly, with quite low level before stage 9 and dramatic increase
thenceforth until stage 34. Numbers indicate embryonic stages. E, unfertilized egg; RT-,
control reverse transcription without transcriptase.
3.2.2 Expression pattern of XCL-2
Spatial expression of XCL-2 was examined by whole mount in situ
hybridization. Signals were first detected in the area close to the ventral
blastopore lip at stage 12.5 (Fig. 3.7A). As neurulation proceeds, its expression
is mainly localized to the most anterior and posterior areas; that is, the most
anterior part of the neural plate (Fig. 3.7B) and a very restricted area ventral to
the closed slit-like blastopore (Fig. 3.7C). Sagittal histological sections through
a stage 15 embryo revealed that in the anterior XCL-2 was expressed in the
mesoderm-free zone at the most anterior tip of neural plate, where the
stomodeum and cement gland form. In the posterior area, it was expressed in the
ventral part of circumblastoporal collar (Fig. 3.7G). From the late neurula stage,
it was expressed significantly in the cement gland and proctodeum (Fig. 3.7D).
The staining pattern was also confirmed by sagittal sections through the head or
tail area of stage 23 embryos, respectively (Fig. 3.7H, I). After stage 34,
expression was only found in the cement gland (Fig. 3.7F). Temporal expression
pattern was also examined using RT-PCR. The signal is already detectable at
stage  10.   The  expression  level   increases   gradually  during  neurulation  and
XODC2
XODC1
E 5 8 9 10 11 12 15 19 23 29 34 38 43 RT-stage 10.5
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reaches the highest level at stage 30. In the late tailbud and swimming tadpole
stages, only low levels were detected (Fig. 3.8A).
Fig.3.7˚ Spatial expres-
sion of XCL-2.  (A)
Posterior view of stage
12.5 embryos. Dorsal is
up. Signal appears at a
restricted area ventral to
blastopore. (B, C)
Anterior and posterior
views, respectively, of a
same stage 15 embryo.
Dorsal is up. In (B),
expression is detected at
the most anterior of
neural plate; in (C) it
shows  t he  s ame
expression zone as in (A). (D) Ventral view of a late neurula.  Anterior is left. It shows the
localized expression in cement gland and proctodeum. (E) Ventral view of an early tailbud.
Anterior is left. The expression in cement gland and proctodeum becomes even stronger. (F)
In late tailbud stages, expression is only detected in the cement gland. (G) A sagittal section
through a stage 15 embryo, confirming that the expression in (B) and (C) is only localized to
the mesoderm-free zone and the ventral circumblastoporal collar. The expression zone is
highlighted with boxes. (H, I) Sagittal sections through the head and tail of a stage 23 embryo,
respectively, confirming that the expression in (E) is only localized to cement gland and
proctodeum. a, anterior view; bl, blastopore; cg, cement gland; mfz, mesoderm-free zone; nf,
neural fold; nt, neural tube; p, posterior view; pc, prosencephalon; pr, proctoduem; pv,
procencephalic ventricle; vbc, ventral circumblastoporal collar.
Expression pattern of XCL-2 in adult tissues was further examined. RNA
was extracted from brain, eye, heart, intestine, kidney, liver, lung, muscle, nerve,
ovary, skin, spleen, stomach and testis. Relatively high levels of expression of
XCL-2 were detected in kidney, lung and stomach, and low levels were detected
in brain, eye, heart, intestine and testis. Expression was not detected in liver,
muscle, nerve, ovary, skin and spleen (Fig. 3.8B). The stomach expression of
XCL-2 confirms that it is closely related to nCL-2, which is predominantly
expressed in rat stomach (Sorimachi et al., 1993).
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Fig. 3.8 Expression patterns of XCL-2 detected with RT-PCR. (A) Temporal expression
during embryogenesis. Numbers indicate developmental stages. Expression was detected
from the onset of gastrulation (stage 10). The expression level continuously increases until the
middle of tailbud stage. After approximately stage 30, the expression level decreases
gradually. (B) Expression in adult tissues. Various levels of expression of XCL-2 were
detected in adult tissues such as brain, eye, heart, intestine, kidney, lung, stomach and testis,
but not in liver, muscle, nerve, ovary, skin and spleen. ODC was used as loading control in
both cases. br, brain; ey, eye; he, heart; in, intestine; ki, kidney; li, liver; lu, lung; mu, muscle;
ne, nerve; ov, ovary; sk, skin; sp., spleen; st, stomach; te, testis; RT-, reverse transcription
without reverse transcriptase.
3.2.3 Expression pattern of XETOR
XETOR transcripts in the nervous system were first detected within the
dorsal ectoderm at stage 12.5 in a pattern of radially symmetrical stripes on
either side of the dorsal midline of the posterior neural plate (Fig.3.9A). This
pattern grows more prominent with the completion of gastrulation and ongoing
of neurulation, after the neural plate has narrowed by convergent extension
movements (Fig. 3.9B, D, E). The pattern of three longitudinal domains
anticipates the expression of N-tubulin, which was previously shown to mark
primary neurons. These primary neurons are formed in lateral, intermediate and
medial stripes that will differentiate into motorneurons, interneurons and sensory
neurons (Rohon-Beard cells), respectively (Oschwald et al., 1991; Chitnis et al.,
1995), on either side of dorsal midline. In the anterior neural plate, expression of
XETOR was also detected in a lateral group of cells associated with trigeminal
ganglia, an extreme anterior group of cells associated with olfactory placode, a
central stripe corresponding to the sites of future brain and in the prospective
anterior neural crest cells (Fig.3.9B, C, D). It is noteworthy that during early
stages of neurulation, there is also an expression domain of XETOR in the
ventral side (Fig.3.9C).  This domain is reminiscent of the expression of Xaml in
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ventral blood island (Tracey et al., 1998). The ventral expression of XETOR
seems to persist only in a very short time window between stages 12-14. Before
and after this time, no expression was observed in this domain at all.  Double in
situ hybridization showed that the expression domain of XETOR is overlapping
with that of N-tubulin. However, the medial stripe of XETOR expression is
broader than the corresponding stripe of N-tubulin, thus some cells located more
laterally with respect to dorsal midline expressing XETOR do not express N-
tubulin (Fig.3.9H, I). This may suggest the role of XETOR in refining the
localization of primary neuron formation. In summary, such an expression
pattern shows that XETOR  is expressed at the location where primary
neurogenesis occurs, and hence a marker for early embryonic neurogenesis.
Fig. 3.9 Spatial expression of XETOR
during embryogenesis revealed with
whole mount in situ hybridization. (A)
From stage 12.5 the signal appears in three
stripes marked with l, i and m on each side
of the embryo. (B) Expression in stripes
grows more prominent as neurogenesis
proceeds, and the expression is also
observed in the trigeminal ganglia. (C) In
addition to expression in neural system,
XETOR is also expressed in the
presumptive ventral blood island. (D) and
(E) The expression moves towards the
midline as the neural plate narrows due to
convergent extension movements. (F)
During early tailbud stage, XETOR
expression is localized to brain and spinal
cord. (G) At late tailbud stage, the
expression domain in spinal cord
disappears but becomes more prominent in
midbrain, hindbrain and sensory organs in
head area. (H) Double in situ hybridization reveals that the expression domain of XETOR
(purple, and indicated with arrow heads) is overlapping with but broader than that of N-
tubulin (magenta, and indicated with asterisks), in particular the medial stripe. (I) Transversal
section through an embryo in (H) confirms the coexpression of the two genes. (A), (B), (D),
(E) and (H) are dorsal view of neurulae, anterior is up; (C) is ventral view of a neurula as in
(B), anterior is up; (F) is doral view of a tailbud, anterior is left; (G) lateral and dorsal view
(inset) of a same tailbud, anterior is left. ba, branchial arch; bl, blastopore; i, intermediate
stripe; l, lateral stripe; m, medial stripe; mc, mescencephalon; op, olfactory placode; rc,
rhombencephalon; re, retina; vbi, ventral blood island.
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From stage 24 on, XETOR was detected to express exclusively in the neural
system, incuding the spinal cord, forebrain, midbrain, hindbrain, eyes, and
olfactory placodes (Fig.3.9F). At around stage 32, the expression in spinal cord
fades out and principally restricts to midbrain, hindbrain and the sensory organs
in the head area (Fig.3.9G).
Expression of XETOR during secondary neurogenesis was also compared to
that of other genes involved in neural development. It can be observed that the
expression of Xngnr-1, XDelta-1, Xath3, and XNeuroD locates in the inner,
mitotically active ventricular zone (Fig. 3.10A, B, C, F). In contrast, N-tubulin is
expressed exclusively in the outer lateral layer of differentiated cells (Fig.
3.10D). The expression of XETOR is different from those above in that the
transcripts seem to be distributed evenly in the dorsal part of neural tube (Fig.
3.10E).
Fig. 3.10 Comparison between
expression of XETOR (E) and the
expression of Xngnr-1 (A), X-Delta-1
(B), Xath3 (C), N-tubulin (D), and
XNeuroD (F) in the neural tube during
secondary neuro-genesis. Embryos at
stage 32 were hybridized with probes
indicated in the figures. Transversal
sections were made approximately
through hindbrain.
3.3 Functional analyses on XODC2, XCL-2 and XETOR
3.3.1 Functional analysis on XODC2
mRNA of XODC2 or dnXODC2 was injected into either two dorsal or two
ventral blastomeres of 4-cell stage embryos. However, no significant disruptions
of embryogenesis in response to XODC2 or dnXODC2 overexpression were
observed (data not shown). This observation suggests that XODC2 might not
play pivotal roles for embryonic development. Therefore, further functional
investigation was not made for XODC2.
Xngnr-1 A
B
XDelta-1 B Xath3 C
N-tubulin D XETOR E XNeuroD F
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3.3.2 Functional analysis on XCL-2
3.3.2.1 Overexpression of XCL-2 causes severe developmental
defects in Xenopus embryos
In order to examine the effects of the XCL-2 gene on the embryonic
development of X. laevis, various doses of mRNA were injected into embryos at
early stages. Injection of mRNA at doses of 2 ng or 2.5 ng into two dorsal
blastomeres close to the vegetal pole of the 4-cell stage embryo did not result in
significant changes in embryonic morphology (data not shown). However,
injections at the equatorial or animal region of two dorsal blastomeres caused
significant developmental defects. The percentage of affected embryos rose with
the increase in injected dose: 2 ng of XCL-2 mRNA resulted in 67% of embryos
with defects, while 97% of embryos showed defects with a dose of 2.5 ng
(Table 3.2). In control embryos injected with 2 ng of β-galactosidase mRNA,
only 10% of the injected embryos showed developmental defects (Table 3.2).
Affected embryos with XCL-2 injection first showed a delay in the gastrulation
process, which resulted in a distinct phenotype at later stages. At the onset of
gastrulation, the dorsal blastoporal lip formed, similar to control embryos.
However, as gastrulation proceeded, the injected embryos showed a much larger
blastopore and yolk plug (Fig. 3.11B) than untreated controls (Fig. 3.11A). The
neural folds of these embryos did not close at the end of neurulation and the
blastopore remained open. Therefore, the endoderm involuted only partially.
Tailbud stage embryos and swimming tadpoles showed a reduction of the
anterior-posterior axis, microcephaly and a bifurcate tail (Fig. 3.11D). The
number of affected embryos and the degree of the phenotypic disorder increased
with higher doses of injected mRNA (Table 3.2). In some cases, head structures
were no longer formed.
Histological sections of the embryos were also prepared to analyze the
phenotypic aberrations in more details. Head formation was disturbed to varying
degrees in most injected embryos. It was difficult to discriminate between
prosencephalon and mesencephalon in most embryos, either. The prosencephalic
and mesencephalic ventricles were much smaller than those in normal embryos.
However, the rhombencephalon developed quite normally. The embryos
generally formed smaller eyes and otic vesicles. In some cases they were totally
missing. Another target of defects was the notochord. Most embryos injected
with  XCL-2 had  notochords with  an enlarged anterior part.  The elongated part
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was oriented in a dorsal-ventral direction. The notochords bifurcated behind the
otic vesicles (Fig. 3.11E, F).
Fig. 3.11   Overexpression of XCL-2
disrupts gastrulation movements
and causes a significant phenotype.
mRNA was injected into two dorsal
blastomeres at the 4-cell stage. (A)
Control embryos at stage 11 with
normal blastopores. (B) Injected
embryos showing blastopores of a
much larger size than in the controls.
(C) Control normal swimming
tadpoles at stage 38. (D) Injected
embryos at the same stage as in (C).
The embryos show significant
microcephaly (top) and even no
discernible head structure (bottom),
and shortening of the anterior-
posterior axis. The foreheads shift
dorsalwards. The endoderm of the
embryos can be clearly seen externally
and bifurcate tails are formed. (E, F)
Transversal sections through the otic
vesicle (E) and the trunk region behind the otic vesicle (F) of an injected embryo at stage 30,
showing bifurcation and further shifting of notochord towards one side of the body. cc, central
canal; no, notochord; ov, otic vesicle; rc, rhombencephalon; rv, rombencephalic ventricle; sp,
spinal cord.
3.3.2.2 Ectopic expression of XCL-2 affects the location of
mesodermal or neural markers and disrupts convergent extension
To determine whether ectopic expression of XCL-2 causes changes in
pattern formation, whole mount in situ hybridization with different mesodermal
and neural markers was carried out. In normal embryos at stage 11, the Xbra
signal formed a ring around the yolk plug (Fig. 3.12A). However, in embryos
injected with XCL-2, Xbra was still expressed around blastopore but was absent
in the dorsal lip (Fig. 3.12D). The expression of Xvent-1 in the lateral mesoderm
was much weaker or even absent in XCL-2-injected embryos (Fig. 3.12E), hence
expression was more restricted to the ventral-most mesoderm than in the control
(Fig. 3.12B). In midgastrulae, Chordin and Xotx2 are normally expressed only in
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dorsal blastopore lip (Fig. 3.12C, G), and in late gastrulae or early neurulae
Chordin is also expressed in the midline (Fig. 3.12M). In contrast, their
expression was extended laterally and posteriorly rather than anteriorly in
embryos overexpressing XCL-2 (Fig. 3.12F, J, P). Further analysis with the
paraxial mesodermal marker XMyoD (Fig. 3.12H, K, N, Q) and the neural
marker Xsox3 (Fig. 3.12I, L, O, R) in midgastrula and midneurula embryos
indicated that expression of these genes was not correctly localized compared
with control embryos.
Fig. 3.12   Overexpression of XCL-2
affects the localization of mesodermal
or neural markers and disrupts
convergent extension movements.
mRNA was injected into two dorsal
blastomeres at the 4-cell stage. (A)
Expression of Xbra is localized to a ring
surrounding the blastopore of control
midgastrulae. In injected embryos the
expression is absent at dorsal blastopore
lip (D). (B) In control embryos of mid-
gastrulae, Xvent-1 is expressed in ventral
and la tera l  mesoderm,  whi le
overexpression of XCL-2  renders the
expression shift more ventralwards (E).
(C) Xotx2 in control midgastrulae is
expressed in the dorsal blastopre lip, but
in injected embryos its expression extends
laterally (F). (G) Chordin (c h d ) is
expressed at the dorsal blastopore lip of
control midgastrulae and (M) at the
midline in late gastrulae, but in injected
embryos its expression extends posteriorly
and laterally (J, P), showing disruption of
convergent extension movement. (H)
X M y o D  is expressed in the paraxial
mesoderm in late gastrulae and (N) mid-
neurulae, but in injected embryos at
equivalent stages (K, Q) it is expressed in a distance away from the midline, showing that
paraxial mesoderm does not converge to the midline. (I, O) The neural plate is shown by the
neural marker Xsox3 in normal late gastrulae and mid-neurulae, respectively, and also
undergoes convergent extension. However, overexpression of XCL-2 causes the posterior
expression area of Xsox3 to shift away from the midline, a further indication for the failure of
convergence of the posterior neural plate towards the midline (L, R).
chd XMyoD Xsox3
control
XCL-2
XCL-2
control
st11 st12.5 st12.5
st12.5 st17 st17
Xbra Xvent-1 Xotx2
control
st11 st11 st11
A CB
E
G H I
J K L
M N O
P Q R
XCL-2
D F
3. Results 57
These results reveal that XCL-2 affects the localization of mesodermal or
neural markers, but does not alter cell fate significantly. In addition, they also
show that XCL-2 disrupts convergent extension movements. During gastrulation
and neurulation, dorsal tissues, including the prospective notochord, somitic
mesoderm and posterior neural plate, converge to the midline of the embryos
and extend along the future anterior-posterior axis. This process of convergent
extension is a prerequisite for the transformation of the spherical early embryo
into an elongated, bilaterally symmetrical organism (Keller et al., 1991; Keller
et al., 1992). In normal embryos, Chordin was expressed in the midline of late
gastrulae or early neurulae formed by convergent extension of the notochord
precursor cells (Fig. 3.12M), whereas the expression domain of Chordin in XCL-
2 injected embryos was not at the midline but extended laterally and posteriorly
(Fig. 3.12P). XMyoD is expressed in the dorsal-lateral mesoderm that also
undergoes convergent extension to a paraxial position and forms future somites
in control embryos (Fig. 3.12H, N). In injected embryos, however, it was
expressed some distance away from the midline and towards the posterior
(Fig. 3.12K, Q). In addition, the results with the neural marker Xsox3 reveal that
the posterior neural plate of injected embryos also does not converge to the
midline (Fig. 3.12L, R) compared with that in the control (Fig. 3.12I, O). This is
a further indication of disruption of convergent extension of the posterior neural
plate.
3.3.2.3 Overexpression of a dominant-negative type
mutant of XCL-2
It was subsequently tested in a loss-of-function analysis whether a
dominant-negative XCL-2 mutant interferes with the in vivo function of XCL-2.
It has been reported that a point mutation of active site Cys 105 functions in a
dominant-negative manner in vivo (Arthur et al., 1995; Huang and Forsberg
1998; Masumoto et al., 1998). A similar mutant was therefore generated in
which Cys105 was changed to serine (hereafter referred to as C105S). Different
doses of C105S mRNA were injected close to the animal pole, equatorial region
or vegetal pole of two ventral blastomeres of 4-cell stage embryos. Injection
close to the vegetal pole did not result in significant development defects (9%,
n = 53). When injection was made in the equatorial region, the number of
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affected embryos increased (26%, n = 57). When injection was done at the
animal pole, the number of affected embryos increased more significantly. The
affected embryos showed a distinct phenotype (see later). When 1.5 ng of C105S
was injected, 64% of embryos were affected. A higher dose of 2 ng caused
defects in 100% of cases (Table 3.2). Interestingly, overexpression of C105S and
wild-type XCL-2 yielded similar phenotypes at the macroscopic level. During
midgastrulae, enlarged yolk plugs were observed (Fig. 3.13B), which were not
reduced in size in subsequent stages. The endoderm remained externally visible
and bifurcate tails were formed (Fig. 3.13D). However, histological sections
showed that the notochord malformations and bifurcation of the tail were quite
different after XCL-2 and C105S overexpression. In contrast to embryos with
XCL-2 overexpression (Fig. 3.11D, E, F), C105S-injected embryos showed a
distinct bifurcation of the tail and a branched notochord (Fig. 3.13D, F, G).
Fig. 3.13 Dominant-negative
mutant C105S also disrupts
gastrulation movement and
results in a significant pheno-
type, which can be rescued by
coinjection with wild-type
mRNA. mRNA of C105S  or
XCL-2 was injected into two
ventral blastomeres at the 4-cell
stage. (A) Control embryos at
stage 11. (B) Injected embryos
at an equivalent stage showing larger-sized blasto-pores. (C) Control embryos at stage 38. (D)
Injected embryos at an equivalent stage showing nearly normal head structure, externally
visible endoderm and bifurcate tail (top) or even no head in an extreme case (bottom). (F, G)
Transversal sections through the otic vesicle (F) and the trunk region behind the otic vesicle
(G) of an embryo injected with C105S at stage 30, showing ventralward movement of otic
vesicles, flattening, ventralward bending, bifurcation and further shifting of notochord toward
each side of the body (compare Fig. 3.11E, F). (E) Embryos rescued by co-injecting C105S
and XCL-2 mRNA. cc, central canal; no, notochord; ov, otic vesicle; rc, rhombencephalon; rv,
rombencephalic ventricle; sp, spinal cord.
3.3.2.4 Rescue of the C105S phenotype by wild-type XCL-2
To test whether the C105S phenotype can be rescued by increasing levels of
wild-type XCL-2, XCL-2 and C105S were coinjected in different amounts. It
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was found that a ratio of XCL-2:C105S of 1:2 ng or 2:2 ng did not result in a
significant rescue effect (data not shown). When the dose of XCL-2 was
increased to 3 ng, the number of normal embryos increased significantly (44%);
3.75 ng XCL-2 rescued 83% of the injected embryos. The rescued embryos
showed a normal or nearly normal phenotype (Fig. 3.13E). At a higher dose,
say, 4.5 ng, the rescue rate decreased again (37%; Table 3.2). These results
demonstrate that the mutant functions in a dominant-negative manner and the
resultant phenotype can be rescued by the wild-type protein at the right
concentration ratio.
Table 3.2 Effect of mRNA overexpression on embryonic development
Number of embryos/percent
mRNA injected (ng)       normal        defected      total
XCL-2 (2)                18/33         37/67          55/100
XCL-2 (2.5)               3/3          93/97          96/100
C105S (1.5)              26/36         46/64          72/100
C105S (2)                 0/0          69/100         69/100
XCL-2:C105S (3:2)        27/44         35/56          62/100
XCL-2:C105S (3.75:2)     93/83         19/17         112/100
XCL-2:C105S (4.5:2)      31/37         52/63          83/100
LacZ (2)                 27/90          3/10          30/100
3.3.3 Functional analysis on XETOR
3.3.3.1 XETOR overexpression inhibits formation of primary
neurons but does not disrupt the neural plates
XETOR mRNA was injected together with LacZ serving as lineage tracer in
the equatorial region of one blastomere at 2-cell stage, while the other served as
internal control. When the embryos were grown to neural plate stage (stage 14-
16), they were fixed and subject to whole mount in situ hybridization using
primary neuron markers. First, it was observed that expression of N-tubulin, a
marker gene for differentiated neurons (Oschwald et al., 1991), was dramatically
downregulated and even totally eradicated in embryos overexpressing XETOR
(45/48 embryos; Fig.3.14A). While in control embryos overexpressing only
LacZ, there was no appreciable change in N-tubulin expression (41/43 embryos;
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Fig.3.14B). Second, it was also observed that overexpression of XETOR
inhibited the expression of Xaml (29/29 embryos; Fig.3.14C), a sensory neuron
marker gene (Tracey et al., 1998; Perron et al., 1999; Koyano-Nakagawa et al.,
2000). The evidence did show that XETOR inhibits the formation of primary
neurons. Then the following question was asked if the inhibition of primary
neurons was the consequence of disruption of neural plate. It was found not to
be the case because the expression of a neural plate marker gene Xsox3 (Penzel
et al., 1997) was not affected in response to XETOR overexpression (Fig.3.14D).
This primary data indicate the specific inhibition of expression of primary
neuron marker genes by XETOR overexpression, and therefore suggest that
XETOR should have functions regulating neuronal differentiation but not neural
plate patterning.
3.3.3.2 Truncation mutants of XETOR behave similarly to the wild
type protein
All the members of ETO oncoprotein family have four conservative
domains (Fig.3.4). Then it is interesting to investigate the functions of these
domains for XETOR activity. A series of truncated mutants were made and
tested how these mutants behave in primary neurogenesis. p13#trunc1 is
composed of aa 1-496, with NHR4 truncated; p13#trunc2 is composed of aa 1-
425, with NHR3 and 4 truncated; p13#trunc3 is composed of aa 216-425, with
NHR1, 3 and 4 truncated; p13#trunc4 is composed of aa 216-586, with NHR1
truncated; while p13#trunc5 is composed of aa 364-586, with NHR1 and 2
truncated (Fig.3.15). mRNAs of these mutants were injected separately into
again one blastomere of 2-cell stage embryos and N-tubulin expression was
examined. Interestingly, overexpression of either of these mutants caused
inhibition of N-tubulin expression, resulting in a phenotype similar to that by
XETOR overexpression (data not shown). In all 25 embryos overexpressing
p13#trunc1, expression of N-tubulin was inhibited; in 25 out of 29 embryos
overexpressing p13#trunc2, N-tubulin expression was repressed; for p13#trunc4
and p13#trunc5 overexpression, N-tubulin expression was repressed in 26/26
and 30/36 embryos, respectively. The data demonstrate that the four mutants
have effect on N-tubulin expression indistinguishable from the wild type protein.
3. Results 61
However, although overexpression of p13#trunc3 inhibits N-tubulin expression,
too, it behaves not as efficiently as the other mutants and the wild type protein.
In 29 embryos, only 14 showed the phenotype of inhibited N-tubulin expression
(Fig.3.14E). Moreover, the inhibition effect in these affected embryos is also not
as robust as in embryos overexpressing the wild type XETOR or other mutants,
in which the N-tubulin expression was completely eradicated in most cases. The
data suggest that either NHR1 and 2 together or NHR3 and 4 together are
sufficient for functions in the regulation of primary neurogenesis.
Fig. 3.14 Overexpression of XETOR or
the truncation mutants inhibit the
expression of N-tubulin, Xaml but not
the expression of Xsox3. In embryos
injected with XETOR (A, C and D) or the
mutants (E), expression of N-tubulin or
Xaml is dramatically inhibited. However,
the expression of Xsox3 (red signal) is not
inhibited in the injected side (D). (B) is a
control in which only LacZ was injected, the expresion of N-tubulin is intact. In all the
figures, mRNAs injected are shown in upper right and genes for which expression were
detected are shown in lower left. The anterior of the embryos is up. The injected side is
marked with X-gal staining, which reveals light blue, and also indicated with an asterisk. The
same as in the following figures.
Fig. 3.15 Schematic structures of
XETOR and truncation mutants.
The four Nervy Homologous
Regions are shown in shadowed
areas. aa, amino acid.
3.3.3.3 XETOR is required for primary neurogenesis
As it was observed that overexpression of XETOR and a series of truncated
mutants exclusively inhibits the expression of the primary neuron markers N-
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tubulin and Xaml, it is logic to ask the question what would happen if the
function of endogenous XETOR is inhibited. Therefore, the antisense
morpholino oligo, a gradually popular approach to loss-of-function analysis
(Heasman et al., 2000; Deardorf et al., 2001; Dibner et al., 2001; Tan et al.,
2001; Zhao et al., 2001), was employed to antagonize the function of XETOR in
vivo. 7-30 ng of antisense morpholino oligo against XETOR (MOXETOR) was
injected together with LacZ into one blastomere at 2-cell stage and the embryos
were analyzed with N-tubulin expression. It was observed that the lateral stripe
Fig.3.16 XETOR is prerequisite for
primary neurogenesis. (A) Injection of
the antisense morpholino oligo against
XETOR (M O X E T O R ) results in an
expansion of lateral stripe of N-tubulin
expression. (B) Injection of a control
oligo (ctr lMO ) does not cause any
significant change in N - t u b u l i n
expression. (C) Co-injection of
MOXETOR  and XETOR rescues the pheno-types caused by injection of XETOR or
MOXETOR, suggesting MOXETOR  speci-fically blocks the function of XETOR. (D)
Blocking lateral inhibition by injecting X-Delta-1STU results in an increased density of neurons
without change in the size of proneural domain. (E) When XETOR and lateral inhibition are
both blocked by coinjection of MOXETOR and X-Delta-1STU, an increased density of primary
neurons in a lateral stripe of significantly enlarged size is observed, showing a phenotype
distinct from those in (A) and (D).
of N-tubulin expression domain expanded but the density of primary neurons
looked similar to those in the control side (43/50 embryos, Fig.3.16A). A control
morpholino oligo (ctrlMO) was also injected, however, no discernible influence
was observed on N-tubulin expression in response to ctrlMO injection (22/26
embryos, Fig.3.16B). This indicates that injection of MOXETOR generated a
neurogenic phenotype as the neurogenic domain expands. Further injections
were made to see if the phenotype by XETOR overexpression could be rescued
by MOXETOR, or vice versa. It proved to be the case because when XETOR was
coinjected with MOXETOR, the expression of N-tubulin was neither inhibited
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nor increased appreciably (49/55 embryos, Fig.3.16C). These data indicate that
the effect of the antisense morpholino oligo is able to abolish specifically the
function of XETOR. Albeit inhibition of XETOR function results in an increase
of neurogenic domain, the salt-and-pepper pattern of primary neuron in the
domain seems to be resulted from the action of lateral inhibition. It was further
examined, therefore, what would happen when XETOR is eradicated in the
absence of lateral inhibition. As previously reported, when lateral inhibition
alone was blocked by overexpressing X-Delta-1STU, a dominant-negative form of
X-Delta-1, an increased density of neurons in the lateral stripe was observed as
shown by increased N-tubulin expression, but the size of the stripe was largely
unchanged (Chitnis et al., 1995; Chitnis and Kintner, 1996; Fig.3.16D).
However, when MOXETOR and X-Delta-1STU were coinjected, an increased
density of neurons was observed in an enlarged lateral stripe (55/59 embryos;
Fig. 3.16E). This phenotype is in striking contrast not only with that generated
by MOXETOR injection alone (Fig.3.16A) but also with that generated by X-
Delta-1STU injection alone (Fig.3.16D). These data confirm that XETOR is
required for primary neurogenesis.
3.3.3.4 XETOR and lateral inhibition are negatively crossregulated
It has been demonstrated that XETOR overexpression generated a phenotype
similar to that caused by activating lateral inhibition, the primary signaling
pathway known so far for repressing neurogenesis. It is therefore important to
ask whether the function of XETOR is orchestrated by lateral inhibition or
whether there is a crosstalk between XETOR and lateral inhibition. First, it was
observed that overexpression of XETOR repressed the expression of ligand gene
X-Delta-1 (25/27 embryos; Fig.3.17A). When lateral inhibition was activated by
overexpression of X-Notch-1ICD, which encodes the constitutively active form
of X-Notch-1, expression of XETOR was inhibited (24/24 embryos; Fig.3.17B).
XETOR expression was also tested in embryos in which the lateral inhibition
signaling was blocked by overexpressing X-Delta-1S T U . Similar to the
neurogenic phenotype of increased density of neuron formation in the absence
of lateral inhibition (Chitnis et al., 1995; Chitnis and Kintner, 1996; Fig.3.16D),
it was noted that expression of XETOR increased significantly (35/35 embryos),
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too, when lateral inhibition signaling was blocked (Fig.3.17C). The data
demonstrate that XETOR and lateral inhibition signaling are mutually inhibited.
Second, as blocking of lateral inhibition signaling can increase the expression of
both XETOR and N-tubulin, it was therefore examined whether XETOR still
inhibits primary neuron formation in absence of lateral inhibition. It was proved
to be the case because N-tubulin expression was repressed when XETOR was
coinjected together with X-Delta-1STU, showing that X-Delta-1STU does not have
any rescuing effect on the inhibition by XETOR (14/15 embryos; Fig.3.17D).
These data suggest that XETOR is not a component of lateral inhibition
signaling pathway but functions in independence of lateral inhibition.
Fig.3.17 XETOR and lateral
inhibition are mutually
repressed and XETOR
functions independent of
lateral inhibition. (A) Over-
expression of X E T O R
inhibits the expression of X-
Delta-1. (B) XETOR expres-
sion is in turn   inhibited by
activated lateral inhibition via overexpression of dominant active form of X-Notch-1. (C)
When lateral inhibition is blocked by overexpressing a dominant negative form of X-Delta-1,
XETOR expression is also augmented. (D) When XETOR is co-overexpressed with X-Delta-
1STU, it still represses the expression of N-tubulin, showing that blocking lateral inhibition does
not rescue the inhibitory effect of XETOR. (E, F) Overexpressed XETOR does not affect the
expression of ESR1 and XNAP. (G, H) XETOR knockout by morpholino oligo does not affect
the expression of ESR1 and XNAP, either.
To gain further support for this idea, expression of two Notch downstream
targets, ESR1 (Wettstein et al., 1997) and XNAP (Lahaye et al., 2002), were
examined in response to XETOR overexpression. Both these genes are expressed
during primary neurogenesis similarly to other genes involved in Notch
signaling, such as X-Delta-1. Expression of these genes is positively regulated
by Notch pathway. It was observed that, however, no changes occurred in the
expression of ESR1 (40/42 embryos) and XNAP (29/29 embryos) in response to
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XETOR overexpression (Fig.3.17E, F). Moreover, intact expression of ESR1
(28/31 embryos) and XNAP (30/31 embryos) were likewise observed when
endogenous XETOR activity was extirpated via M O X E T O R injection
(Fig.3.17G, H). All the evidence shows that XETOR is not a constituent of the
Notch pathway, it works independently for the negative regulation of primary
neurogenesis but not via the mediation of lateral inhibition signaling.
3.3.3.5 Crossregulation between the expression of XETOR and
proneural genes
In order to know more details about the concrete function of XETOR during
Xenopus primary neurogenesis, crossregulation between the expressions of
XETOR and proneural genes were examined. Again mRNAs for XETOR or
other proneural genes along with LacZ were injected into one blastomere at 2-
cell  stage  and  the  other  left  as  internal  control, and  their  expressions  were
Fig. 3.18 Crossregulation
between the expression of
XETOR and proneural
genes.  Overexpression of
Xngnr-1 (A) or Xath3 (B)
induces significant ectopic
XETOR expression. In turn,
overexpression of XETOR
does not affect X n g n r - 1
expression  (C), but inhibits
Xath3 expression (D). XETOR expression is also activated or enhanced by overexpressed
Xash-3 (E), or XNeuroD (H). Conversely, Overexpression of XETOR inhibits the expression
of XMyT1 (G), but not Xash3 (F).
analyzed using whole mount in situ hybridization. It was observed that
overexpression of both Xngnr-1 (32/32 embryos; Fig.3.18A) and Xath3 (25/25
embryos; Fig.3.18B) activated strong ectopic expression of XETOR. Conversely,
overexpressed XETOR had no appreciable effects on the expression of Xngnr-1
(43/43 embryos; Fig.3.18C), but downregulated the expression of Xath-3 (20/22
embryos; Fig.3.18D). Overexpression of Xash-3, a neural determination gene,
caused an enhancement of XETOR expression within its normal expression
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domains (36/40 embryos; Fig.3.18E), but no discernible change in Xash-3
expression was observed in response to XETOR overexpression (55/59 embryos,
Fig.3.18F). It was further observed that expression of the zinc-finger protein
gene XMyT1 was inhibited by XETOR overexpression (17/19 embryos;
Fig.3.18G), while overexpressed XMyT1 did not affect XETOR expression (data
not shown). XNeuroD, a gene expressed for terminal differentiation of neurons
in later stage, was found to enhance XETOR expression, too (37/39 embryos;
Fig.3.18H).
3.3.3.6 XETOR overexpression inhibits the function of proneural
genes except Xngnr-1
The crossregulation at transcriptional level between XETOR proneural genes
gave rise to another question whether XETOR also regulates these genes post-
transcriptionally. mRNA of XETOR was coinjected together with mRNA of
either of the proneural genes XMyT1, Xash-3, Xath3 and XNeuroD, and N-
tubulin expression was analyzed in injected embryos using whole mount in situ
hybridization. XMyT1 is a gene with weak neuron inducing activity,
overexpression of XMyT1 results in an increased density of neurons within N-
tubulin expression domain (Fig.3.19A). It serves to confer insensitivity to lateral
inhibition, and when overexpressed together with Xash-3, strong ectopic neuron
formation is resulted (Bellefroid et al., 1996). While when XMyT1 was
coinjected with XETOR, its neuron inducing activity was abolished (Fig.3.19B),
showing a decreased expression of N-tubulin as compared to the control side
(29/29 embryos). Further, it is revealed that overexpressed either Xath3 or
XNeuroD causes strong ectopic neuron formation (Fig.3.19C, E), as reported
formerly (Lee et al., 1995; Chitnis and Kintner, 1996; Perron et al., 1999).
However, ectopic and even endogenous expression of N-tubulin  was
dramatically reduced or totally eradicated in embryos coinjected of XETOR with
either Xath3 (23/23 embryos; Fig.3.19D) or XNeuroD  (10/10 embryos;
Fig.3.19F), forming a striking contrast to the control embryos. In the case of
Xash-3, it enhances neuron formation when overexpressed in low doses while
suppresses neuron formation when overexpressed in high doses due to activation
of lateral inhibition. Nevertheless, it consistently induces neuron formation
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within proneural domains when lateral inhibition is blocked, as shown
previously (Chitnis and Kintner, 1996; Fig.3.19J). Here it is shown that, in the
absence of lateral inhibition, neuron-inducing activity of Xash-3 was blocked in
embryos coinjected with Xash-3 and XETOR (7/8 embryos; Fig.3.19K). These
data clearly show that XETOR inhibits not only the expression of these genes,
but also their functions in vivo.
Fig. 3.19 Overexpression
of XETOR inhibits the
function of proneural
genes, except Xngnr-1. (A)
XMyT1 has a weak neuron-
inducing activity, such an
activity is inhibited in
response to XETOR over-
expression (B). When over-
expressed alone, Xath3 (C)
or XNeuroD (E) induces
strong ectopic expression of
N-tubulin; while in contrast,
when XETOR is coinjected
with them (D, F), not only
the ectopic but also the endogenous expression of N-tubulin is inhibited. (G) Overexpressed
Xngnr-1 induces strong ectopic expression of N-tubulin, and (H) such a proneural activity of
Xngnr-1 is inhibited by activated X-Notch-1, in contrast overexpression of XETOR does not
affect the proneural activity of Xngnr-1 (I). (J) When lateral inhibition is blocked, Xash-3
consistently induces ectopic neuron formation, while this induction is abrogated when
coinjected with XETOR (K).
 It was previously reported that proneural genes have different sensitivity to
lateral inhibition (Chitnis and Kintner, 1996). Lateral inhibition tends to repress
the functions of genes that are expressed in earlier stages, for instance the neural
determination genes Xngnr-1 and Xash-3. But it does not repress the functions
of genes that are expressed in later stages, for instance the neural differentiation
genes XNeuroD and Xebf3 (Pozzoli et al., 2001). As a result, co-overexpression
of Xngnr-1 and X-Notch-1ICD will lead to the inhibition of ectopic neuron
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formation by Xngnr-1 (Ma et al., 1996; Fig.3.19H), while co-overexpression of
XNeuroD  and X-Notch-1ICD  results in a phenotype similar to that by
overexpressing XNeuroD alone (Chitnis and Kintner, 1996). These data set a
groundwork for the idea of different sensitivity of proneural genes to lateral
inhibition. Now that it has been shown that XETOR inhibits the function of
XNeuroD and XMyT1, which escapes or helps to escape lateral inhibition, then
it would be interesting to ask whether XETOR affects the function of earlier
proneural genes, albeit it was known at least that overexpression of XETOR does
not affect the expression of Xngnr-1. The findings will address the question
whether proneural genes also have different sensitivity to the inhibitory effect of
XETOR. As previously shown, overexpression of Xngnr-1 leads to strong
ectopic expression of N-tubulin (Ma et al., 1996; Fig.3.19G). When Xngnr-1 was
coinjected with XETOR, the ectopic formation of neurons by Xngnr-1 was not
significantly affected (15/15 embryos; Fig.3.19I), showing that Xngnr-1 is not
sensitive to the inhibition by XETOR at both transcriptional and post-
transcriptional levels. Considering together that Xash-3  is not inhibited
transcriptionally, either, these data suggest that proneural genes also have
different sensitivity to XETOR inhibition, i.e., earlier genes are refractory while
later ones are sensitive to the inhibitory function of XETOR.
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4. DISCUSSION
The research done here proved that large-scale whole mount in situ
hybridization is an efficient way to screen genes involved in embryogenesis
from cDNA libraries. The advantage of the approach is that it allows direct
identification of single clones and hence single genes according to expression
patterns. 29 of 384 single clones were sorted out because of specific expressions.
Subsequently, 3 of 29 genes, namely, XODC2, XCL-2, and XETOR were
selected for further study based on comparison with Genbank databases and
their expression patterns. Actually, XODC2 is a piece of evidence that there
exists a second type of ornithine decarboxylase in specific cells besides the
ubiquitous form, although no solid indication was acquired in the present study
that it plays a significant role in embryonic development. While the other two
genes, XCL-2 and XETOR, were shown to play pivotal functions respectively in
two developmental procedures: morphogenetic movements and primary
neurogenesis.
4.1 XCL-2 and its role during embryogenesis
4.1.1XCL-2 is a novel m-type Calpain and disrupts morphogenetic
movements during embryogenesis in Xenopus laevis
It has been shown that XCL-2 encodes a large subunit of m-type Calpain, a
novel family member of the calcium-dependent proteases. Typical Calpains,
either ubiquitous or tissue-specific, are around 700 amino acids in length and
consist of four domains. The first domain is responsible for autolysis, which
reduces calcium requirement for proteolytic activity; the second domain has
three active sites, Cys 105, His 262 and Asn 286, for proteolytic activity; the
third domain has an unknown function; and the fourth domain, comprising EF-
hand motifs, is for Ca2+ binding. This domain structure and the active sites are
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conserved in all typical Calpains identified so far, including XCL-2 in the
present study. Therefore, it is reasonable to assume that XCL-2 also possesses
the calcium-dependent proteolytic activity. As a prerequisite for functional
analyses, whole mount in situ hybridization and RT-PCR were performed to
examine the expression patterns of XCL-2 during X. laevis development. Using
whole mount in situ hybridization, embryos showed no detectable signals earlier
than the late gastrula stage. Expression was first detected in the area close
beneath ventral blastopore lip at around stage 12.5. During neurulation, signals
were found in the mesoderm-free zone at the most anterior and ventral parts of
the circumblastoporal collar at the most posterior zone. At the tailbud stages,
expression was restricted to the cement gland and proctodeum, and to the
cement gland only at the late tailbud stages. Using RT-PCR, weak expression
could already be observed at stage 10. It also demonstrated the tissue-specific
expression of XCL-2 in adult tissues, such as brain, eye, heart, intestine, kidney,
lung, stomach and testis. The relatively high level of expression in stomach
suggests that XCL-2 and nCL-2 are evolutionarily conserved homologues. The
latter is predominantly expressed in rat stomach.
The restricted expression of XCL-2 in late gastrulae or early neurulae in the
ventral circumblastoporal collar could be suggestive for its function. The
circumblastoporal collar, including the dorsal and ventral parts, represents a
massive accumulation of mesodermal cells. From this region, dorsal axial
mesoderm is continuously generated by radial intercalation and convergent
extension. This was the initial impetus to investigate whether XCL-2 could be
involved in cell movements during X. laevis early embryogenesis.
Overexpression of XCL-2 and a dominant-negative mutant, C105S, were
therefore carried out to investigate its functions during early embryogenesis.
Injections were made into either two dorsal blastomeres or two ventral
blastomeres at the 4-cell stage. It was found that overexpression at the vegetal
pole did not affect embryonic development significantly, in contrast to
overexpression at the animal pole or even the equatorial region. This is probably
due to the fact that the injected RNA at the vegetal pole will mainly be
distributed in the endoderm and therefore it cannot exert its activity in the
circumblastoporal collar. Therefore the effect of overexpression of the mRNAs
at the animal pole was studied.
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Overexpression of XCL-2 results in a delay of the involution of mesoderm.
At the beginning of gastrulation, the blastopore in injected embryos formed
normally, as in uninjected control embryos. However, during gastrulation the
blastopore of injected embryos failed to close and a large yolk plug was
observed in subsequent developmental stages. This disturbance of involution
generates a significant phenotype. The results suggest that overexpression of
XCL-2 causes the disruption of the blastopore and disturbance of the gastrulation
movements. It was examined whether there are obvious cell fate changes in
these affected embryos using mesodermal or neural markers, including Xbra,
Chordin, Xvent-1, XMyoD, Xotx2 and Xsox3. In fact, all of these markers are
expressed at similar levels to the controls but are not correctly localized, which
suggests that no obvious cell fate alteration takes place, but rather distinct
changes in cell migration. Furthermore, it was shown with Chordin, XMyoD and
Xsox3 in injected embryos that during gastrulation and neurulation the
mesoderm and the posterior neural plate do not converge towards the midline, as
in normal embryos. These data suggest that XCL-2 participates in the
convergent extension movements starting from the midgastrula stage.
It was further revealed, by overexpressing a dominant-negative-type mutant
C105S, that XCL-2 activity is required for morphogenetic movements.
Overexpression of C105S and wild-type XCL-2 resulted in similar phenotypes
(open blastopore and bifurcate tail). These on the first glimpse confusing results
could be explained by the observation that both overexpression of wild-type
XCL-2 or inhibition (partial or total loss of function) by a dominant-negative
mutant, C105S, will cause the disturbance of morphogenetic movements. These
data are in agreement with results using other genes, where overexpression of
both wild-type and truncated forms of Wnt11 (Tada and Smith, 2000) or
Frizzled-7 (Djiane et al., 2000) also blocks convergent extension movements
and generates similar phenotypes. However, our histological sections show that
the embryos injected with C 1 0 5 S form distinct bifurcate notochord
malformations, in contrast to wild-type XCL-2 overexpression. This phenotype
can be rescued by coinjection of XCL-2 and C105S mRNA at the proper ratio.
These results suggest that the mutant acts specifically in vivo by competition
with wild-type protein for proteolytic substrates. However, because Calpains
have been identified as a large gene family in other vertebrates, such as human
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and rat, it can be suggested that such a family also exists in X. laevis. Therefore,
the possibility cannot be ruled out that the dominant-negative mutant C105S also
suppresses other related members. In summary, present data suggest that XCL-2
is a prerequisite for morphogenetic movements during early embryogenesis in X.
laevis. It is highly probable that Calpain regulates cell movements by changing
cell adhesive activity via proteolytic cleavage of proteins that are essential for
morphogenesis, but this remains to be elucidated.
4.2 XETOR and its role during primary neurogenesis
Here in this study it is presented for the first time the expression and
function of an ETO related gene, XETOR, during primary neurogenesis in
Xenopus laevis. Like other members of ETO oncogene family, XETOR is also
expressed primarily in the nervous system. Both gain- and loss-of-function
studies showed that XETOR plays key roles in primary neurogenesis. It inhibits
primary neuron formation by establishing a negative feedback loop with
proneural genes. This inhibition is not mediated by lateral inhibition signaling
but a result of an independent action. Lateral inhibition and XETOR antagonize
each other but both are required for primary neurogenesis. They consist of a dual
inhibitory mechanism to refine the exact localization and number of primary
neurons.
4.2.1 XETOR is an inhibitory factor for primary neurogenesis in
independence of lateral inhibition
XETOR encodes a putative protein that shares all characteristics of other
members of oncoprotein family ETO/MTG8: the four conserved Nervy
Homologous Regions and the two unusual zinc-finger motifs. Besides the
common structure, another feature shared among these genes examined,
including Nervy in Drosophila, is that they all have expression in the nervous
system (Feinstein et al., 1995; Wolford and Prochazka, 1998). This suggests a
conserved function of ETO proteins in nervous system. In Xenopus laevis,
expression of XETOR during primary neurogenesis begins at stage 12.5 in a
pattern of longitudinal stripes at either side of dorsal midline, similar to the
patterns of primary neuron marker genes. Double in situ hybridization showed
that expression domain of XETOR is overlapping with, however broader than
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that of N-tubulin, confirming that XETOR is another marker gene for primary
neurogenesis. The broader expression domain of XETOR may suggest that it
plays to refine the localization of primary neurons, and this has been confirmed
by the study. Temporally, expression of XETOR starts at stage 12.5, following
that of Xngnr-1 , Xash-3, XMyT1, X-Delta-1, Xath3 and preceding that of
XNeuroD, but at the same time when the differentiated neuron marker gene N-
tubulin is turned on. This temporal sequence should suggest that XETOR is
turned on when neuronal differentiation begins and hence a role in regulating
neuronal differentiation.
Further lines of evidence support this idea more directly. It was proved that,
on the contrary to promoting neuronal differentiation as bHLH proneural
proteins do, it acts to repress the procedure. First, gain-of-function data show
that XETOR inhibits expression of neuron marker genes N-tubulin and Xaml.
This loss of primary neuron formation is not a result of disruption of neural
plate, as indicated by intact expression of Xsox3 in response to XETOR
ovexpression. Second, overexpressed XETOR extirpates the neuron-inducing
activity of proneural genes, Xash-3, Xath3 and XNeuroD, as well as the zinc-
finger gene XMyT1, as revealed by coinjections of XETOR together with any
one of these genes. Therefore, XETOR should be able to inhibit primary neuron
formation via repressing the function of proneural genes. Third, inhibition of
XETOR function in vivo leading to a neurogenic phenotype of expanded
neurogenic domain also suggests that XETOR is a key negative regulatory
factor for primary neurogenesis.
 It seems that a negative feedback loop is established between XETOR and
proneural genes. The reason is that expression of XETOR  is exclusively
activated or promoted by the genes examined in the study except the zinc-finger
gene XMyT1, and in turn, XETOR inhibits the function of these genes, with the
exception of Xngnr-1. Although all proneural genes can activate XETOR
expression, it is proposed here that XETOR is more likely to be activated directly
by Xath3 than by Xngnr-1. The first reason is that Xngnr-1 activates Xath3 in a
unidirectional way and Xath3 is a direct downstream target of Xngnr-1. The
second reason is that, in temporal sequence, XETOR begins to express at stage
12.5 almost immediately after Xath3, which starts to express at stage 12 (Perron
et al., 1999). Therefore, the temporal expression of XETOR suggests that it
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functions in the late stage of primary neurogenesis. This is also confirmed by the
fact that XETOR does not affect the expression or/and function of neuronal
determination genes Xngnr-1 and Xash-3, but instead inhibits the function of
neuronal differentiation genes.
In the data and discussion above, it can be noticed that XETOR and lateral
inhibition signaling have certain characteristics in common: both are activated
by proneural genes, and conversely, both inhibit the function of proneural genes
and hence primary neuron formation. Considering the similarity between the
expression of XETOR, X-Delta-1 and other components in lateral inhibition, it
was asked whether XETOR is also a component of this signaling pathway such
that XETOR function is orchestrated by lateral inhibition. A few lines of
evidence negate the idea but support that XETOR and lateral inhibition are two
different working mechanisms. The first point is that expression of X-Delta-1 is
repressed in response to overexpressed XETOR , and vice versa, XETOR
expression is inhibited by activated lateral inhibition signaling pathway. In
addition, when lateral inhibition is blocked, XETOR expression is promoted.
This phenomenon is just contrary to that for Notch targets, which are promoted
by activated lateral inhibition pathway while repressed by the blocked pathway.
Therefore, lateral inhibition and XETOR is a pair of antagonists. The second is
that XETOR still efficiently inhibits N-tubulin expression in the absence of
lateral inhibition, as shown by coinjection of XETOR and X-Delta-1STU. The
third is that the expression of Notch targets, ESR1 and XNAP, is not affected
either with XETOR or without XETOR. Finally, that Xngnr-1 is refractory
while XNeuroD is sensitive to XETOR activity suggests again that XETOR
should not be a component of lateral inhibition pathway, because it was
previously shown that early proneural genes as Xngnr-1 and Xash-3 are sensitive
to lateral inhibition while late genes as XNeuroD and Xebf3 are refractory.
4.2.2 The molecular mechanism for transcriptional repression
activity of XETOR
The initial idea for constructing truncation mutants of XETOR was to test
whether any one of them could function antimorphically to the wild type
protein, such that loss-of-function assays could be performed. Unexpectedly, all
these truncation mutants exclusively exhibit a repression effect, showing that
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XETOR is a robust transcription repressor. The data on these mutants revealed
important information on the function of different Nervy Homologous Regions
(NHRs). One principal mechanism for transcriptional repression is the
modification of chromatin conformation by histone deacetylases (HDACs; for
reviews, see Grunstein, 1997; Struhl, 1998; Torchia et al., 1998). ETO has been
identified as a potent repressor of transcription by recruitment of HDAC1 and 2
via corepressors N-CoR (nuclear receptor corepressor), mSin3 or SMRT
(silencing mediator for retinoid and thyroid-hormone receptors) (Gelmetti et al.,
1998; Lutterbach et al., 1998; Wang et al., 1998). Moreover, ETO itself acts also
as a corepressor recruited by promyelocytic leukemia zinc finger protein
(PLZF), which mediates transcriptional repression via the action of HDACs
(Melnick et al., 2000). Multiple regions in ETO have been shown to cooperate in
transcriptional repression. In the four conserved NHRs, both NHR3 and NHR4
but not NHR4 alone were shown to be essential for the interaction between ETO
and N-CoR (Hildebrand et al., 2001). However, the binding of N-CoR with
NHR3 and 4 per  se is not sufficient for the mediation of transcriptional
repression. While the core repressor domain (CRD), consisting of NHR2 and its
N- and C-terminal flanking sequences, is the smallest region that shows
significant repression activity on its own. Furthermore, this domain interacts
strongly with mSin3A (Hildebrand et al., 2001). It is somewhat mystic for the
function of NHR1, as ETO short of this region still induces maximal repression.
While it is interesting for the sequence between NHR2 and NHR3, because it
was clarified as the binding site for PLZF, and ETO short of this part
significantly decreases repression activity (Melnick et al., 2000; Hildebrand et
al., 2001).
The information on ETO domain functions may help explain the results of
overexpression of XETOR truncation mutants. It was observed that the
inhibitory effects of overexpression of truncation mutants p13#trunc1, 2, 4, and
5 on primary neuron formation are indistinguishable from that of the wild type
XETOR. Therefore, these data suggest that single truncations of either NHR1 or
NHR4, or double truncations of either NHR1 and 2 or NHR3 and 4 have no
dramatic influences on their repression activity. The data are reasonable because
the CRD homologous sequence is intact in p13#trunc1, 2 and 4. Especially,
p13#trunc4 should retain the maximal repression activity because NHR1 is not
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essential for ETO activity. Although p13#trunc3, containing only the CRD
homologous sequence, showed also repression activity, it functions not as
efficiently as other mutants. These data suggest that CDR need the cooperation
with either NHR1 (as in p13#trunc2) or NHR3 and 4 (as in p13#trunc4) to exert
a similar level of transcriptional repression activity to that of the wild type
protein. However, based on the information available so far, it is not readily able
to explain the result of p13#trunc5 overexpression, because this mutant showed
similar inhibitory effect to those of other mutants. In the case of ETO as
mentioned above, NHR3 and 4 can bind N-CoR, but this binding by itself is not
sufficient for the mediation of transcriptional repression. The present data
suggest that XETOR may mediate transcriptional repression not only through
machineries that are well known, but also those that are not well known. Up to
today, XETOR has been the only protein of ETO oncoprotein family identified
in Xenopus. Therefore, it is difficult to conclude whether it is an orthologue or
paralogue of ETO. According to amino acid identity data, XETOR is more
closely related to MTGR1 (72%) than to ETO (59%), hence it is more likely to
be a paralogue. There is evidence that MTGR1 tends to form heterodimers with
ETO via the oligomerization domain NHR2. It remains to be elucidated that if
this also holds true in Xenopus.
4.2.3 XETOR and lateral inhibition comprise a dual inhibitory
mechanism to refine the number and localization of primary
neurons
The data have shown that XETOR can be exclusively activated by proneural
genes. Conversely, XETOR tends to inhibit the neuron-inducing functions of
proneural genes, with the exception of Xngnr-1. Thus a negative feedback loop
is formed between XETOR and proneural genes. Such a responding mechanism
is reminiscent of that between proneural genes and lateral inhibition signaling.
Are these two the same machinery? There is evidence that they are different
because they inhibit each other and work independently, as discussed above.
Why do they coexist during certain period of primary neurogenesis?
Loss-of-function assay discloses important clues for such a question. When
XETOR alone is knocked out, a neurogenic phenotype of significantly enlarged
neurogenic domain is resulted. It is in congruence with the fact that the
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expression domain of XETOR is broader than, though overlapping with, that of
N-tubulin. However, the density of neurons does not vary appreciably. These
data suggest a role of XETOR in refining the localization of primary neuron
formation. The nearly normal salt-and-pepper pattern of N-tubulin expression
should be generated by an increased level of lateral inhibition signaling, because
XETOR can antagonize lateral inhibition by disabling the ligand gene X-Delta-
1, and consequently an enhancement of lateral inhibition could be expected
when XETOR activity is repressed. It was confirmed by double depletion of
XETOR and lateral inhibition, which caused a phenotype of increased density of
neurons in enlarged proneural domain. Such a phenotype is apparently distinct
from that generated either by depletion of XETOR alone (enlarged proneural
domain with an unaltered density of neurons) or by depletion of lateral
inhibition alone (increased density of neurons with an unaltered proneural
domain). These data suggest that XETOR and lateral inhibition are both required
for primary neurogenesis: lack of either one will lead to overproduction of
primary neurons either in an extra large sized neurogenic domain or in an
excessive density. Hence, lateral inhibition and XETOR must cooperate to
define the exact number and localization of primary neurons.
The unidirectional genetic cascade Xngnr-1-Xath3-XNeuroD underlies the
major pathway promoting neurogenesis, which is in turn regulated by lateral
inhibition. At the beginning of primary neurogenesis, expression of Xngnr-1
defines the proneural domains where primary neurogenesis will occur. As a
result of lateral inhibition, Xngnr-1 makes neuroectodermal cells competent to a
neuronal state. While this state is unstable, genes like XMyT1, Xath3 and XCoe2
are subsequently activated by Xngnr-1 to stabilize the competent state
(Bellefroid et al., 1996; Takabayashi et al., 1997; Dubois et al., 1998; Perron et
al., 1999). By this way early proneural genes and lateral inhibition establish a
mechanism for defining the number of primary neurons. However, this is
possibly only part of the landscape for primary neurogenesis. It is known that
proneural gene Xngnr-1 defines a proneural domain much broader than the area
where primary neurons form. Similarly, the expression domains of early
expressed genes are much broader than that of late expressed proneural genes.
Such a correlation of temporal and spatial expression is also reported between
XMyT1 and N-tubulin (Bellefroid et al., 1996). Therefore a regulatory system
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should be there for the refinement of the neurogenic domains in the later period
of primary neurogenesis. Proneural genes should be not the candidates because
the consistently promote neuron formation. Neither is lateral inhibition because
it is primarily responsible for cell fate selection, and knockout of lateral
inhibition does not alter the proneural domain size but only the density of
primary neurons. It is proposed here that XETOR is such a factor because of a
few lines of evidence. First, the most direct evidence is that eradication of
XETOR function in vivo results in an enlargement of proneural domain, as
discussed above. Second, XETOR begins to express at a time later than X-Delta-
1 and does not inhibit neuron determination genes, especially Xngnr-1. This
feature of XETOR function will ensure the initiation of early neuronal
determination, which is regulated by lateral inhibition. Third, evidence has
shown that each proneural gene activates three things: X-Delta-1, XETOR and
the downstream proneural genes. Considering additionally that X-Delta-1 is
activated earlier than XETOR and that X-Delta-1 and XETOR antagonize each
other, it would be reasonable to assume that some cells expressing X-Delta-1
will not express XETOR, and vice versa. Due to the inhibitory effect of XETOR
on the expression and function of proneural genes, the neurogenic domain
defined by the downstream proneural gene will be more restricted than the
domain defined by the upstream gene.
Although late expressed neuronal differentiation genes, as XNeuroD and
Xebf3, are resistant to lateral inhibition, they still activate lateral inhibition. This
activation might be reasonable because it can serve to regulate the expression of
XETOR during this stage of primary neurogenesis.
Based on the data and discussion above, a fresh model for primary
neurogenesis is summarized as follow: expression of proneural gene Xngnr-1
marks the initiation of primary neurogenesis and defines the proneural domain.
At the same time, Xngnr-1 also activates downstream proneural genes and
lateral inhibition. Some cells are committed to a neuronal fate and others remain
ectodermal via a negative feedback loop. In this way lateral inhibition
determines the density of primary neurons. However, the size of neurogenic
domain where primary neurons will form is not determined. At the time
approximately when neuronal differentiation begins, XETOR is activated also by
proneural genes. Because XETOR  expression is antagonized by lateral
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inhibition, and XETOR represses the expression and function of late expressed
proneural genes, thus it is possible to restrict the neurogenic domain to a correct
localization.
The functions of proneural and neurogenic genes are all proved to be
conserved throughout the spectrum of organisms from Drosophila to Xenopus. It
has been shown that there also exist XETOR homologues in other organisms,
including Nervy in Drosophila. Moreover, the expression of these homologues
is restricted to the nervous system, too. It is logic to deduce that certain XETOR
homologue in other organisms play the same or at least similar role. Hence the
dual inhibitory mechanism identified in this study may also conserve in other
organisms.
It should be mentioned in passing that XETOR could also be involved in
hematopoiesis. The XETOR  homologue ETO/MTG8  in human is often
translocated to AML1 to make a fusion transcript in acute myeloid leukemias. It
has been shown that Xaml, the AML1 homologue in Xenopus laevis, functions
in the specification of hematopoietic stem cells in vertebrate embryos (Tracey et
al., 1998). Considering their expression in both primary neurons and the
presumptive ventral blood island, therefore it is proposed here that XETOR may
also play a role in primitive hematopoiesis.
In summary, based on the present data, it is proposed here that during
primary neurogenesis, lateral inhibition and XETOR comprise a dual inhibitory
mechanism to refine the exact number and localization of primary neurons, via
repression of the expression and function of proneural genes.
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5. SUMMARY
Using a strategy of large-scale whole mount in situ hybridization, three
genes were identified from a cDNA library constructed from endoderm-like
tissue induced from activin treated animal caps. One gene, XODC2, encodes a
paralogue to ubiquitous ODC (Genbank accession number: AF217544); another,
XCL-2, encodes a tissue-specific m-type Calpain (Genbank accession number:
AF212199); while the third one, XETOR, encodes a novel member of the
ETO/MTG8 oncoprotein family (Genbank accession number: AF212198).
Spatial and temporal expressions of these genes were examined by ways of
whole mount in situ hybridization and RT-PCR. Functional analyses were
focused on XCL-2 and XETOR.
Overexpression of wild-type XCL-2 suggests that this gene is involved in
gastrulation movement and convergent extension during gastrulation and
neurulation. Overexpression of a dominant-negative mutant caused a phenotype
morphologically similar to, but histologically different from, that caused by
overexpression of wild-type XCL-2. The mutant phenotype can be rescued by
injection of wild-type XCL-2. These data suggest that XCL-2 plays an important
role in convergent extension movements during embryogenesis in Xenopus
laevis.
XETOR is expressed during neurula stage in three bilaterally symmetrical
stripes at each side of dorsal midline, a pattern similar to that of the genes
involved in primary neurogenesis. Indeed, overexpression of XETOR or a series
of truncated mutants led to the inhibition of primary neuron formation without
disruption of neural plates. Such an inhibitory effect is not mediated by lateral
inhibition, but an independent action. Moreover, it was shown that XETOR and
lateral inhibition antagonizes each other. Further evidence showed that
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expression of XETOR is activated or promoted by overexpressed proneural
genes such as Xngnr-1 , Xash-3 , Xath3, and XNeuroD , and conversely,
overexpressed XETOR  inhibits the expression and function of Xath3 and
XNeuroD. The neuron inducing activity but not expression of Xash-3 is inhibited
in response to XETOR overexpression, while neither the expression nor the
function of Xngnr-1 is inhibited. Thus a negative feedback loop is established
between XETOR and proneural genes. Blocking of XETOR function in vivo
resulted in a neurogenic phenotype of an enlarged neurogenic domain without
alteration in neuron density. Nevertheless, double depletion of XETOR and
lateral inhibition led to primary neuron formation with an increased density in
enlarged domains. Based on these data, it is concluded that during primary
neurogenesis, lateral inhibition and XETOR comprise a dual inhibitory
mechanism to refine the number and localization of primary neurons via
repression of the expression and function of proneural genes.
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6. ZUSAMMENFASSUNG
Mittels in großem Maßstab (large-scale) durchgeführte Whole Mount in situ
Hybridisierung konnten 3 Gene aus einer cDNA Bibliothek isoliert werden, die
in entoderm-ähnlichem Gewebe (Activin behandelte animalen Kappen)
exprimiert wurden. Ein Gen, XODC2, kodiert für ein Paralog zum ubiquitären
ODC; ein weiteres XCL-2 kodiert für gewebespezifisches m-type Calpain; und
schließlich XETOR dessen Produkt ein weiteres Mitglied der ETO/MTG8
Oncoprotein-Familie representiert.
Die räumliche und zeitliche Expression dieser Gene wurde untersucht
mittels whole mount in situ Hybridisierung und RT-PCR. Funktionelle Analysen
konzentrierten sich auf XCL-2 und XETOR.
Überexpresssionsexperimente des Wildtypes XLC-2 deuten darauf hin, dass
dieses Gen beteiligt ist an Gastrulationsbewegungen und der sog. konvergenten
Extension während der Gastrulation und Neurulation. Überexpression einer
dominant negativen Mutante resultierte in einem Phänotyp, der morphologisch
ähnlich, aber histologisch unterschiedlich zu dem Typ der Überexpression des
Wildtypes XCL-2 ist. Der annormale Phänotyp der Mutante kann gerettet
werden (rescued) durch gleichzeitige Injektion des Wildtyps XCL-2. Diese
Ergebnisse deuten darauf hin, dass XCL-2 eine wichtige Rolle in der
konvergenten Extensionsbewegung während der Embryogenese bei Xenopus
laevis spielt.
X E T O R  wird während der Neurulation in Form von 3 bilateral
symmetrischen Streifen auf jeder Seite der dorsalen Mittellinie exprimiert, ein
Muster ähnlich zu dem der Gene, die beteiligt sind in der primären Neurogenese.
Tatsächlich führt die Überexpression von XETOR  oder einer Reihe von
Rumpfmutanten (truncated) zu einer Inhibition der primären Neuronbildung
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ohne Veränderung der Neuralplatte. Ein solcher Inhibitionseffekt wird nicht
durch laterale Inhibition bewirkt, sondern durch eine unabhängige,
eigenständige Aktion. Darüber hinaus konnte gezeigt werden, dass XETOR und
laterale Inhibition antagonistisch wirken. Weiterhin ergaben sich Hinweise, daß
die Expression von X E T O R  aktiviert oder gefördert wird durch die
Überexpression proneuraler Gene wie Xngnr-1, Xash-3 und XNeuroD, und daß
umgekehrt die Überexpression von XETOR die Expression und die Funktion von
Xath3 und XNeuroD inhibiert. Die Neuroninduktionsaktivität, aber nicht die
Expression, von Xash-3  wird inhibiert in Abhängigkeit zur X E T O R
Überexpression, während weder die Expression, noch die Funktion von Xngnr-1
igehemmt wird. Das zeigt, dass eine negative Rückkoppelung (negative
feedback loop) etabliert ist zwischen XETOR und proneuralen Genen. Die
Blockade der XETOR-Funktion in vivo ergibt einen neurogenen Phänotyp mit
vergrößerter neurogener Domäne, ohne Veränderungen der Neurondichte. Trotz
gleichzeitiger Ausschaltung von XETOR und der lateralen Inhibition kommt es
zur primären Neuronformation mit einer erhöhten Dichte in vergrößerten
Domänen. Auf der Basis dieser Daten kann angenommen werden, dass XETOR
während der primären Neurogenese eine wesentliche Rolle bei der primären
Neurogenese via Repression der Expression und Funktion proneuraler Gene
spielt.
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7. SYNOPSIS
7.1 Eine kurze Darstellung der frühen Embryogenese und das Ziel
dieser Untersuchungen
Effektive entwicklungsbiologische Untersuchungen sind eng korreliert mit
einem geeigneten Modellsystem. Wegen der hohen Zahl der abgelegten Eier (ca.
1500 pro Weibchen) mit einer Eigröße (1-2 mm im Durchmesser) und einer
schnellen embryonalen Entwicklung ist der afrikanische Krallenfrosch Xenous
laevis besonders geeignet für das Studium der Wirbeltierentwicklung. Dies war
auch der Grund, warum gerade mit diesem Modellsystem große zellbiologische
und molekulargenetische Fortschritte erzielt wurden.
Verschiedene zentrale Ereignisse während der Embryonalentwicklung sind
durch elegante Studien belegt. Vor der Befruchtung weist das Xenopus-Ei eine
animale-vegetative Polarität auf. Durch die Befruchtung ergibt sich eine neue
dorsal ventrale Polarität, die sich durch die corticale Rotation und Akkumulation
von β-catenin auch auf der Dorsalseite ergibt (Moon und Kimelman, 1998; De
Robertis et al., 2000). Eine dieser Konsequenzen ist die Formation des sog.
Nieuwkoop-Centers, das gebildet wird auf der dorsalen Seite der vegetativen
Zone (Nieuwkoop, 1952; Nieuwkoop, 1973). β-catenin ist die erste Komponente
des Signalweges, die erforderlich ist, für die Formation der dorsalen
Achsenformation und die Dorsalisierung der drei Keimschichten. Ein Zwei-
Stufen-Modell wurde für die Induktion des Entoderms vorgeschlagen (Yasuo
und Lemaire, 1999; Yasuo und Lemaire, 2001), in dem der maternale
Transkriptionsfaktor VegT eine wichtige Rolle spielt. Mesoderm wird durch 3
Signale determiniert (Dale and Jones, 1999; Chan und Etkin, 2001) bzw. auch
verschiedentlich als Zwei-Signal-Weg definiert (De Robertis et al., 2000). Das
erste Signal geht aus vom ventralen Entoderm und induziert ventrales
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Mesoderm, während das Nieuwkoop-Center ein zweites Signal abgibt, um das
dorsale Mesoderm zu induzieren. Ergebnis ist die Spemann-Mangold
Organisator Region. Der Organisator selbst vermittelt dann ein drittes Signal,
verantwortlich für das initiale Mesoderm. Veg1 und VegT sind beide als primäre
Kandidaten für die mesoderme Induktion angesehen (Dale et al., 1993; Thomsen
und Melton 1993; Kessler und Melton, 1995; Joseph und Melton, 1998; Zhang
et al., 1998; Kofron et al., 1999). Ektoderm leitet sich ab von den Zellen der
animalen Region. Dorsales Ektoderm in der Nähe des Organizers entwickelt
sich in die Neuralfalten, woraus sich das Zentrale Nervensystem entwickelt,
während aus dem ventralen Ektoderm Epidermis hervorgeht. Der BMP- und
Wnt-Signalweg spielt eine zentrale Rolle für die Organisation des Ektoderm. Im
dorsalen Ektoderm wird der BMP4 und Wnt Signalweg durch die Antagonisten
des Organisator inhibiert, so dass es sich in neuraler Richtung entwickelt,
während das ventrale Ektoderm mit aktiven (nicht blockiertem) BMP- und Wnt-
Signalweg Epidermis bildet (Chan und Etkin, 2001).
Die Entdeckung des Spemannschen Organisator ist ein Meilenstein in der
Entwicklungsbiologie. Die molekulare Natur des Organisators ist mittlerweile
genauer beschrieben worden. Prinzipielle Funktionen des Organisators sind
Körperachsenmusterbildung, neurale Induktion und Morphogenese (Harland
und Gerhart, 1997; Bouwmeester, 2001). Als erstes organisiert der
„Rumpforganisator“ die dorsale-ventrale Körperachse auf Grund der
Sezernierung von  Chordin, Noggin und Follistatin, die als dorsalisierende
Faktoren und Antagonisten zu BMP-4 das ventrale Mesoderm organisieren.
Zweitens, der „Kopforganisator“ organisiert die anteriore-posteriore Achse, in
dem es Cerberus, dkk-1 und Frzb-1 als Antagonisten zu den Wnt Glycoproteine
sezerniert. Drittens, zusätzlich zur Funktion als dorsalisierende Faktoren wirken
Chordin, Noggin und Follistatin auch als neurale Induktoren. Weiterhin
kontrolliert der Organisator komplexe morphogenetische Bewegungen (Harland
und Gerhard, 1997; Bouwmeester, 2001).
Obwohl einige Schlüsselmoleküle während der Xenopus-Entwicklung
charakterisiert worden sind und auch weitere Zusammenhänge während der
Embryonalentwicklung genauer beschrieben wurden, sind trotzdem eine große
Zahl von Genen in Struktur und Funktion unbekannt. Es wird angenommen,
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dass 50 000 Gene bei der Embryonalentwicklung von Xenopus laevis beteiligt
sind (Wolpert et al., 1998). Eine wichtige Methode ist es, Gene zu identifizieren,
die homolog zu Genen sind, die schon bei anderen Organismen beschrieben
wurden, so bei Drosophila und Maus. Ein weiterer Weg besteht darin, Gene aus
cDNA-Bibliotheken zu identifizieren, die aus spezifischen Stadien oder
Geweben erstellt wurden. Untersuchungen mit diesen Gen-Bibliotheken haben
zur Identifizierung von vielen Genen geführt, die eine genaue Kenntnis über die
frühe Embryonalentwicklung erlauben. Viele interessante Gene des
Spemannschen Organisatorbereiches wurden durch Erstellung einer dorsalen
Urmundlippen-Bibliothek erzielt (Bouwmeester et al., 1996) oder eine
Bibliothek aus Embryonen, die mit Lithium-Chlorid im Stadium 13 behandelt
wurden (Glinka et al., 1998). Andere Strategien beschäftigten sich mit der
Isolierung von Genen für sezernierte Proteinen (Klein et al. 1996; Jacobs et al.,
1997; Pera and De Robertis, 2000; Matsui et al., 2000; Tsuda et al., 2002) oder
DNA-binding Proteine (Mead et al., 1998).
Als weiterer viel versprechender Weg war die Konstruktion cDNA-
Bibliotheken, die aus Activin behandelten Ektoderm erstellt wurden. Dabei
wurde ein in vitro-System auf der Basis früherer Untersuchungen benutzt
(Grunz, 1969; Minuth und Grunz, 1980; Grunz, 1983; Grunz und Tacke, 1989).
Dabei wurden disaggregierte Ektodermzellen  der animalen Kappe des Stadium
8-9 mit hohen Konzentrationen von Activin behandelt, die sich darauf hin in
homogener Weise in Entoderm ähnlichen Strukturen überwiegend in Chorda-
Gewebe differenzierten. Die aus Entoderm-ähnlichen Gewebe konstruierte
cDNA-Bibliothek wurde nach neuen Genen durchsucht. Das
Expressionsmusters war bei 3 Genen besonders interessant: XODC2, XCL-2 und
XETOR. Deshalb erfolgte eine weitere Analyse ihrer Funktion während der
Embrogenese (eine detaillierte Darstellung der angewandten Techniken findet
sich unter Material und Methode der Dissertation.
7.2 Identifizierung von XODC2, XCL-2 und XETOR
Eine im großen Maßstab (large-scale) durchgeführte whole mount in situ
Hybridisierung ergab insgesamt 384 Klone, von denen 29 ein sehr interessantes
whole mount in situ Expressionsmuster aufwiesen. Im Vergleich mit Sequenzen
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in Gen-Banken konnte gezeigt werden, dass unter den 29 Klonen 11 homolog
waren zu schon bekannten Genen von Xenopus laevis, mit über 90% Identität; 9
wiesen Homologien  zu anderen Spezies auf, z.B. Mensch. Die übrigen 9 Klone
wiesen geringe Sequenzidentität auf (siehe Tabelle 3.1). Aufgrund des
interessanten whole mount in situ Expressionsmusters wurden 3 Klone
ausgewählt, 18D11, 18G11 und 18H2 für weitere Untersuchungen.
Eine cDNA-Sequenz von 1842 bp wurde erhalten für den Klon 18D11. Die
1368 bp des offenen Leserahmens (ORF) ergaben 456 Aminosäuren (Abb.
3.1A). Vergleichende Untersuchungen im BLAST-Programm zeigten, dass das
Protein 66% Identität in der Aminosäure-Sequenz mit der ubiquitären Ornithine
Decarboxyglase (ODC) im Menschen, 65% in Xenopus laevis und Ratte und
63% im Huhn aufwies (Abb. 3.1B). Die Schlussfolgerung war, dass es sich um
ein Paralogue des Xenopus ubiquitären ODC handelte (XODC1; Bassez et al.,
1990.). Deshalb wurde diese cDNA bezeichnet als XODC2 (Accession Nr.
AF217544).
Anwendung von 5’RACE (Rapid Amplification der cDNA Enden;
Frohmann et al., 1988), beim Klonen 18G11 wurde eine cDNA Sequenz von
2639 bp mit einem kompletten ORF, eine große Calpain Proteine Untereinheit
erhalten (Abb. 3.2A). Das Protein war am nächsten verwandt mit dem
Rattenmagen-spezifischen m-type Calpain nCL-2 (Sorimachi et al., 1993), mit
64% Identität auf dem Aminosäure-Niveau und ubiquitären m-typ Calpains in
Spezies wie Mensch, Huhn, beide mit 60% Identität (Abb. 3.2B). Weiterhin hat
das Protein exakt die gleiche Domänstruktur, Kalzium-Bindungsmotiv (EF-
hands) und die drei aktiven Positionen (Cys 105, His 262 und Asn 286) in der
proteolytischen Domäne wie in anderen typischen Calpains (Abb. 3.3). Deshalb
wurde es bezeichnet als Xenopus CL-2 (XCL-2) (Accession Nr. AF212199).
Mittels 5’RACE wurde bei Klon 18H2 eine cDNA-Sequenz von 2936 bp
mit einem kompletten ORF erhalten (Abb. 3.4A). Die abgeleitete Protein-
Sequenz besteht aus 586 Aminosäuren mit einer Gesamthomologie von 72% zu
MTG8 ähnlichem Protein MTGR1, 59 % zu ETO beim Menschen und 29 % zu
Nervy in Drosophila (Abb. 3.4B). MTG8 (auch bekannt als ETO oder CDR) ist
ein Proto-Oncogen, weil es Fusionstranskripte repräsentiert, die bei akuter
myeloiden Leukämie mit der t(8;21) Translocation repräsentieren. XETOR in
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der Struktur ähnliche zu anderen ETO/MTG8 verwandten Proteinen hat vier
konservierte Nervy homologe Regionen und zwei Zink-Finger Motive (Abb.
3.4B). Es wurde deshalb bezeichnet als Xenopus ETO verwandtes Protein
(XETOR) und die Nukleinsäure-Sequenz wurde in der Gen-Bank mit der
Accession Nr. AF212198 angemeldet.
7.3 Zeitliche und räumliche Expression von XODC2, XCL-2 und
XETOR
Die räumliche Expression von XODC2 wurde im Bereich des animalen Pols
von Stadium 9 an mittels whole mount in situ Hybridisierung nachgewiesen
(Abb. 3.5D, E). Während der Neurula-Stadien finden sich Signale wohl in der
extremen anterioren als auch in der posterioren Region der dorsalen
Körperachse (Abb. 3.5F). Im Schwanzknospenstadium ist die Expression weiter
verschoben zur Kopf- und Schwanzregion (Abb. 3.5G, H, I, J, K).
Vergleichende Untersuchungen zeigen, dass XODC1 im Gegensatz zu XODC2
ubiquitär im ganzen Embryo während der Embryonalentwicklung verteilt ist
(Abb. 3.5L, M, N). RT-PCR konnte zeigen, dass Transkripte von beiden
XODC1 und XODC2 bereits im unbefruchteten Ei vorhanden sind und das
Expressions-Niveau von XODC1 auf dem gleichen Niveau in allen Stadien
bleibt, während sich die Expression von XODC2 ab Stadium 9 bis zum
Schwanzknospenstadium kontinuierlich erhöht (Abb. 3.6).
Die räumliche Expression von XCL-2 wurde zuerst nachgewiesen in der
Zone der ventralen Urmundlippe im Stadium 12,5 (Abb. 3.7A). In der späten
Gastrula und Neurula ist das Gen  ausschließlich ventrale um den Urmund und
der mesodermen freien Zone des anterioren Bereiches der Neuralfalte exprimiert
(Abb. 3.7B, C, G). In späteren Stadien ist die Expression sichtbar in der
Haftdrüse (cement gland) und dem Proctodeum (Abb. 3.7D, E, F, H, I). Die
zygotische Transkription von XCL-2 wird erstmals nachgewiesen im Stadium 10
mittels RT-PCR (Abb. 3.8A). Weiterhin ist eine gewebespezifische Expression
zu beobachten. Im erwachsenen Gewebe werden unterschiedliche Expressionen
im Gehirn, Auge, Herz, Darm, Niere, Lunge, Magen und Hoden, aber nicht in
Leber, Muskel, Nerven, Ovar, Haut und Milz beobachtet (Abb. 3.8B).
XETOR Transkripte im Zentralennervensystem werden mittels whole mount
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in situ Hybridisierung innerhalb des dorsalen Ektoderm ab Stadium 12,5 in
einem Muster von radial symmetrischen Streifen seitlich der dorsalen Mittellinie
gefunden (Abb. 3.9A, B, D, E). In der anterioren Neuralplatte wird die
Expression in einer lateralen Gruppe von Zellen gefunden, die assoziiert sind
mit trigeminalen Ganglien, einer extreme anterioren Gruppe von Zellen
assoziiert mit der Riechplacode, einem zentralen Streifen, der die zukünftige
Gehirnregion und Region der anterioren neuralen Ganglienleisten-Zellen
bezeichnet (Abb. 3.9B, C, D). Doppelte in situ-Hybridisierung ergab, dass die
Expressionsdomäne von XETOR die Region von N-tubulin überlappt, aber
trotzdem breiter ist (Abb. 3.9H, I). Dieses Muster deutet darauf hin, dass
XETOR  ein Marker-Gen ist oder eine besondere Rolle bei der primären
Neurogenese spielt.
7.4 XCL-2 unterbricht die morphogenetischen Bewegungen
während der Embryogenese in Xenopus laevis
Der Wildtyp XCL-2 und eine dominant-negative Mutante, C105S, wurden
bei Überexpressionsexperimenten eingesetzt, um die Funktion von XCL-2
während der Embryogene zu studieren. Die Überexpression von XCL-2 ergibt
eine Verzögerung der Involution des Mesoderms. Die injizierte Embryonen
konnten den Urmund während der Gastrulation nicht schließen und ein großer
Dotterpfropf wurde in den nachfolgenden Entwicklungsstadien beobachtet (Abb.
3.11B). Dies ergab einen ganz charakteristischen Phänotyp (Abb. 3.11D). Dieses
Ergebnis lässt vermuten, dass Überexpression von XCL-2 den Verschluss des
Urmundes verhindert und die weiteren Gastrulationsbewegungen behindert.
Weiterhin wurde das Zell-Schicksal der betroffenen Embryonen mittels
mesodermaler oder neuraler Marker wie Xbra, Chordin, Xvent-1, XMyoD, Xotx2
und Xsox3 untersucht. Trotz ähnlich starker Expression ergaben sich
Unterschiede in der Versuchsserie und den Kontrollen in der Lokalisation der
einzelnen Marker. Dies deutet auf unterschiedliche Zellmigrationen hin (Abb.
3.12). Weiterhin konnte gezeigt werden, dass während der Gastrulation und
Neurulation das Mesoderm und die posteriore Neuralplatte nicht zur Mittellinie
hin bewegt wurden, wie dies aus der Translokation von Chordin, XMyoD und
Xsox3 ersichtlich wurde (Abb. 3.12). Diese Ergebnisse deuten darauf hin, dass
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XCL-2 beteiligt ist an der sog. convergent extension während der Midgastrula-
Stadien.
In weiteren Überexpressionen-Studien mittels einer dominant-negativen
Mutante C105S, konnte gezeigt werden, dass XCL-2 benötigt wird für
morphogenetische Zellbewegungen. Die Überexpression von C105S und
Wildtype XCL-2 ergab ähnliche Phänotypen (offener Urmund und
Doppelschwanz) (Abb. 3.13B, D). Diese auf den ersten Blick sich
widersprechende Ergebnisse konnten gedeutet werden, durch die Beobachtung,
daß sowohl  eine Überexpression des Wildtypes XCL-2 bzw. die Inhibition
(partielle oder totaler Verlust von Funktionen (loss-of-function)) durch die
dominant-negative Mutante C105S ähnliche Störungen der morphogenetischen
Bewegungen bewirkt. Diese Ergebnisse sind in Übereinstimmung mit den
Ergebnissen anderer Gene, wo die Überexpression sowohl des Wildtyps und der
Rumpfform (truncated) von Wnt11 (Tada und Smith, 2000) oder Frizzled-7
(Djiane et al., 2000), ebenso die konvergente Extension inhibieren und ähnliche
Phäntoypen hervorrufen. Andererseits zeigen die histologischen Schnitte von
Embryonen, in  die C105S injiziert wurden, im Gegensatz zur Wildtyp XCL-2
Überexpressionen (Abb. 3.11E, F) eine zweigeteilte Chordamißbildung
aufwiesen (Abb. 31.3F, G). Eine Restauration dieses Phänotypes (rescue-
Experiment) kann durch Koinjektion durch XCL-2 und C105S mRNA erreicht
werden (Abb. 3.13E; Tabelle 3.2). Diese Ergebnisse deuten daraufhin, dass die
Mutante spezifisch unter in vivo-Bedingungen durch Kompetition mit Wildtyp-
Proteinen für proteolytische Substrate wirkt. Zusammenfassend kann man sagen,
dass die Daten vermuten lassen, dass XCL-2 eine Voraussetzung für geordnete
morphogenetische Bewegungen während der frühen Embryogenese in Xenopus
laevis darstellt. Es ist höchstwahrscheinlich, daß  Calpain die Zellbewegungen,
durch Veränderungen der Zelladhesitionsaktivität via proteolytischen Spaltung
von Proteinen reguliert, die essential für die Morphogenese sind.
7.5 XETOR ist ein Schlüssel Inhibitionsfaktor während der primären
Neurogenese
Die Funktion von XETOR in vivo während der primären Neurogenese wurde
erkennbar durch Expression von Markergenen für primären Neuronen wie N-
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tubulin und Xaml, die als Antwort auf die Überexpression von XETOR oder
Rumpfmutanten inhibiert wurden (Abb. 3.14A, C, E). Diese Inhibition ist
keineswegs das Ergebnis einer Störung der Neuralplattenformation wie es durch
die normale Expression von Xsox3 gezeigt werden konnte (Abb. 3.14D).
Andererseits, wenn die XETOR-Aktivität durch die Injektion von antisense
Morpholino Oligo MOXETOR inhibiert wurde, ergab sich ein neurogener
Phänotyp mit vergrößerter neurogenen Domäne. Die Dichte der primären
Neurone war jedoch nicht signifikant erhöht (Abb. 3.16A). Da die laterale
Inhibition einen prinzipiellen Mechanismus darstellt, um die Zahl der primären
Neurone zu kontrollieren (Chitnis et al., 1995), wäre es von Interesse zu sehen,
was passiert, wenn sowohl XETOR und die laterale Inhibition ausgeschaltet
werden. In der Tat wurde ein Phänotyp einer vergrößerten neurogenen Domäne
mit vergrößerter Dichte der primären Neurone beobachtet (Abb. 3.16E). Diese
Beobachtungsteht im Gegensatz zu dem Phänotyp, der hervorgerufen wird durch
den Verlust von XETOR (vergrößert neurogene Domäne mit unveränderter
Dichte mit Neuronen, Abb. 3.16A) oder durch die Ausschaltung der lateralen
Inhibition (vergrößerte Dichte der Neuronen bei unveränderter neurogener
Domäne, Abb. 316D). Diese Daten sind ein solider Beweis dafür, dass XETOR
benötigt wird für die korrekte Musterbildung der primären Neurogenese.
Im nächsten Schritt wurde die Korrelation zwischen XETOR und laterale
Inhibition weiter untersucht, um nachzuweisen, ob die Funktion des ersteren
Gens durch das letztere beeinflusst wird. Einige Tatsachen deuten darauf hin,
dass dies nicht der Fall ist. Erstens, die Expression des Liganden-Gens X-Delta-
1 wurde herabgesetzt in Abhängigkeit der Überexpression von XETOR (Abb.
3.17A), und umgekehrt die Expression von XETOR wurde verringert durch den
aktivierten Notch-Signalweg (Abb. 3.17B). Außerdem, wenn die laterale
Inhibition blockiert ist, wird die XETOR Expression gesteigert (Abb. 3.17C).
Deshalb stellt die laterale Inhibition und XETOR ein Antagonistenpaar dar.
Weiterhin inhibiert XETOR effektiv N-tubulin in der Abwesenheit der lateralen
Inhibition (Abb. 3.17D). Der dritte Hinweis ist, dass die Expression, der Notch-
Zielgene ESR1 und XNAP, nicht beeinflusst wird, sowohl in Anwesenheit (Abb.
3.17E, F) wie in Abwesenheit von XETOR (Abb. 3.17G, H). Diese Ergebnisse
deuten darauf hin, dass XETOR und die laterale Inhibition Antagonisten sind,
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aber unabhängig voneinander agieren.
Im nächsten Schritt wurde die gegenseitige Regulation zwischen XETOR
und proneuralen Genen untersucht. Die Überexpression von proneuralen Genen,
Xngnr-1 (Abb. 3.18A), Xath3 (Abb. 3.18B), Xash-3 (Abb. 3.18E) oder XNeuroD
(Abb. 3.18H) aktiviert die ektopische Expression von XETOR. Umgekehrt
inhibiert überexprimiertes XETOR die Expression von Xath3 (Abb. 3.18D) und
XMyT1 (Abb. 3.18G), aber nicht die Expression von Xngnr-1 (Abb. 3.18C) und
Xash-3 (Abb. 3.18F). Außerdem wurde beobachtet, dass die Neuronen-
Induktionsaktivität von XMyT1 (Abb. 3.19B), Xath3 (Abb. 3.19D), XNeuroD
(Abb. 3.19F) oder Xash-3 (Abb. 3.19K) ausgeschaltet wurde, als Antwort auf
eine XETOR  Überexpression. Doch bleibt die Funktion von Xngnr-1 in
Anwesenheit von überexprimierten XETOR intakt (Abb. 3.19I). Die Ergebnisse
weisen darauf hin, dass XETOR aktiviert wird durch proneurale Gene und in
Folge die Funktion der spät exprimierten proneuralen Gene unterdrückt wird wie
XNeuroD, aber nicht die frühexprimierten wie Xngnr-1. Das bedeutet, dass eine
negative Rückkoppelung etabliert wird zwischen XETOR und proneuralen
Genen. Die negative Rückkoppelung ist trotzdem unterschiedlich von derjenigen
proneuralen Gene und lateralen Inhibition, in der Form, dass die laterale
Inhibition die Funktion der frühexprimierten Gene wie Xngnr-1 unterdrückt,
während sie ineffektiv ist für die spätexprimierten Gene wie XNeuroD. Dies
bedeutet, daß die laterale Inhibition (Stadium 11,5) früher aktiviert wird als
XETOR (Stadium 12,5), mit der Schlussfolgerung das die laterale Inhibition und
XETOR nacheinander während der primären Neurogenese wirksam werden.
Auf der Basis der oben dargestellten Ergebnisse, postulieren wir ein neues
Modell für die primäre Neurogenese. Die in einer Richtung ablaufenden
Cascade Xngnr-1-Xath3-XNeuroD stellt den Hauptweg der Neurogenese dar.
Die Expression von Xngnr-1 repräsentiert die proneuralen Domäne, wo die
primäre Neurogenese stattfinden wird. Gleichzeitig aktiviert es die laterale
Inhibition ebenso wie XMyT1 und Xath3 oder andere proneurale Gene für die
endgültige neuronale Zelldetermination (Bellefroid et al., 1996; Takabayashi et
al., 1997; Dubois et al., 1998; Perron et al., 1999). Dieser Mechanismus
determiniert die korrekte Zahl der primären Neurone. Deshalb wird XETOR
aktiviert durch proneurale Gene und zeigt die volle Funktion zu der Zeit, wenn
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die Neuronendifferenzierung beginnt. Durch Repression der Expression und
Funktion der spät exprimierten proneuralen Gene, begrenzt XETOR deshalb die
Domäne der primären Neurogenese in einem sehr limitierten Bereich.
Zusammenfassend kann gesagt werden, dass die laterale Inhibition und XETOR
einen dualen Inhibitionsmechanismus darstellen, um die genaue Zahl und
Lokalisation der Neuronen während der primären Neurogenese zu
gewährleisten.
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